Medications and meanings in Maori households with chronic illnesses by Carlson, Teah
 
 
 
http://waikato.researchgateway.ac.nz/ 
 
 
Research Commons at the University of Waikato 
 
Copyright Statement: 
The digital copy of this thesis is protected by the Copyright Act 1994 (New Zealand). 
The thesis may be consulted by you, provided you comply with the provisions of the Act 
and the following conditions of use:  
 Any use you make of these documents or images must be for research or private 
study purposes only, and you may not make them available to any other person.  
 Authors control the copyright of their thesis. You will recognise the author’s right to 
be identified as the author of the thesis, and due acknowledgement will be made to 
the author where appropriate.  
 You will obtain the author’s permission before publishing any material from the 
thesis.  
 
 Medications and meanings in Māori households with 
chronic illnesses 
 
By 
 
Teah Anna-Lee Carlson 
 
A thesis submitted to the University of Waikato 
in the fulfilment of the requirements for the degree 
of 
 
Master of Applied Psychology 
 
The University of Waikato 
Te Whare Wānanga o Waikato 
2010
ii 
 
 
 
 
 
 
 
 
 
 
I dedicate this thesis to my tāne Caleb  
and our beautiful boy Òkaire 
  
  
iii 
 
ABSTRACT 
Domestic spaces have always featured as sites for health care. The home is 
increasingly referred to as a new therapeutic space within which chronic illnesses 
are managed within everyday life. This research explores the meanings and use of 
medications within four Māori households containing at least one chronically ill 
householder.  A broad ethnographic approach was used to capture popular 
understandings and medication use in daily life.  Multiple methods were used, 
including group discussions with household members, individual interviews, 
household mapping, and photographic and diary elicitation tasks.  Findings shed 
light on the sources and uses of medications, householder knowledge of 
medications, communal practices of sharing, caring, rationalising use, grappling with 
side-effects and the management of illness. I consider what it means for 
householders to take medications themselves or give these to others, and the care-
giving practices that feature in the everyday consumption of medicines.  The 
research is based on the premise that medications are material objects with 
therapeutic uses that enter into and take on meaning within people‟s lives.  
Medications become culturally embedded phenomena that carry meanings and 
shape social relationships and practices with Māori households.  As such, 
medications were used in a way that reflected the cultural values and bonds within 
the households.  Within household relationships, medications were invested within 
meaning to show aroha, support and care.  Within a Māori whānau context, the 
values of maanakitanga, rangatiratanga, and whanaungatanga were recognised as 
having an integral role in understanding the social practices with medications in each 
household. 
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MÁORI GLOSSARY 
Aroha Affection, compassion, love 
Hapū Kinship group, clan, sub-tribe 
Harakeke New Zealand flax, native plant with long, stiff, 
upright leaves and dull red flowers. 
Hōhā Tiresome, bored 
Iwi Extended kinship group, nationality 
Kia ora Hello 
Kōhanga Reo Māori language preschool 
Kotahitanga A movement for self-government and 
national unity among Māori kinship groups 
during the 19th Century 
Kōwhai Small-leaved native trees noted for their 
hanging clusters of large yellow flowers in 
early spring 
Mana Prestige, authority, control 
Manaakitanga Hospitality, kindness, caring 
Manaakitia To support, take care of, give hospitality to  
Mātauranga Education, knowledge, wisdom 
Mauri ora Breath of life, life principle, special nature 
Pākehā New Zealander of European descent 
Pōhutukawa New Zealand Christmas tree, bear large, red 
flowers and have leaves which are velvety-
white underneath 
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Pupuri  To hold, retain possession of, keep 
Pūriri A large spreading tree, having hand-shaped 
glossy leaves with 3-5 'fingers' and wavy 
margins, has pinkish-red flowers 
Rangatiratanga Sovereignty, chieftainship, right to exercise 
authority 
Rongoā Medication, remedy, drug 
Taonga Property, goods, possessions 
Te Ao Māori The Māori worldview 
Tikanga Correct procedure, custom 
Tohatohatia Capacity of whānau to share resources 
Tūranga Stand, position, situation 
Wairuatanga Principles associated with a spiritual 
embodiment 
Waka Allied kinship groups descended from the 
crew of a canoe which migrated to New 
Zealand 
Whakamana To give authority to 
Whakapapa Genealogy, lineage, descent 
Whakatakato Wise management and development of 
whānau resources 
Whānau Extended family, family group, a familiar term 
of address to a number of people 
Whanaungatanga Relationship, kinship, sense of family 
connection 
Whāngai Foster child, adopted child
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MEDICAL GLOSSARY 
Accuretic Trade name for the combination medication, 
containing a fixed amount of quinapril and 
hydrochlorothiazide. The ace inhibitor widens 
blood vessels making it easier for the heart 
to pump blood, while the diuretic makes the 
kidneys pass more water and salt while 
retaining more potassium, which helps 
reduce high blood pressure. 
Agents affecting the  
Renin-Angiotensin System Class of medication used in the treatment of 
renal hypertension and predisposes patients 
to progressive chronic kidney disease and 
highly effective in lowering blood pressure in 
patients with essential hypertension. 
Antipsycholotics Tranquilising psychiatric medication which is 
primarily used to manage psychosis 
(including delusions or hallucinations, as well 
as disordered thought), particularly in 
schizophrenia and bipolar disorder. 
Antiulcerants Group of medications used in the prevention 
and treatment of ulcer disease by providing 
reduction in the production of gastric acids. 
Arthritis Group of conditions involving damage to the 
joints of the body. 
Aspirin Medication used long-term, at low doses, to 
help prevent heart attacks, strokes, and 
blood clot formation. 
Atopic Eczema  Inflammatory chronically relapsing, non-
contagious and pruritic skin disorder. 
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Beclazone Medication, which is a metered dose aerosol 
inhaler which delivers 50 micrograms of 
beclomethasone dipropionate. 
Benazepril Medication used to treat high blood pressure 
(hypertension), congestive heart failure, and 
chronic renal failure. 
Benzodiazepine Medication used to enhance the effect of the 
neurotransmitter gamma-aminobutyric acid, 
which results in sedative, hypnotic (sleep-
inducing), anxiolytic (anti-anxiety), 
anticonvulsant, muscle relaxant and amnesic 
action.  It is useful in treating anxiety and 
insomnia. 
Beta Adrenoceptor Blockers Class of medication used for various 
indications, but particularly for the 
management of cardiac arrhythmias, 
cardioprotection after myocardial infarction 
(heart attack), and hypertension. 
Blood Glucose Levels Medical term for the amount of glucose 
(sugar) present in the blood. 
Blood Pressure Medical term used to describe the pressure 
exerted by circulating blood upon the walls of 
blood vessels, and is one of the principal vital 
signs. 
Bronchodilator Medication that dilates the bronchi and 
bronchioles, decreasing airway resistance 
and thereby facilitating airflow. 
Bumetanide Loop diuretic medication, used to treat heart 
failure.  It is often used in patients in whom 
high doses of furosemide are ineffective. 
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Calcium Dietary supplement that is used to prevent 
and to treat calcium deficiencies. 
Cervical Cancer Medical term to describe a malignant 
neoplasm (cancer) in the neck of the uterus 
or uteri, which opens into the vagina. 
Cholesterol Waxy steroid metabolite found in the cell 
membranes and transported in the blood 
plasma. Cholesterol is an important 
component for the manufacture of bile acids, 
steroid hormones, and fat-soluble vitamins.  
Chronic Asthma Medical term to describe a chronic 
inflammatory disease of the airways 
characterised by variable and recurring 
symptoms, airflow obstruction, and 
bronchospasm. 
Chronic Hay Fever Medical term to describe an allergic reaction 
to pollen or dust.  When an allergen is 
inhaled by an individual with a sensitised 
immune system, it triggers antibody 
production. 
Cranberry Dietary supplement used to prevent urinary 
tract infections. 
Digoxin Medication used in the treatment of various 
heart conditions, namely atrial fibrillation, 
atrial flutter and sometimes heart failure that 
cannot be controlled by other medication. 
Diuril Diuretic medication used to manage excess 
fluid associated with congestive heart failure. 
Dysphasia Medical term to describe a language disorder 
in which there is an impairment of any 
xv 
 
language modality. This may include difficulty 
in producing or comprehending spoken or 
written language. 
Epilepsy Medical term used to describe a chronic 
neurological disorder characterised by 
recurrent unprovoked seizures.  These 
seizures are transient signs and/or 
symptoms of abnormal, excessive or 
synchronous neuronal activity in the brain. 
Ferrograd C Medication which is used as an iron 
preparation containing ferrous sulphate and 
vitamin C. 
Fibrillating Heart Condition Medical term used to describe an autosomal 
dominant heart condition that causes 
disruptions in the heart's normal rhythm. 
Fluid Retention Medical term used to describe abnormal 
accumulation of fluid in the circulatory 
system or within cavities of the body. 
Fluoxicillin Sodium Antibiotic medication which is used to fight 
skin infections, where it kills bacteria or 
inhibits their growth. 
Furosemide Loop diuretic medication used to treat 
hypertension and edema often due to 
congestive heart failure or renal insufficiency. 
Gall Bladder Small organ that aids digestion and stores 
bile produced by the liver. 
Gangrene Medical term used to describe the death of 
an area of the body. It develops when the 
blood supply is cut off to the affected part as 
a result of various processes, such as 
xvi 
 
infection, vascular (pertaining to blood 
vessels) disease, or trauma. 
Glipizide Anti-diabetic medication used to lower the 
glucose levels in the blood. 
Glycerine Cetomacogol Medicated topical cream used to soften skin 
and moisturise.  It is used to correct dryness 
and scaling of the skin. 
Heart Attack Medical term used to describe when blood 
flow to a section of the heart muscle 
becomes blocked.  If the flow of blood is not 
restored quickly, the section of heart muscle 
becomes damaged from lack of oxygen and 
begins to die. 
Hepatitis C Medical term used to describe an infectious 
disease affecting the liver, caused by the 
hepatitis C virus (HCV). 
Indapamide Medication used in the treatment of 
hypertension, as well as decompensated 
cardiac failure. 
Insulin Hormone that is central to regulating energy 
and glucose metabolism in the body. 
Levothyroxine Medication which is a synthetic form of 
thyroxine (thyroid hormone), used as a 
hormone replacement for patients with 
thyroid problems. 
Lipids Broad group of naturally occurring molecules 
which includes fats, waxes, sterols and fat-
soluble vitamins. 
xvii 
 
Locoid Cream  Trade name for medicated cream which is 
used as a topical steroid. Used in the 
treatment of rash, eczema, and dermatitis. 
Mastectomy Medical term for the surgical removal of one 
or both breasts, partially or completely.  
Mastectomy is usually done in the treatment 
or prevention of breast cancer. 
Metformin Oral anti-diabetic medication.  It is the first-
line medication of choice for the treatment of 
type II Diabetes. 
Mirtazapine Medication which is a tetracyclic 
antidepressant used primarily in the 
treatment of depression.  It is also used as a 
hypnotic, antiemetic, and appetite stimulant, 
and for the treatment of anxiety, among other 
indications. 
Moduretic Medication used in the treatment of 
hypertension and congestive heart failure. 
Contains a combination of amiloride and 
hydrochlorothiazide. 
Nitrofurantoin Antibiotic medication usually used in treating 
urinary tract infection. 
Omeprazole Medication which is a proton pump inhibitor 
used in the treatment of dyspepsia. 
Painkiller Medication used to relieve pain (achieve 
analgesia). 
Panadol Trade name medication used as a mild pain 
reliever. 
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Peak Flow Meter Small, hand-held device used to monitor a 
person's ability to breathe out air. It 
measures the airflow through the bronchi and 
thus the degree of obstruction in the airways. 
Phenytoin Sodium Medication that acts to suppress the 
abnormal brain activity seen in seizure. 
Potassium Chloride Dietary supplement.  Potassium is vital in the 
human body and oral potassium chloride is 
the common means to replenish it. 
Prednisone Synthetic corticosteroid medication used as 
an immuno-suppressant, and affects virtually 
all of the immune system. It is used to treat 
certain inflammatory diseases and (at higher 
doses) cancer, but has significant adverse 
effects. 
Rheumatoid Arthritis Medical term used to describe a chronic, 
systemic inflammatory disorder that may 
affect many tissues and organs, but 
principally attacks synovial joints. 
Semi-incontinence Medical term used to describe the loss of 
regular control of the bowels. 
Simvastatin Sodium Hypolipidemic medication used to control 
hypercholesterolemia (elevated cholesterol 
levels) and to prevent cardiovascular 
disease. 
Steroid Medication which is given either in a short 
burst to stop serious asthma flare-ups or on 
a low dosage as maintenance for severe 
asthmatics to prevent symptoms. 
xix 
 
Stroke Medical term for the rapidly developing loss 
of brain function(s) due to disturbance in the 
blood supply to the brain. 
Symbicort Medication, which is a combination 
formulation containing budesonide and 
formoterol, used in the management of 
asthma and chronic obstructive pulmonary 
disease. 
Thyroid Gland One of the largest endocrine glands in the 
body.  The thyroid controls how quickly the 
body uses energy, makes proteins, and 
controls how sensitive the body should be to 
other hormones. 
Type I Diabetes Metabolic disorder used to describe a form of 
diabetes mellitus that results from 
autoimmune destruction of insulin-producing 
beta cells of the pancreas.  Type I diabetes is 
fatal unless treated with insulin. 
Type II Diabetes Metabolic disorder that is characterised by 
high blood glucose in the context of insulin 
resistance and relative insulin deficiency. 
Diabetes is often initially managed by 
increasing exercise and dietary modification. 
As the condition progresses, medications 
may be needed. 
Ulcer Medical term for a sore on the skin or a 
mucous membrane, accompanied by the 
disintegration of tissue. 
Urinary Tract Infection Reoccurring bacterial infection that affects 
any part of the urinary tract. 
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CHAPTER ONE: INTRODUCTION 
Medications are one of the most widely used medical technologies, both 
for treating illness and for sustaining health.  They also carry a significant 
cost to the health care system.  PHARMAC reports the community drug bill 
for the year June 2008-June 2009 at $653 million, which is a $17.6 million 
increase on spending compared to the previous year (PHARMAC, 2008).  
Government subsidies on medications administered by PHARMAC are 
widening every year, with eight new medications being introduced in the 
2008/09 period and with an estimated 30,400 new patients. 3.1 million 
New Zealanders receive taxpayer funded medications and over 35.1 
million prescriptions were written in 2007 (PHARMAC, 2008).  The top six 
expenditure groups for medications were Lipid modifying agents, used for 
raised cholesterol levels at a total cost of $63.47 million; Antipsycholotics, 
used for mental health disorders at a total cost of $61.58 million; 
Antiulcerants, used to treat heart burn and stomach ulcers at a total cost of 
$43.42 million; Beta Adrenoceptor blockers, used to treat heart disease at 
a total cost of $32.01 million; Agents affecting the Renin-Angiotensin 
System, used to treat raised blood pressure at a total cost of $31.19 
million; and Diabetes medications, used to treat both Type I and II 
Diabetes at a total cost of $31.06 million. 
Considerable research has been devoted to issues such as adverse drug 
reactions, side-effects, and compliance (Barter & Cormack, 1996; 
Campbell, McCosh, & Reinken, 1983; Carrick, Mitchell, Powell, & Lloyd, 
2004; Conrad, 1985; Ingersoll & Cohen, 2008).  Despite studies showing 
that medicines are often not taken as intended by health professionals 
(Schoen, Downey, & Osborn, 2003), we know little about what happens 
with medications when taken home; why people do what they do with 
medications; or how medications are understood by people.  Although 
more than 200 variables have been studied, none could be considered 
consistently predictive of compliance behaviours (Vermeire, Hearnshaw, 
Van Royen, & Denekens, 2001).  Compliance to prescribed medications is 
an ever present and complex problem. This is particularly prevalent for 
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those with chronic illnesses as they may have multiple symptoms, take 
high dosages of medication, face long-term treatment and take multiple 
medications (Wilson, Hutchinson, & Holzemer, 2002). 
Research into the everyday meaning and use of medications is sporadic. 
However, what literature there is provides insights relevant to my study. 
Pound and colleagues (2005) synthesised studies on medicine taking and 
identified three styles of users; those who accepted medicines readily, 
those who accepted medicines reluctantly, and those who resisted 
medicines, with each style leading to different medication usage.  
Shoemaker and Ramalho de Oliveira (2008) reviewed studies of 
medication use experience, concluding that different meanings given to 
medications were important for explaining variations in medication 
practices and needed to be taken into account by health professionals.  
Such studies provide useful indications of the complexities of meanings 
and everyday practices surrounding medication use. 
My thesis is based on the premise that medications are material objects 
with therapeutic uses that enter into, and take on meaning within people‟s 
lives.  They are culturally embedded phenomena that carry meanings and 
shape social relationships and practices.  As van der Geest and Harden 
(2006, p. 1) note “Things acquire meaning, when they enter into the life of 
people”.  I will investigate Māori households with people who have a 
chronic illness, to explore participant understandings of medications and 
their medication-taking practices.  The specific research aims are to: 
I. Explore householder knowledge of medications, how medications 
work, and what it means to take medication. 
II. Document social practices involving medications within households, 
such as how, when and where they are used, and how they are 
accessed and distributed. 
The primary objective of this research is to advance knowledge about the 
meanings of medications in Māori households and the socio-cultural 
practices that surround medication use. 
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Documenting a clear understanding of medication-taking practices for 
Māori, and how these are incorporated into their daily lives, may enhance 
efforts to support the health needs of Māori and the development of 
services and interventions that support whānau in the management of 
chronic illness. 
This chapter begins with an exploration of the literature on medications 
and chronic illness, providing an overview of the current health picture of 
Māori.  Next consideration was given to Māori cultural concepts and 
values and how these set a context for the meaning and use of 
medications within Māori households.  I then turn to the scholarly literature 
pertaining to chronic illness experiences, discussing its impact on identity, 
biography and goals, and the ways in which people approach treatment 
are examined within the context of the management of ailments with 
medications.  Next, I consider the processes of meaning making within a 
Māori social and cultural context.  This provides a framework for 
considering connections between assessing medications; medication 
knowledge; medication practices, including the perspective of compliance 
and medication related interactions, all of which contribute to the 
meanings of medications to individuals and their households. 
Māori and chronic illness 
In the last 40 years, almost all of today‟s medicines, medical equipment 
and medical technologies came into use (Weisbrod, 1991).  The new 
technologies have revolutionised the ways in which healthcare is 
practiced.  As the population ages the prevalence and diagnosis of chronic 
illness rises, diabetes, heart disease and asthma have become the leading 
cause of illness, disability and mortality (Gerritsen, Stefanogiannis, 
Galloway, & New Zealand Public Health Intelligence, 2008).  Today‟s 
health system remains overly devoted to dealing with acute and episodic 
healthcare needs. Concurrently, the treatment and long-term care and 
support for chronic illnesses are increasingly being met in domestic 
settings (Weisbrod, 1991).  
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Chronic illnesses are the leading cause of preventable morbidity and a key 
factor in life expectancy disparities between Māori and non-Māori 
populations (Gerritsen et al., 2008).  Chronic illnesses can function as 
barriers to independence, participation in the workforce and social 
functioning. Such ailments can have an adverse affect on patients and 
their families as they limit the daily lives of those affected and those who 
support or depend on them. According to a number of studies, Māori have 
different health outcomes in comparison to the general population.  When 
compared with people of European descent within the same income 
bracket, Māori were significantly less likely to; have seen a doctor when 
unwell, received adequate tests, and accessed medication (Schoen & 
Doty, 2004).  In the Portrait of Health (2008), statistics for Māori indicated 
that the prevalence of high blood pressure and diabetes was two-and-a-
half times higher for Māori than non-Māori.  Māori women had twice the 
likelihood of having ever been diagnosed with ischemic heart disease and 
were 40% more likely to be taking medication for asthma than women in 
the total population.  Māori children were four times more likely to die from 
asthma than New Zealand European children.  Māori men were 15% more 
likely to develop arthritis compared to men in the total population and they 
die up to 14 years earlier than other New Zealand men, often from heart 
disease. 
Research suggests that Māori do not receive the same health 
management support for chronic conditions.  For instance, Māori have 
significant difficulties in accessing specialist support for cancer when 
needed, and higher hospitalisation rates than non-Māori (Ministry of 
Health & Wellington School of Medicine, 2005).  Māori also have lower 
referral rates for surgical and specialist services than non-Māori and 
experience lower levels of quality hospital care than non-Māori (Ellison-
Loschmann & Pearce, 2006).  Diabetes (Baxter, 2002), heart disease 
(Westbrooke, Baxter, & Hogan, 2001), and cancer (Robson, Cormack, & 
Purdie, 2006) are all examples where Māori have delayed referral and 
treatment and received less intervention. 
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Socio economic status is another important factor when considering the 
prevalence of chronic illness among Māori.  People on low incomes are 
generally more likely to develop chronic illnesses (New Zealand National 
Advisory Committee on Health Disability, 2007).  Between 1981 and 2001, 
Māori were disproportionately represented in lower socio-economic strata 
and consequently, disproportionately affected by the health consequences 
of lower socio-economic status (Statistics New Zealand, 2007).  The 
management of chronic illnesses have significant financial deterrents that 
extend beyond direct health costs.  Households on lower incomes are 
more likely to enter into cycles of poverty and poor health (New Zealand 
National Advisory Committee on Health Disability, 2007). For example, 
living standards are lower among families with high numbers of doctor 
visits for illness, moreover these families become restricted in their social 
and economic participation due to a family member‟s serious health 
conditions (Ministry of Social Development, 2009). 
Māori face many disadvantages well beyond the health effects attributed 
to economic status.  Māori experience unequal access to the health 
system, which contributes to health inequalities between Māori and non-
Māori (Fawcett, 2006).  The decades of disparity report by the Ministry of 
Health, Wellington School of Medicine and Otago University (Fawcett, 
2006), found that Māori have poor access to resources and facilities, 
which help, prevent, treat and manage illness before it progresses to a 
chronic state.  Life expectancy has consistently increased in New Zealand 
since the 1950s; however, there remains an 8.6-year gap between Māori 
and non-Māori (Ministry of Social Development, 2009). Consequently, the 
health inequalities gap is widening between the Māori population and the 
general population (Ministry of Social Development, 2009). 
The prevalence of chronic illness among Māori is an on-going issue, and 
medications are a major part of the way in which technology is used to 
respond to chronic illness.  Presently no one has studied medications 
within Māori households, what meanings they give to their medications 
and how it affects social practices. Studies have been conducted on 
chronic illness among Māori in which they focus on specific aliments.  
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Examples include barriers to health care for those Māori diagnosed with 
diabetes (Baxter, 2002; Simmons, Weblemoe, Voyle, & Prichard, 1998), 
health seeking behaviour for Māori men with prostate cancer (Willams et 
al., 2003) and prevalence of lung cancer among Māori (Harwood, 
Aldington, & Beasley, 2005).  
The main findings of such studies include barriers to services for Māori, 
provider communication and patient knowledge.  A number of 
organisational issues were also identified including a lack of community-
based services, transportation difficulties, the timing and availability of 
services, appointment systems, the lack of appropriate educational and 
promotional material, and the universal Western approach. The universal 
Western approach to health care is based on the foundation that 
irrespective of wealth, socio economic status or ethnicity, people have 
equal access to services, ignoring obstacles that are faced by ethnic 
groups (Reid, Robson, & Jones, 2002).  Staffing issues were also raised 
such as the under-representation of Māori in the health professions. The 
characteristics of non-Māori health staff were critiqued including their 
perceptions of, and attitudes about Māori patients and a lack of 
appropriate provider-patient communication.  Further, personal or 
community level issues came to the fore highlighting the socio-economic 
position of many Māori making healthcare simply unaffordable.  Lastly, 
individuals may have had previous negative experiences with the 
healthcare system and/or perceptions of bias, such as non-Māori health 
services not being seen as acceptable or clients hearing negative 
comments from others. 
Illness can be conceptualised as encompassing both a physical disease 
and a person‟s subjective perception of the objectively defined disease 
(Radley, 1994).  Understandings of illness vary significantly around the 
world.  Of the thousands of published studies about illness, most discuss 
the notions of disease and illness within their different social, 
environmental and political contexts (Hughner & Kleine, 2004).  However, 
there are clear distinctions between definitions of illness and disease.  
Radley (1994) defined disease as the pathological changes in one‟s body, 
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and illness as the experience of disease and sickness as a social role that 
sufferers occupy in relation to the healthy.  Further, one may be ill, but not 
be considered to have a disease or to be sick; conversely, one may have 
a disease without feeling ill.  
The Ministry of Health (2004) defined chronic illness as “a physical or 
mental illness that has lasted, or is expected to last, for more than six 
months.  The symptoms may come and go or be present all the time” (p. 
4).  In the context of this research, chronic illness was defined as a long-
term, often permanent, and progressive illness, where an individual is in a 
state of poor health.  However, it is important to acknowledge that, an 
individual‟s subjective perception of their health status is a vital part of 
recognising if one has a chronic illness.   
Illnesses are understood and take shape within broader social, 
environmental and political contexts that partially shape everyday life. 
Illnesses affect the lives and daily routines, not only of the person who is 
ill, but also of people who are connected in any way to the affected person 
(Lyons & Chamberlain, 2006).  Health psychology has viewed chronic 
illness as a life crisis requiring change and adjustment, as people often 
need to make considerable adaptations in their lives.  Such adjustments 
include medication management, dietary and exercise changes and pain 
management (Radley, 1994).  These adjustments may also encompass 
psychological responses to the illness which are specific to their social 
situation, and context, identity changes, maintaining or changing ones 
personal appearance or self-image, sustaining social relationships with 
friends family and colleagues, and planning for an uncertain future (Lyons 
& Chamberlain, 2006). Despite these adjustments experienced by most 
chronic illness suffers, many do not seek formal assistance. Conversely, 
they rely on their own personal and social resources to find solutions 
(Herek, Costa, & VandenBos, 1990). These issues are clearly relevant to 
the ways in which Māori households experience, react to and manage 
illness in culturally patterned ways.  
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Culture, illness and medication  
Part of adjustment to, and management of, illness is culturally based. The 
fundamental characteristics of culture assume many forms varying from 
behavioural practices that are held and maintained between people such 
as family interrelationships, economic exchanges, material artefacts such 
as tools and building structures, to intangible concepts such as values and 
beliefs (Barnard & Spencer, 2002). Culture encompasses a system of 
shared beliefs, values, customs, behaviours (Ferraro, 2006) that often 
involve the use of material objects that take on cultural meanings and 
communicate shared values (Barnard & Spencer, 2002).    
Medications are cultural objects, their meaning, interpretation and use are 
the products of their specific cultural contexts.  When in the hands of 
particular groups, medications often take on new meanings .  In a Māori 
cultural context, the function of medications remains in many respects the 
same as in Pākehā culture to improve heath, medicate symptoms and 
ward off illness.  However, in terms of the use and social practices around 
medications, these objects come to represent cultural meanings and 
values.  For example, when a person is caring for another, such as a 
daughter caring for her elderly parent, an object such as a pill, which is 
exchanged and administered between the two people begins to present 
itself as a symbol of that relationship.  A relationship that is culturally 
defined and driven by cultural values like manaakitanga and 
whanaungatanga (Ritchie, 1992).  
A person‟s culture provides resources for making sense of the world and 
prescribes social roles for its members, shaping “how they show feelings, 
express emotions and distress, and experience conflict in behaviour, 
thought or action” (Baxter, 2002, p. 65).  To explore what medications 
mean to Māori households, consideration must be given to the cultural 
context of a Māori household. In the remainder of this section, the 
concepts of tikanga, whānau, whanaungatanga, maanakitanga, 
rangatiratanga and kotahitanga will be considered in relation to medication 
use. These concepts prescribe principles and wisdom Māori use in 
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everyday life to varying degrees, informing people‟s behaviours and 
governing responsibilities and relationships (Collins & Willson, 2008). 
Hirini (1997) identifies that Māori social structure is based on core values 
governed by tikanga.  Tikanga provides the guidelines, manners, rules and 
correct procedures that are developed and performed in the daily lives and 
practices of whānau.  Whānau are continually changing and evolving to 
adapt to modern society where values and beliefs are tested and 
reinforced.  The word whānau is used in a number of contexts and it is 
important to define what it means in terms of the relationships presented in 
Māori households. 
Whānau is a concept that is used by Māori with wide definition and 
reference (Metge, 1995).  Whānau is based on whakapapa and kinship 
ties, and provide an environment in which social knowledge and 
relationships is learned and maintained (Barlow, 1991).  Stewart-Harawira 
(1995) describes whānau as the foundation for Māori social interaction 
and social assimilation, which encompasses mātauranga Māori, mauri ora 
and tūranga Māori. 
The concept of whānau can be described as a definable object or 
structure based on descent, a cause or a collection of ideas (Metge, 
1995).  Whānau can be interpreted as a basic family structure with a 
mother, father and children.  It can also stretch to encompass extended 
family members such as aunties, uncles and cousins, partners and 
whāngai members (Broughton, 1993; Metge, 1995).  Another 
interpretation of whānau is based on genealogy or whakapapa, describing 
the ancestral link, including both patriarchal and matriarchal lines 
regardless of whether they are living or have passed away (Barlow, 1991).  
Metge (1995) also discusses how whānau is not limited to descent or 
whakapapa, but has an active component whereby whānau members are 
actively involved in the collective group.  The concept of whānau can also 
be described as a belief system of reciprocity and commitment to benefit 
members of that group, applying the whānau values of aroha, mutual 
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support, cooperation and unity (Gibbons, Temara, & White, 1994; Metge, 
1995). 
Whānau can include groups that have a common cause or interest such 
as, a school classroom, Kōhanga Reo and recreational group in which 
they are associated through common environments (Metge, 1995). 
Considering the various definitions of whānau, its description varies 
according to context (Metge, 1995).  Based on the household focus of this 
research whānau is referred to as a kinship network based on whakapapa, 
including spouses and whāngai members who actively participate in 
whānau activities. The practical implications of values within a whānau are 
vitally important to the interpretation of Te Ao Māori as whānau 
membership involves a range of roles, responsibilities, commitments, and 
a number of functions. 
Whānau is the fundamental kinship arrangement that supports the rearing 
of children in the Māori world.  Whanaungatanga refers to relationships we 
have with others, related by whakapapa or otherwise (Nikora, 2007).  
Whanaungatanga describes the bonds and commitments made to 
preserve the integrity and strength of the family.  The wellbeing and 
success of a person is reflected in their ability to support and nurture their 
whānau.  Furthermore, a strong healthy whānau is a reflection of its 
qualities and strength of the individual members. The bonds and 
commitments to other whānau members is an important component in 
explaining social relationships and behaviours. 
Hirini (1997) describes whanaungatanga as a value that strengthens the 
commitment whānau members have towards each other.  
Whanaungatanga provides structure within the social hierarchy, where it 
can help determine and identify individual‟s rangatiratanga by drawing on 
ancestral links to determine ones mana (Nikora, 2007).  Whanaungatanga 
is very significant as it both establishes, and sustains, tribal identity 
(Ritchie, 1992).  It is concerned with the acknowledgment and 
management of relationships and “gives meaning to these relationships 
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across time and place.” (Nikora, 2007, p. 77).  As a value, it is also 
influenced and boosted by the value of maanakitanga. 
The functional basis of whanaungatanga is the ability of the whānau to 
empower (whakamana) and encourage each other to reach their goals 
and contribute to the community.  Whanaungatanga encourages the 
whānau to guard and preserve its assets (pupuri taonga) for future 
generations, such as land, heritage and heirlooms (Durie, 2001).  
Whanaungatanga is also about the whānau‟s capacity to plan as it allows 
the whānau to see past present moments and to prepare for future 
challenges that they may face in order to revitalise, preserve and promote 
Māori culture, values and language (Durie, 2001). 
Manaakitanga is the practice of reciprocal caring.  Caring for another 
creates a sense of duty and responsibility whereby an individual is 
affirming they are a part of something larger than themselves; a part of a 
whānau.  The reciprocal nature of caring for another need not be repaid 
immediately, rather, there is simply faith that one day it will (Ritchie, 1992).  
The major components of manaakitanga include the act of loving concern, 
the gift of exchange and hospitality, an act of generosity and the gift that 
returns a gift.  Manaakitanga embodies much of the processes that occur 
when whānau members care for each other within their respective 
households (Hirini, 1997).  Manaakitanga describes the process in which 
one performs and expresses aroha, hospitality, mutual respect and 
generosity, while upholding the person‟s mana, as it has equal or greater 
importance than their own (Winiata, 2007). 
The functional basis of manaakitanga is the ability of the whānau to care 
(manaakitia) and share (tohatohatia), as the young and old are cared for, 
sick and disabled are looked after and those who require resources are 
replenished.  Maanakitanga encourages self-sacrifice for the betterment of 
the collective group. The capacity to share within the whānau depends on 
the generosity and sense of collective responsibility (Ritchie, 1992). 
Rangatiratanga, as mentioned above, can be determined through 
whakapapa whereby a person can hold status.  Ritchie (1992) explains 
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that rangatiratanga is not acquired by birth alone, but can also be obtained 
through respect by illustrating a certain skill and talent whereby it “draws 
from the spiritual dimension an additional boost of power or strength and 
mana” (Ritchie, 1992, p. 70). Rangatiratanga is about self-determination 
and self-agency, the capacity to control one‟s future and to decision-make 
in this regard.  Being self-determining within whānau is an important value 
in which recognises the importance of individuality, while respecting the 
value of kotahitanga, collective responsibility. 
Kotahitanga is described as the principals associated with a collective 
unity considering the complexity of status, history, kinship.  It is a central 
value that informs Māori culture in which it recognises individual‟s 
prominence while also considering the needs of the collective group.  The 
functional basis of Kotahitanga is achieved when whānau members invest 
time and energy in getting to know each other, work through differences 
and accepting responsibility for each other‟s actions (Metge, 1995). 
Collectively, these values can provide a basis of understanding the Māori 
cultural context, where it can inform household behaviours with varying 
degrees, as each Māori household can interpret and play out these values 
in different ways in relation to the use of medications. Medications are 
usually a necessary part of living with a chronic illness.  In a Māori cultural 
context, medications can hold individual and collective meaning, they can 
be understood as functional objects, to better and maintain health and 
prevent illness.  Within relationships, they can be invested within meaning 
to show aroha, affection and manaakitanga.  Interpreting such actions as 
aroha lies in the cultural context of the household, where Māori values are 
interpreted and practiced, providing insight and understanding into 
behaviour, practices, and responsibilities.   
Experiences of chronic illness  
The experience of chronic illness is an important part of understanding the 
broader context of a person‟s identity and life (Frank, 1995). It involves a 
process of learning, coping and the (re)negotiation of personal and 
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professional relationships.  Understanding the different ways in which 
people cope, manage and live with chronic illnesses can help inform the 
social context in which medications have meaning in the lives of people.  
The chronic illness experience begins with the individual circumstances 
that led them to being diagnosed with a chronic illness.  The journey can 
begin from the symptoms they experienced, or did not experience, through 
to the circumstances that led them to seeking medical attention.  These 
can be influential factors towards the reactions of the person‟s ability to 
cope with diagnosis, where they may have had no previous knowledge of, 
or clue about having any illness, through to being totally aware of the 
medical circumstances that lead them to a diagnosis of a chronic illness.  
Pinder‟s (1990) study of recently diagnosed patients with Parkinson‟s 
disease described three kinds of roles, the seekers, weavers and 
avoiders. Seekers sought as much information as they could on the 
diagnosed illness, which at times led to anxiety as some questions simply 
could not be answered.  Weavers sought information on occasion and 
would selectively construe information that suited them.  Avoiders chose to 
ignore the diagnosis all together and live in ignorance of the implications of 
the disease.  In this section, chronic illness experiences are explored in 
relation to issues of identity: biographical disruption, goals and 
motivations, coping, medication management, the efficacy of medication, 
and compliance with taking medications and ageing. 
Shoemaker‟s (2008) study of chronic illness experiences captured 
participant‟s descriptions of their journey with medications, their bodily 
effects, and how they tried to exert some kind of control over their 
medications. The research provides an informative account of an 
individual‟s experience of medication use.  Common themes emerged 
from the participant accounts.  Participants discussed their first encounter 
with medications and explored the positive and negative effects 
medication had on their body.  Participants also presented fears around 
the perceived need for medication and increased risks of dependency.  
Lastly, participants discussed accounts of trying to exert control over their 
situation and medication-taking practices, by altering the use and 
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administration of medication in accordance with medical advice.  Exploring 
ones medication experiences and accounts can inform and enrich the 
understandings of the meanings that medications hold for those who have 
a chronic illness. 
Studies such as those by Anderson and Bury (1988), Chamberlain and 
colleagues (2007), Charmaz (2006), Cohen, McCubbin, Collin, and 
Perodeau (2001) demonstrate that the meanings and understandings of 
medication are not only shaped through personal experience, but also 
through social experiences and relationships.  Radley (1994) 
acknowledges that chronic illness affects the individual on two different 
levels, the physical and personal.  The social consequences of having a 
chronic illness can impair one‟s mobility and performance, as one may 
have to alter their physical activities and change their pace of lifestyle. 
Radley (1994) notes that the experience of chronic illness is very different 
to those who are temporally ill, as a person‟s self-image is permanently 
changed.  For instance, modifications may be made to their image and/or 
the way they conduct themselves to hide or accommodate symptoms. 
Dealing with a chronic illness can also impact on a person‟s unique 
identity, as their perceived state of health changes to a person that has to 
live with an on-going illness (Frank, 1995).  Identity refers to the way an 
individual characterises, performs, locates and differentiates their sense of 
self from others (Viswanathan & Lambert, 2005).  Chronic illness can 
disrupt plans, performances, and the meanings that contributed to a 
person‟s self-perception.  For example, the application of medications in 
one‟s life may requires adjustments where a person may need to find an 
appropriate place to administer and store their medications as they would 
prefer others to not find out they were unwell.  This can also include 
storing medications away when guests come over to ones house.  Identity 
can also become a way in which people wish to define themselves, 
whereby wishes can become intentions, goals and objectives (Burke, 
1980).  In contrast to this, the chronically ill can feel a sense of loss, and 
lowered sense of value.  
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Another impact chronic illness can have on one‟s identity and life is the 
concept of biographical disruption (Frank, 1995).  Biography is related to 
one's perceived life course.  A chronic illness disrupts and dislocates a 
person‟s sense of identity, biographical time and normal bodily functions 
(Corbin & Strauss, 1987).  When one has a chronic illness, the individuals 
sense of health, life span, achievement in life-goals, and responsibilities 
are disrupted.  Any present or future related stress, suffering or decisions 
are compared to past experiences, present condition and future promise, 
invariably affecting the remainder of the person‟s life (Radley, 1994; 
Viswanathan & Lambert, 2005).  It is important to acknowledge that not all 
chronic illnesses are the same as individual symptoms, experience of pain 
and the determent to one‟s health may differ.  For example, in the short 
term or initial stages, people with chronic asthma, diabetes or chronic 
eczema might not perceive these conditions to be as life threatening as 
those with heart disease or cancer (Radley, 1994).  Another perspective to 
consider is those who are posed with high risks of contracting a disease.  
For instance, a person may have high blood pressure or high blood sugar 
levels, which increases their risk of having a heart attack or developing 
diabetes.  This may result in increased vigilance by the person affected by 
changing their diet or mentally preparing for the disease (Radley, 
1994).Therefore, the chronic illness symptoms, severity, treatment side-
effects and disease progression are all prominent features for those who 
are affected.  
An important part of learning about the influences chronic illness has on a 
personal biographical journey, is the disturbance it can cause to one‟s life 
goals and motivations. An individual‟s goals and motivations are key 
contributing factors in a person‟s treatment, whether these are shared with 
the medical professionals or not, they can take precedence over medical 
advice and motivations to slow or reverse their illness.  Viswanathan and 
Lambert (2005) state that people with chronic illness are largely motivated 
to reduce and/or treat the progression of their illness.  Therefore, if a 
recommended treatment is perceived to aid in curing or reducing their 
symptoms and/or enabling them to return to some kind of normalcy, then 
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the recommended treatment is more than likely to be followed 
(Viswanathan & Lambert, 2005).  If the treatment is perceived to obstruct 
ones valued pursuits, like affecting independence such as stopping a 
person from driving, then recommendations may be altered or ignored 
(Viswanathan & Lambert, 2005).  Perceived rational treatment options 
recommended by medical professionals can sometimes be over ruled by 
the persons own rationality in the context of their beliefs, motivations, 
goals, responsibilities and preferences (Adams, Pill, & Jones, 1997; 
Conrad, 1985).  Disruptions to a person‟s goals and motivations can both 
defeat or invigorate a person to make the most of their situation. 
Chronic illness can impose a number of physical, practical and 
psychological challenges. These may include adjusting to bodily changes 
from the illness and/or adverse affects from medications.  Practical issues 
may include adjusting material surroundings to accommodate reduced 
mobility, managing work and social obligations.  Psychological issues may 
involve not being able to cope with the adjustment and developing 
depression and/or anxiety (Corbin & Strauss, 1987; Radley, 1989; Voysey 
Paun, 1975).  Herek and colleagues (1990) found in their study that most 
chronic illness suffers do not seek professional help to cope with the 
present and foreseen challenges, rather, they more than often rely on their 
own internal and social resources to cope.  To some, the diagnosis of 
chronic illness can become a frightening, challenging and intimidating 
journey and at times can lead to the initiation of coping strategies (Herek 
et al., 1990).  
Coping strategies encompass people‟s abilities to face and deal with 
responsibilities, problems, or difficulties that are environmental and 
internal (Oxford University Press, 2000). Such strategies can include 
problem solving which include seeking out and using professional help or 
social support networks, such as family and friends (Dunkel-Schetter, 
Feinstein, Taylor, & Falke, 1992); distancing, which can involve efforts to 
distance oneself from a stressful situation, which also included avoiding 
certain stressful situations (Dunkel-Schetter et al., 1992);  positive focus 
which is described by the efforts to find meaning in ones experiences, 
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such as feeling like you are going through this experience to help others 
who may be going through same situation (Dunkel-Schetter et al., 1992); 
escape, wishing that circumstances would change, or luck would come 
their way (Dunkel-Schetter et al., 1992); denial, refusing to acknowledge 
there is an illness and ignoring the symptoms and progression of the 
illness (Meyerowitz, 1983); minimising, choosing to ignore or play-down 
the pain or discomfort experienced, this may enable the person to 
preserve their healthy image, however, this becomes more difficult as the 
illness progresses (Charmaz, 1995); and behavioural responses such as 
using substances to avoid the situation or reality such as eating, drinking 
alcohol, smoking and taking illegal drugs (Dunkel-Schetter et al., 1992; 
Dunkel-Schetter, Folkman, & Lazarus, 1987).  As people progress through 
their journey with chronic illness, their coping strategies fluctuate and 
change, as people can go through phases of denial, acceptance and then 
retreat back to a state of denial.  The development and use of coping 
strategies illustrates how households respond to the realities of illness.  
Individuals experience with chronic illness can range from the 
transformation of one‟s self-perception, biographical outlook, valued 
pursuits and coping strategies. However, another important factor is the 
introduction and integration of medication into their everyday lives.  
Meaning, use and placement of medications in the home  
The purpose of this study is to explore what medications mean to Māori 
households, with members living with chronic illness.  To identify, interpret 
and understand what medications mean to Māori households, one needs 
to understand how meaning is developed for individuals and families 
through social interactions.  This research is based on the assumption that 
the negotiation of meanings is a multi-faceted and on-going process 
influenced by an individual‟s experiences, his or her internal and external 
dialogue, conversations with others, emotional responses, actions, 
education, culture and wider society (Credo Reference Firm, 2006; 
Hutchinson Firm, 2008; Pickett, 2000).  Through social interactions, 
thought and behaviour are constructed in the exchange of symbols 
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between individuals and collectives (Cohen et al., 2001; Credo Reference 
Firm, 2006). This section explores previous research on the meanings of 
medications and use.  The construction and comprehension of meaning is 
explored through the lens of social constructions and symbolic 
interactionalism.  The section then discusses the management of chronic 
illness in the home and how spaces function or impede medication use.  
As chronic illness can become consuming in a person‟s life their homes 
can become reconstructed as therapeutic spaces.  Within these 
therapeutic spaces, routines are developed and maintained within homes 
and relationships become important influences to these routines.  
Medication use is then explored, as the practices and performances with 
medications reflected the associated values and meanings.  Furthermore, 
obtaining knowledge on medication is covered as it provides an important 
indication that medications are vital objects within the patient‟s lives.  
Lastly, literature on medication compliance will be examined, as a 
perspective it enables insight into the various capacities of patients, 
including ones personal and cultural beliefs and understandings, which 
may impact on the use of medications. 
Due to the complex nature of meaning making, philosophical stances and 
theories have been developed to explain the processes involved.  Social 
constructionists view meaning as a „construction‟ rather than a „discovery‟ 
(Crotty, Schwandt, & Arens, 2001).  The world and objects in the world 
only have meaning when human consciousness engages with them.  
Without human interaction in the world, there is no meaning, objects that 
exist in the world, such as a road, no longer can be associated with the 
name, purpose or context that was once given by humans (Crotty et al., 
2001).  The social constructionist theory considers how a social 
phenomenon develops within a social context.  The theory acknowledges 
that meaning is not purely objective or subjective, it is based on the 
relationship of the object within the world and the social context in which it 
was constructed (Crotty et al., 2001).  The creation of meaning is 
developed and interpreted within a social context on differing social levels, 
such as interactions between people, spaces and objects within 
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households, communities and wider institution, professions and society 
(Crotty et al., 2001; Nightingale & Cromby, 1999).   
People‟s understandings of illness, disease and good health states are 
dynamic and sometimes jumbled, shifting in response to personal 
experience and circumstances, such as emotional states.  Although most 
patients do not have free access to biomedical knowledge, they do not 
necessarily come to the doctor-patient encounter as empty vessels 
passively awaiting the wisdom of the doctor (Blaxter, 1979).  Popay and 
Williams (1996) stated that lay people go through a “systematic process 
whereby experience is checked against life events, circumstances and 
history.  They acquire an „expert‟ body of knowledge, different from but 
equal to that of professionals in the public health field” (p. 760). 
Medications are material objects that encompass both medical, personal 
and familial meanings for householders.  Medications have “social lives” 
as well as pharmacological lives (Whyte, van der Geest, & Hardon, 2002) 
and once in the hands of people they can represent, not only relief from 
suffering or the maintenance of health, but also identity, morality, 
relationships, care, healing and hope, amongst other things (Cohen et al., 
2001; van der Geest & Hardon, 2006).  For something to have meaning, it 
must have value or significance to a person.  Herbert Blumer developed a 
theory called „symbolic interactionalism,‟ which provides a conceptual 
context of understanding the relationships between subjective experiences 
and behaviour  (Kimmel & Mahler, 2007).  It is based on the premise that 
people use and act towards objects based on the associated meanings 
they have been given.  These interactions are developed through social 
interaction with one‟s household, community and wider society.  These 
meanings are interpreted and relayed to others through the individual 
interacting with the objects (Kimmel & Mahler, 2007).  It is therefore 
important to understand the meanings people associate with medications 
to gain insight into their related behaviours.  The home is one of the 
primary places that give shape and meaning to people‟s lives. Few studies 
have explored the practical implications of chronic illness management in 
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the home, as it becomes a site for long-term care (Imrie, 2004) and 
medication use.  
The meanings given to medications and the use of these substances are 
also influenced spatially.  For example, the structure of the home can 
impact on where to medications are placed. Homes and the rooms within 
them are built to accommodate the functional needs of people, such as a 
kitchen to cook meals in and a bedroom to sleep in.  Hockey (1999) states 
that the construction of a home is based on positive aspects of life such as 
autonomy, companionship and security but deny other aspects of 
domestic life such as illness, disability and dying. When one has a chronic 
illness, the functional spaces in the home need to accommodate the 
storage and placement of medications.  
Homes are increasingly being reconstructed as therapeutic spaces. Dyck, 
Kontos, Angus, and McKeever (2005) term the process of changing ones 
home into a site for care as „homespace‟ where the home becomes a 
“material practice of care provision with medically defined needs” (p. 174).  
In medication management, routines are considered a vital part of keeping 
up with everyday life and maintaining long-term compliance (Haslbeck & 
Schaeffer, 2009).  Routines can be described as a course of action that is 
followed regularly, in which they can be conscious or subconscious 
behavioral patterns which are used to organise and coordinate activities 
(Brooker, 2002; Zisberg, Young, Schepp, & Zysberg, 2006). 
Studies also suggest that social networks such as friends and family 
provide more support in developing and maintaining routines in the home 
than health professionals (Gordon, Smith, & Dhillon, 2007; Reid et al., 
2006).  These studies indicate that practical support from social networks 
such as, reminding loved ones to take medication, designing easily 
accessed storage places and developing memory joggers are significant 
factors in the maintenance and support of productive routines (Gordon et 
al., 2007; Reid et al., 2006).  Studies have also shown that risk factors are 
apparent when managing medications and risk increases with the 
complexity of the medication regimes. The more complex the regimen the 
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higher the risks of confusion, duplication and non-compliance (Conrad, 
1985). 
The meaning of medications is complex. For instance, the introduction of 
medications can represent dependence as one may need to rely on the 
medication to stay well, or, in contrast, independence, as it may relieve 
symptoms which otherwise restricted and confined interactions in the 
world (Adams et al., 1997; Conrad, 1985; Montagne, 1988; Nichter & 
Thompson, 2006; Rogers et al., 1998).  Research indicates that 
individuals approach medications differently therefore, the meanings they 
associate with medications can also be various.  Factors that contribute to 
different approaches include how long they had been on medication, the 
severity of their illness, and the adverse effects they experience.  A 
number of studies (Gallant, 2003; Haslbeck & Schaeffer, 2009; Pinder, 
1990) indicate that participants experiment with their medications by 
altering their treatment regimes.  Patients find creative ways to manage 
their medications enabling them to gain a sense of control, such as 
changing administration times to suit one‟s lifestyle, reducing dosage 
amounts to manage side-effects (Adams et al., 1997; Charmaz, 2002; 
Haslbeck & Schaeffer, 2009; Ockleford, Shaw, Willars, & Dixon-Woods, 
2008; Shoemaker & Ramalho de Oliveira, 2008), accessing medication 
and gaining knowledge and compliance.  Medications have the ability to 
consume one‟s life, as they demand time, thought and consideration.  
Patients in these studies reduced the dominance of medication use and 
administration, by treating medication use as flexible and adaptable 
products, despite the consequences of reducing the effectiveness of the 
medication. 
Obtaining knowledge around the use, application, and storage of 
medications, is an important part of understanding what medications mean 
to a person and a household.  Obtaining knowledge on medications 
indicates that they are an important part of a person‟s life, as this takes 
time, motivation and initiative.  Gaining knowledge allows the user and 
their carers to become fully informed of medications, its bodily effects and 
allows the users to become informed decision makers in relation to their 
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own health (Read & Wuest, 2007).  Users and carers become empowered 
through knowledge, giving them a sense of knowing and reassurance 
about the outcomes of medication use and other medical decisions and 
are better mentally prepared for the future (Read & Wuest, 2007). 
Knowledge and in particular the capacity to access that knowledge, 
contributes a great deal to a person‟s ability to take some control over a 
chronic illness.  Another important factor in gaining control is the notion of 
compliance or non-compliance, where people go against medical advice 
and follow their own regimen, application and practices with medications.  
Compliance provides a perspective of use that enables researches to 
explore the various practice and behaviours with medications, where these 
behaviours can inform the meanings medications have in their everyday 
life.  
Compliance is a perspective, usually from the viewpoint of medical 
professionals, where patients are advised to follow medical advice and 
prescriptions when taking medications.  Compliance is a helpful way of 
viewing everyday practices that emerge around medication taking.  A 
review of quantitative psychological research into compliance covering 
three decades concluded that, rather than being a static or fixed 
phenomenon, compliance is better considered as a fluctuating choice that 
is rationalised in the context of everyday life (Chia, Schlenk, & Dunbar-
Jacob, 2006; Vermeire et al., 2001; Wilson et al., 2002).  Earlier research 
by Dowell and Hudson (1997), New Zealand National Advisory Committee 
on Health Disability (2007), and Vermeire and colleagues (2001) reveals a 
range of understandings and practices people have with their medications 
such as: a varied knowledge base around the role of medication in 
peoples treatment regimes, discontinuing medication when they felt well, 
stockpiling medication for future use, and sharing medications with others 
who have similar conditions or symptoms. 
Recent studies (Chia et al., 2006) show that compliance is a multifaceted 
role associated with various capacities including memory recall, problem-
solving abilities, as well as personal and cultural values and beliefs.  
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Kairuz and colleges (2008) study on identifying compliance issues, 
described how medication users would alter medication labels and transfer 
medicine into other containers, which was not advised by medical 
professionals. Such practices were introduced as participants had trouble 
swallowing the pills or found the medication container did not meet their 
specific needs.  Other reasons for not taking medication included cost and 
adverse side-effects. Further, Pound and colleagues (2005) synthesis of 
studies on medicine taking suggest there are classes of patients; those 
who accept readily, accept reluctantly or resist medicines, each of whom 
used medications in different ways.  Studies have also shown that patients 
did not view their medication practices as being non-compliant, as while 
medical advice was considered, other social and cultural factors were 
seen as having higher priority (Adams et al., 1997; Urquhart, 1994). 
Vermeire et al (2001) recommends that the social and cultural context of 
medication users and their carers should be central to any medical 
decisions made by health professionals.  Compliance should be viewed as 
a flexible and realistic aim.  Medication users especially those with chronic 
illness, should be encouraged to make decisions about treatment options 
that are more suitable to their lifestyles, beliefs and personal 
circumstances (Vermeire et al., 2001).  An important feature in the 
application of medications in ones everyday life is the consultation and on-
going relationship chronic illness suffers have with medical professionals.  
Medications are objects that have a functional purpose to improve a 
person‟s health, mediate symptoms and ward off ill health.  One‟s 
associated understandings, situations and identity all contribute towards 
understandings of medications.  When chronic illness is experienced it can 
change performances, plans, meanings and self perception, which 
formerly contributed to one‟s identity.  For people with chronic illness, 
medications function as a mediator of ill health, as opposed to warding off 
ill health or improving health. Chronic illness will still be present with or 
without the medication; however the use of medication may reduce 
symptoms. 
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The following chapter will discuss the research design, participant 
recruitment, data collection methods and data analysis methods that were 
used to explore what medications mean to Māori households. 
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CHAPTER TWO: METHODOLOGY 
Medications are a fundamental technology for treatment in health care, 
and a substantial component of health care cost in this country 
(PHARMAC, 2008).  Exploring what medications mean to people and how 
these objects are used within everyday life provides information that can 
inform strategies for enhancing the safety and efficacy of medication use. 
This research utilises a broad ethnographic approach (Griffin & Bengry-
Howell, 2007) to capture the complexities and fluidity of popular 
understandings and medication use in daily life.  It investigates 
understandings and practices around medications within Māori 
households containing people living with chronic illnesses.  Multiple 
methods were used, including group discussions with household 
members, individual interviews, household mapping and photographic and 
diary elicitation tasks.  The research was informed by the notion that 
households are a therapeutic space for the care and maintenance of 
health, and constitute a significant place for medication storage and use in 
everyday life. My study is important because Māori are disproportionate 
users of the health system, experience health inequalities, and have the 
poorest health status of any ethnic group in New Zealand (King & Turia, 
2002).   
This chapter provides rationale for my focus on specifically Māori 
households with members living with chronic illness. Following this, I 
provide an overview of the recruitment processes used and the 
characteristics of the four households that participated. Section three then 
explores the four phases of my engagement with the households and the 
specific research methods used.  The chapter concludes with an 
explanation of analysis process used, namely my approach to the analysis 
was based on an inter-disciplinarily method that brought together 
analytical strategies necessary for the needs of the specific research.  This 
approach corresponded well with the messiness of everyday life and the 
complexities of medication practices in domestic settings. 
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Why focus on the use of medications to address chronic illnesses in 
Māori households? 
Despite medication being a common object in many homes, there has 
been no research that has examined the spatial and material practices 
involved in the everyday use of medications within Māori households.  
Such a focus is significant because homes provide a spatial context that is 
related to personal identity, security, privacy, respite and care (Mallett, 
2004).  People experience a sense of control and freedom in the home, in 
which everyday routines and practices, including the use of medications, 
are enabled and enacted (Dupuis & Thorns, 1996).  The home is thus a 
particularly important social and psychological space (Easthope, 2004; 
Saunders & Williams, 1988), providing a locale that fuses the “physical 
unit of the house” and the “social unit of the household” (Saunders & 
Williams, 1988, p. 83).  The household represents the particular mode of 
social organisation that is distinctive to a particular home (Saunders & 
Williams, 1988).  Further, medications and their associated 
understandings are substantially implicated in the care practices that 
occur, and identities that are forged, within the home.  Much of this relates 
to self-care and self-medication, contributing to the contemporary 
transformation of the home into a „therapeutic landscape‟ (Gesler & 
Kearns, 2002; Williams, 2002).  The interpersonal interactions and the 
placement of bodies and objects in domestic spaces serves to reconstruct 
the home as a setting for care giving that is also influenced by external 
professional knowledge, policies and practices (Dyck et al., 2005; Gleeson 
& Kearns, 2001). 
Chronic illnesses are the leading cause of preventable morbidity and 
mortality, and are an important factor in unequal health outcomes in New 
Zealand (Ministry of Health, 2010).  People with chronic illness are 
significant users of medications, with this group consuming 70% of 
national health expenditure (New Zealand National Advisory Committee 
on Health Disability, 2007).  Issues such as compliance, risk and identity 
involving medications are highly relevant in this context (Hugtenburg, 
Blom, & Kisoensingh, 2006).  Households containing a person with a 
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chronic illness, therefore, provide a site where medication use will be 
frequent, important, and, given the nature of chronic illnesses, will 
potentially involve other household members.  These households also 
constitute a therapeutic place of care where the meanings of medications 
and their use are highly salient. 
„Medications‟ can be loosely defined as „things that keep us well‟, including 
anything that is ingested, injected, inhaled, inserted or applied.  In 
Churchill Livingstone's Dictionary of Nursing (Brooker, 2002) medication is 
defined as:  
[a] therapeutic substance, taken orally or administered by injection 
subcutaneously [under the skin] intramuscularly [into a muscle], 
intravenously [injected into a vein]; also by inhalation [breathing in], 
sublingually [under the tongue], rectally [inserted into the rectum], topically 
[on the skin] or transdermally [in the form of a patch worn on the skin] (p. 
56). 
For this research the term „medication‟ is used to describe objects, 
materials and devices used to manage or mediate symptoms of illness, to 
ward off ill health, and to cure ailments.  Medications include prescription 
medicines, over-the-counter-medicines, dietary supplements, and 
alternative medicines including home remedies, rongoā Māori and other 
cultural remedies.  Medications that are not included in the research are 
any illegal drugs or substances. 
Participant recruitment and household profiles 
The participants for this research came from four Māori families living in 
Hamilton, Aotearoa New Zealand.  Each household contained at least one 
adult or child with a diagnosed chronic illness.  Such households provided 
sites where medication use was likely be frequent, important, and involve 
other household members.  Households were broadly defined as an 
individual‟s residence or a collection of people living together in the same 
place.  To maintain the privacy and confidentiality of the families involved, 
each household and their individual members were given pseudonyms.  
Each household has been “named” after native plants that have rongoā 
Māori properties: Kōwhai, Pūriri, Harakeke, and Pōhutukawa. 
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Prior to participant recruitment an ethics application for the research was 
submitted to The University of Waikato‟s Psychology Research and Ethics 
Committee and approved on the 20th May 2009.  Recruitment of 
participants began in early April 2009 and was completed in late June 
2009.  I began my recruitment process by approaching individuals about 
the study (as opposed to approaching the whānau as a collective). This 
targeted approach allowed me to fully explain the study and process of 
data collection to one member of the household, enabling that member to 
approach their whānau and contact me if they wanted to participate in the 
research.  It was important to approach recruitment in this way in order to 
eliminate any difficulty or fear whānau may have perceived about the 
complexity of this research. This enabled me to create a space, when data 
collection commenced, in which participants felt confident and comfortable 
in sharing their views and perspectives. Prospective participants were 
recruited through known local contacts, connected socially or 
professionally, who passed on the „General Information Sheet‟ (see 
appendix A), to a household.  A household member then contacted the 
researcher to express interest, ask questions and engage in the research 
process.  This recruitment method, known as „snowballing‟, was helpful as 
it enabled participants to be approached through known contacts whom 
they trusted (Biernacki & Waldorf, 1981; Penrod, Preston, Cain, & Starks, 
2003).  Trust was vitally important, as the project required the researcher 
to enter into participants‟ homes to talk about personal health matters. 
Data collection was conducted over a three-week period.  A total of eleven 
people participated in this study.  Of those, ten identified as Māori and one 
person identified as Pākehā.  Seven participants were women and four 
were men, households comprised of ages ranging from two years to 78 
years.  A diverse range of occupations were represented.  Characteristics 
of each household such as location, medication regimes, and medication 
use are described in detail below.  The amount of information on the 
chronic illness(s), condition(s) and medication(s) the householders used 
reflects the amount of information the household shared with the 
researcher and whether or not they knew the names of the medication. 
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Harakeke Household 
The Harakeke household is located in east Hamilton, in a low socio-
economic area (New Zealand Parliament, 2006).  Harakeke house is not 
related in any way to any of the other households in the study.  The house 
is a small two-bedroom home with one bathroom.  The household is 
comprised of three members, two adults and one child.  Kahu is a 26-year-
old unemployed Māori male who lives with his partner Megan and their 
child, Sarah.  Megan is a 25-year-old Pākehā female who is currently 
studying at university.  Sarah is two years old and attends a local crèche. 
In the Harakeke household, both Kahu and Megan very rarely take 
medication.  They generally consider themselves healthy and perceive 
medication as unnecessary unless they become severely ill. Sarah is the 
main user of medications.  In particular, she uses medicated creams every 
day and often consumes prescription antibiotics.   When Sarah was one 
year old, she developed chronic atopic eczema.  The eczema is a generic 
condition, which she may have all her life and currently cannot be cured. 
Symptoms, however, can be reduced, with medication or topical creams.  
At times, Sarah‟s eczema gets infected and has to be treated with a long-
term (3-6 months) antibiotic, Fluoxicillin Sodium.  Sarah has also been 
prescribed a topical cream, Glycerine cetomacrogol, to help temporarily 
relieve the itching.  This needs to be administered 10 times a day and 
requires Sarah to be totally undressed and coated with cream from head 
to toe. 
Pōhutukawa Household 
Pōhutukawa house was located in East Hamilton, also in a low socio-
economic area (New Zealand Parliament, 2006).  The house is a one 
story, three-bedroom home with one bathroom.  The house is comprised 
of two adults, who occasionally have mokopuna stay. John is a 63-year-
old Chinese-Māori male who lives with his wife Rachael.  John works for 
the local council.  Rachael is a 60-year-old Māori female and is a nurse.  
Rachael did not participate directly in this study, but is mentioned 
frequently by John. 
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In the Pōhutukawa household, John and Rachael have their own 
medication regime, ranging from taking around eight to 16 pills a day and 
two injections.  Both John and Rachael have chronic illnesses and 
perceive their medications necessary for maintaining their health and daily 
functioning.  John has been taking prescription medications for over 10 
years, as he has Type II Diabetes and regularly injects insulin into his 
abdomen.  John has a prescription for 20 units of Insulin, Glipizide and 
Metformin medication for his diabetes.  He also takes Accuretic medication 
for his blood pressure and uses home remedies such as manuka honey 
and aloe vera for other ailments.  John has a number of tasks he needs to 
perform to monitor and maintain his blood glucose levels.  Tasks involve 
regular monitoring of blood glucose levels with reagent strips and a drop of 
blood from a finger prick; and a strict dietary plan with specific types and 
amounts of food and a number of insulin injections, usually once or twice a 
day, with complex dosage adjustments when needed.  John drinks Pepsi 
Max1 as part of his diet to maintain his blood glucose levels. 
John advises that Rachael has consumed prescription medications for the 
past eight years and takes Accuretic medication, daily, for her blood 
pressure.  She also takes two other forms of medication, which John was 
unable to name. 
Pūriri Household 
The Pūriri household is located in North Hamilton, in a medium socio-
economic area.  The house is a two story, five-bedroom home with two 
bathrooms and the household is comprised of three adults and two 
teenagers. Tui is a 78-year-old Māori male who lives with his son Tāne, 
Tane‟s wife Erin and their two children.  Tāne is a 47-year-old Māori male 
and is a computer scientist.  His wife Erin is a 44-year-old Māori female 
and is an academic auditor.  Teowaina is a 15-year-old Māori female who 
attends high school.  Their son did not participate in the research. 
                                            
1Pepsi Max is a low-calorie, sugar-free cola, marketed by PepsiCo as an alternative to regular Pepsi and Diet Pepsi (Pepsi-
Cola Company, 2010). 
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In the Pūriri household, each adult has their own medication regime, 
ranging from taking around eight to 16 pills a day.  Three household 
members (not including Miriama) have several chronic illnesses and all 
perceive their medications as a necessity to stay alive and maintain their 
health. Tui has had two heart attacks and a ruptured ulcer that nearly 
turned gangrenous.  He also has high blood pressure. He has been on 
long-term medication for four years.  Tui takes an array of medication, 
which include Aspirin, Digoxin, Furosemide, Benazepril medication.  He 
also wears a compression sock and has a Beclazone asthma inhaler. 
Tāne has sleep apnoea and has to use a Continuous Positive Airway 
Pressure (CPAP) machine to help him sleep at night.  He also has high 
blood pressure and heart problems. He has been on long-term medication 
for two and half years.  Tāne takes a number of medications including 
Aspirin, Digoxin, Diuril, Furosemide, Metformin and Mirtazapine. Erin also 
has sleep apnoea and uses a CPAP machine.  She has recently come out 
of hospital after a wound in her leg became infected.  She has high blood 
pressure and heart problems. Erin has been on long-term medication for 
the past three years.  Erin takes a number of medications including 
Aspirin, Bumetanide, Digoxin, Diuril, Indapamide, Metformin and 
Moduretic. Teowaina was not taking any medication at the time of the data 
collection. 
Kōwhai Household 
The Kōwhai household is located in North Hamilton, in a high 
socioeconomic area.  The house is a two story, five-bedroom home with 
three bathrooms.  This household is comprised of three female adults and 
one cat. Miriama is a 74-year-old Māori female who lives with her daughter 
Lana, and Lana‟s partner, Noi.  Lana is a 45-year-old Māori female, and is 
an academic.  Noi is a 60-year-old Māori female, and is also an academic. 
The Kōwhai household is closely related to the Pūriri household as Lana 
and Tāne are siblings. In addition, Miriama and Tui are husband and wife 
and Miriama will often spend time at Tāne‟s house.  When Miriama is 
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staying at the Pūriri household, Tāne administers her medication and 
performs related care giving tasks. 
In the Kōwhai household, each whānau member had their own medication 
regime, ranging from taking around one to 24 pills per day.  Two 
household members have multiple chronic illnesses and both perceived 
their medications as a necessity to stay well and preserve their state of 
health. 
Miriama has been on long-term medication for over 10 years and has 
survived through a number of life threatening illness, attacks and 
procedures.  These include two strokes; stroke induced epilepsy; 
mastectomy; a gall bladder operation; an on-going fibrillating heart 
condition; and thyroid difficulties.  The adverse effects of these conditions 
have resulted in Miriama having several chronic illnesses and conditions.  
These include dysphasia, which affects Miriama‟s ability to articulate 
words and memory recall, fluid retention, semi-incontinence, deafness and 
decreased mobility.  Miriama has also become susceptible to chronic 
urinary tract infections.  Miriama takes a number of medications including 
Digoxin, Furosemide, Levothyroxine, Omeprazole, Nitrofurantoin, 
Phenytoin Sodium, Potassium Chloride, Sodium valproate, Simvastatin 
Sodium, and Warfarin.  She also takes a cranberry pill once a day to help 
prevent urinary tract infections. 
Noi has been taking prescription medications consistently for over 10 
years and has a number of chronic illnesses, which include asthma, hay 
fever, gastric complications, Hepatitis C (HCV), and rheumatoid arthritis.  
Noi is also a cervical cancer survivor.  Noi regularly takes Symbicort 
inhaler twice a day and will take Prednisone in extreme conditions.  She 
regularly uses a peak flow meter to monitor her asthma.  Noi takes 
complementary herbs for her HCV.  She also takes a number of 
medications daily for her gastric problems including Ferrograd C, 
complementary herbs and calcium. 
Lana has been taking medications for the past two years.  She currently 
takes Benzodiazepine daily to help with depression, anxiety and sleep. 
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Medications are not only limited to the adults in the household, the cat 
Pango is on Levothyroxine medication for a thyroid condition.  He also had 
a stroke eight months ago and was taking Warfarin medication at the time 
of the initial household discussion.  He has recently developed arthritis in 
the spine and is currently on painkillers. 
Research design for engaging with the four households 
The project used a multi-layered and multi-method approach to data 
collection and analysis.  The intent of this broadly ethnographic approach 
is to acquire a rich and deep set of relevant materials that will provide 
insights into the complexities of understandings and practices around 
medications (Griffin & Bengry-Howell, 2007).  The advantage of my 
approach is that it can function with flexibility and use diverse data 
collection methods (Gray, 2003; Holland & Leander, 2004).  Data 
collection assembled a variety of forms of data, including group 
discussions, individual interviews, photographs, diaries, household maps, 
and material objects relevant to medication.  
A difficulty with this study was that participant understandings and use of 
medications can become so routinised to the point of being enacted rather 
than readily represented.  The use of exercises requiring participants to 
draw floor plans [household map] and photograph objects provided a way 
of rupturing the taken-for-granted and produced a representation that 
could be discussed, and used to open up experiences of medications.  In 
a sense, these exercises comprised a kind of breaching experiment in the 
ethnomethodological sense (Garfinkel, 1967), which renders the unnoticed 
noticeable and aspects of medication placement and use intelligible.  
Specific processes for the data collection and justifications for the methods 
involved are outlined in turn below. 
Data collection was organised into four phases within each household that 
included digital-recorded group discussions with household members, 
observations, mapping, photographic and diary elicitation projects.  In 
phase 1, a meeting was held with a member of the selected household to 
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introduce the person to the research process, this enabled them to then go 
away and discuss the information with their household.  Once the 
household agreed to participate in the research phase 2 began and an 
initial meeting was held with members of each household to introduce the 
research, gain informed consent, and identify key participants for the 
various forms of data collection within the household. This was followed by 
a general discussion about medication sources, uses and meanings with 
householders. As part of this discussion, household members drew a map 
of the house (household map), indicating where all medications were 
located. These locations were digitally photographed and referenced to 
the plan.  Phase 3 involved one member of the household producing a 
diary record relating to the everyday use of medications and noting any 
aspects of the medication experience at the end of each day for one week. 
Where appropriate, another family member produced another diary 
recording instances in which medications came to their attention from 
advertisements, billboards, and interactions with others. In practice, these 
two forms of diary tended to be merged and completed by one person. 
Diaries provided the focus for personal interviews at the end of the week, 
where the meaning of entries and noted practices were discussed. Phase 
3 also involved photo-production exercises where a member of the 
household was given a disposable camera and asked to “photograph the 
world of medications”. Photographs were developed and used in a photo-
production interview with the participant.  Phase 4 involved an exit 
discussion with the entire household that reviewed the research process; it 
was viewed as a suggestion rather than a necessity, which resulted in one 
household participating in the process.  
Engagements with the households resulted in a large and complex data 
set comprised of some five household discussions (introductory and exit), 
four household maps, eight interviews, six diaries and over 50 
photographs. This corpus offered multiple forms of overlapping data, 
various vantage points on the placement, meaning and everyday practices 
surrounding the use of medications in domestic settings.  
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Below I provide more information on the activities conducted with the 
households during each of the four research phases.  
Phase 1: Pre-data collection  
Firstly, I met with a householder to explain the research collection process 
and answer any questions.  This discussion involved informing the person 
of the aims of the project and the data collection process.  The 
householder was given the „Medications in Everyday Life Information 
Sheet‟ (see appendix A) for themselves and additional copies for the 
family.  After this introductory meeting, if the household was willing to 
participate they made contact with me and arranged a time for an initial 
household discussion. 
Phase 2: Initial household discussion 
Phase two consisted of a meeting with household participants for three 
main purposes, these being, to gain informed consent from the 
participants, to complete the household mapping exercise and to 
participate in the household discussion and allocate tasks.  
At the beginning of the household discussion, two recording devices were 
turned on.  The participants were thanked for their participation and 
patience.  I revisited the information sheets highlighting the goal of the 
research, the tasks involved, rights as participants, rights of withdrawal, 
and the researcher‟s contact details. I elaborated on each point and gave 
the participants an opportunity to ask further questions. The participants 
were taken through the consent process and forms, which once satisfied 
with the explanations, they then signed. 
Two householders were asked to complete the Household Mapping task 
(for an example of the household mapping exercise, see Figure 2). One 
participant was asked to draw a simple map of the household, labelling all 
the rooms. The other participant was asked to photograph all medications 
(which the participants had consented to photograph) in their respective 
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locations in the household. I also made it clear to the photographer that 
capturing the exact or normal location of the medication was very 
important to the research. The participant doing the photography also 
checked with the household that all medications were accounted for in the 
photographic catalogue.   
When the drawing of the household map and the photographs were 
completed, the participant responsible for taking the photographs was 
asked to mark with an „X‟ on the household map, the locations where the 
photographs were taken and to number the „X‟s.  For example number 1 
recorded next to the „X‟ representing the location where photograph one 
was taken, and the number 2 next to the „X‟ where photograph two was 
taken, and so on. This coding helped locate photographed items 
(medications) on the household map. The „Household Mapping‟ was also 
used as a tool for the household discussion as participants were able to 
refer to the photographs and map to explain why medications were placed 
in those household locations. 
The household map was used as a tool to help rupture the taken-for-
granted processes that can come with storing medication and the flow of 
medications; and to identify how the medication arrived, where it was 
located, who used it, how it was consumed, and if it moved beyond the 
house.  Drawing the household map and referencing the storage and 
placement places of medication allowed the householder to explore their 
house through the lens of medication use. This enabled the householders 
to walk around their house and discover medications, rather than 
reference them from memory.  It also enabled them to think about 
medications within the household and to focus on and engage the topic. 
The term „household discussion‟ was used here to describe a session 
where the household participants and I partook in a conversation about 
medications, guided by the „Household Interview Schedule‟ (see appendix 
C). Household discussions for each of the four households began by 
referring to the household map and examining each photo taken of a 
medication‟s location. Conversation around the location of medications 
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identified what and how medications were both used and stored within the 
household. Furthermore, the „flow‟ of each medication through the 
household was determined.  That is, how it arrived, where and why it was 
located in that specific location, how it was consumed and whether the 
medication moved beyond the household. 
Following the discussion about the photos and the map, I asked each 
household „What does the word medications mean to you‟? This question 
allowed for further conversation about the topic of interest. During the 
discussion about medications, further questions or prompts were added as 
a result of issues arising from the household discussion. These 
discussions for each household took on average 60 minutes. 
Before the initial household discussion was finished, the householders 
decided who was going to perform the three tasks over the coming week: 
photo elicitation task, medication use diary, and general medication diary.  
Each household member were given a specific information sheet about 
the task they had chosen, providing them with the task instructions, their 
rights as participants (including the right to withdraw) and the researcher 
and supervisors contact details. 
Part of phase two included providing, or having on hand, materials and 
tools to help complete the household discussion and „Household Mapping‟ 
exercise. Materials included „Medications in Everyday Life Information 
Sheet‟ (Appendix A); „Medications in Everyday Life Consent Form‟ 
(Appendix B); „Interview Schedule‟ for the household discussion2 
(Appendix C); „Medication Use Diary Information Sheet‟ (Appendix D); 
„General Medications Diary Information Sheet‟ (Appendix E); „Photo 
Elicitation Information Sheet‟ (Appendix F); two MP3 recorders; drawing 
materials to aid the household mapping task (at least five blank sheets of 
A4 paper, and a pen); a digital camera or disposable camera to take 
photographs of medication and material objects; and new diaries for each 
                                            
2
 Note that this interview schedule did not have fixed questions, but was rather a tool to 
help guide and prompt the researcher during the household discussion (Breakwell, 
Hammond, & Fife-Schaw, 2003). 
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participant conducting the „Medication Use and General Medications diary‟ 
exercise. 
The data set for Phase 2 included digital recordings of the discussion; 
household map with the identified locations of the household medications 
and photographs of the medications and material objects around the 
house. 
Phase 3: Diaries, photographs and interviews 
This phase of the data collection process required one person from the 
household to take photographs of anything about medications; one other 
person in the household to keep a Medication Use Diary; and another 
member of the household to keep a General Medication Diary. It was 
anticipated that by completing these three tasks, a rich set of data 
regarding the household‟s world of medications could be collected.  It was 
not essential, however, that all of the tasks be performed, this depended 
on how many people were present, who was interested in the tasks.  One 
person could do more than one task if they wanted too and this is what 
happened for some of the households.  Participation in the various data 
collection tasks was conducted with flexibility and with sensitivity to the 
specific wishes and capabilities of each household.  Therefore, tasks that 
were performed, varied across households, as they changed and altered 
their level of participation.  Flexibility is one of the advantages afforded by 
the ethnographic approach of this research (Gray, 2003; Holland & 
Leander, 2004). In sum, each household, where practicable, provided two 
specific diary records; a medication use and a general medications diary. 
Medications Use Diary: One household member who was regularly taking 
medication of any sort was asked to keep a medications use diary.  This 
involved recording for one week, the daily consumption of all types of 
medication, and noting any aspects of the medication experience at the 
end of each day.  Methods of recording the consumption component of the 
diary was chosen by the participant and included recording on paper, 
audio recordings, or typed on their computer.  This diary was then used as 
39 
 
the focus for an individual interview at the end of the week, where the 
meaning of entries and noted practices was discussed. 
General Medications Diary: In relation to the general medications diary, 
another member of the household was asked to keep a one-week 
medication diary recording any time that medications of any sort come to 
attention in any way (while watching television, reading magazines, 
shopping, and so on).  This could include medications of all types such as 
prescription medicines, over-the-counter medicines, alternative medicines, 
dietary supplements, and health care remedies.  At the end of each day, 
this person selected one encounter and recorded more detail about it.  
Again, the form of recording for this diary was negotiable to suit the 
specific participant.  At the end of the week, an individual interview was 
held with the diarist to discuss what was noted, not noted and the 
meanings of entries. 
Diaries comprised an introduced data collection method that enabled 
participants to actively contribute to both recording and reflecting on their 
own practices (Milligan, Bingley, & Gatrell, 2005).  The diaries augmented 
individual interview methods, fit well with participatory research approach 
to everyday life (Johnson & Bytheway, 2001; Milligan et al., 2005), and 
reveal understandings about taken-for-granted issues in health and illness 
(Elliot, 1997; Verbrugge, 1980).  These diaries also provide “a record of an 
ever-changing present” (Elliot, 1997, p. 2), that was useful in researching 
sensitive issues (Meth, 2003) over a short period of time (Ross, Rideout, & 
Carson, 1994).   
Photo elicitation: A third data collection method offered to the household 
members was the photo elicitation task.  One member from the household 
was asked to take photos over a two-week period, of anything about 
medications; photos that show us how they see “the world of medications”.  
These photographs were about any aspect of medications that they 
wanted to show, as there were no specific expectations about the nature 
or type of photographs.  The photographs were taken either on their own 
digital camera or they were given a disposable camera.  Photographs 
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were then developed or viewed on a laptop, and used in a photo elicitation 
interview with the participant. Photo elicitation proved useful in enabling 
participants to move beyond discussions and the written word and explore 
medications in everyday life through the lens of a camera. 
Photo elicitation techniques are increasingly used in social science 
research (Mitchell, DeLange, Moletsane, Stuart, & Buthelezi, 2005; 
Nowell, Berkowitz, Deacon, & Foster-Fishman, 2006; Pink, 2007).  They 
are often located within participatory research approaches (Carlson, 
Engebretson, & Chamberlain, 2006) as the process enhances participant 
reflexivity and provides participants with a means to articulate their lives 
particularly in relation to taken-for-granted everyday events, that can be 
difficult in conventional interviews (Klitzing, 2004).  The photo elicitation 
task also enabled participants to experience a sense of ownership and 
enjoyment in the research process (Hodgetts, Hodgetts, & Radley, 2006), 
and facilitated interactions between myself and participants (Felstead, 
Jewson, & Walters, 2004).  Photo elicitation processes involve more than 
simply taking photographs.  When participants are asked to produce and 
then talk about their photographs, I was able to ask about the 
commonplace objects and routines, highlighting what may seem mundane 
or unimportant to them (Radley & Taylor, 2003).  The technique invoked 
processes of picturing their world (Hodgetts, Chamberlain, & Radley, 
2007), where the task of photographing things relevant to the research 
objectives orientates them to see their world differently, with a focus on 
things worth picturing.  This orientates participants to material aspects of 
their everyday lives and to relationships that give meaning to places and 
things (Snell & Hodgetts, 2007).  When participants make sense of what 
they see and experience by picturing, links between personal experiences, 
local contexts and social practices are invoked and revealed (Harper, 
2002). 
The materials for Phase 3 included; „Medication Use Diary Consent Form‟ 
(Appendix G); „General Medications Diary Consent Form‟ (Appendix H); 
„Photo Elicitation Consent Form‟ (Appendix I); and two MP3 recorders. 
Data from Phase 3 consisted of:  diaries; photographs (that the participant 
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consented to include); and the recorded discussion about the diaries and 
photographs. 
Phase 4: Exit discussion 
The exit discussion provided for a review process where the household 
had the opportunity to disengage formally from the research process.  The 
discussion was offered to participants as a suggestion, as opposed to 
requirement.  If the participants opted to not engage in the exit discussion 
there was an informal disengagement from the process where the 
participants were given the opportunity to ask any further questions and 
they were thanked for their time.  Exit discussion covered and reviewed 
the processes that occurred within that household, and generally involved 
an overview of what happened, and what was shown, with the researcher 
also gathering participant reactions and comments to this.  Discussions 
were audio recorded and treated as a data source and a forum for sharing 
generic findings with the participants. 
Analysis 
A particular challenge for the analysis of the diverse data set compiled for 
this research was how to achieve coherence of interpretation across the 
various forms of data that preserves the complexities involved. Cohen and 
colleagues (2001) state that a number of factors should be considered: 
complexity, given the diversity of interacting processes involved change, 
given the ongoing changeable nature of these processes and social 
constructions, given the important role of human understandings and 
meanings involved. In this section the analysis process is described for the 
household map and reference photographs, photo elicitation photographs, 
household discussions, individual interviews and diary entries. 
My approach to the analysis is based on the notion of researchers as 
bricoleurs (Kincheloe, 2005) who operate inter-disciplinarily to bring 
together analytical strategies necessary for the needs of the specific 
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research.  Here, research is seen as a process involving problem solving 
and flexibility that is adjusted in response to emerging insights (Kincheloe, 
2005).  This approach corresponds well with the messiness of everyday 
life and the complexities of medication practices in domestic settings.   
A key feature of the analysis was to unravel meanings invested in taken-
for-granted everyday life practices.  This required particular attention be 
paid to mundane actions and events (Sheringham, 2006) and the 
rendering of the familiar as unfamiliar (Chaney, 2002).  Specifically, 
materials were analysed thematically and interpretatively with respect to 
social and symbolic aspects of medications in general and personal 
situations in particular.  I accomplished this by focusing on routine, on the 
incidental events and accumulated moments that make up everyday life 
and how these link to broader patterns of social relations (de Certeau, 
1984; Sheringham, 2006), patterns that are intimately caught up in the 
meanings and practices surrounding medications in the home.  This 
orientation foregrounds the dialogical nature of the analyses, moving from 
detailed engagements with the home space, daily situations, material 
objects, personal experiences and practices to broader socio-structural 
contexts and patterns that frame and constitute them (Lefebvre & 
Nicholson-Smith, 2007).  On the one hand, I unpacked participants‟ 
understandings of medications and their use embedded in daily practices 
and on the other, I conceptualised the social significance of these local 
instances for the meanings and practices of medications in society today. 
More specifically, I employed techniques commonly associated with 
thematic analysis. Thematic analysis is the process of identifying, 
analysing and highlighting patterns (themes) within the data (Boyatzis, 
1998; Braun & Clarke, 2006).  Braun and Clarke (2006, p. 3) write that it 
“minimally organises and describes your data set in rich detail”.  The 
researcher plays an integral role in this process as ultimately they make 
decisions based on their experience and knowledge of the topic (Braun & 
Clarke, 2006).  This approach allows the researcher to make sense and 
meaning of the participants experiences and, in turn, the ways the broader 
social context impinges on those meanings.  Using thematic analysis as a 
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framework allowed me to draw on content, rhetorical, discursive and 
narrative analytical techniques as required (Braun & Clarke, 2006; 
Yanchar, Gantt, & Clay, 2005). 
The household map was used as a tool to document the storage spaces of 
medications within the household.  During the analysis process the map 
was used a reference tool.  Matching the photographs with the map 
enabled me to remember placement and storage areas of the medications 
and cross-reference the areas in the home with the transcribed material 
from the household discussion and individual interviews. The photographs 
were also used as tools to help further interpret participants‟ accounts of 
where they placed, stored and used specific medications and how 
relationships of care were played out in the household.  The photographs 
were also analysed according to their content.  A photo table was 
developed to help assess what was present in the pictures (see appendix 
J for an example).  A grid was completed, for each photograph taken, 
providing an overall view of who was presented in the photographs, the 
places they were taken and the objects present.  This allowed the 
photographs to be viewed through a different lens, as they were more than 
tools for discussion, as their material content was also important. 
After analysing the household map and photographs the household 
discussions and individual interviews were transcribed verbatim.  I read 
over the transcripts and diary entries numerous times, enabling me to 
become familiar with the participants accounts.  While reading the data set 
I noted down, on one side of the margin, information deemed to be 
significant from what the participants said (Braun & Clarke, 2006).  Some 
of the comments were attempts at summarising a response, using one 
word.  Then on a separate document, the comments were extracted and 
connections were developed between them.  Particular subjects, ideas or 
practices were placed under an umbrella term (theme) that could be 
recognised as the „same type‟.  During this process, I also extracted 
passages (extracts) that best represented the theme, enabling me not to 
lose meaning from what the participants said.  Each passage or extract 
was coded with what household it was from, what interview it was and the 
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page number (for example H1.I2.p3).  These processes involved a cyclical 
progression of reading literature, re-reading the transcripts and diary 
entries, listening to the recordings, discussing the topic with supervisors 
and project team members while also re-examining the themes or sub 
themes in context with other sections (Braun & Clarke, 2006; Bryman, 
2004). 
Eventually the lists of themes (topics) were narrowed down to eleven main 
findings.  Most of the findings emerged from the core research questions, 
which had developed from the research aims and previous literature 
research (Braun & Clarke, 2006).  Research questions include, What do 
medications mean to you and your household? What do you do with your 
medications? How do medications enter into your home? Where do you 
store your medications? What material objects in the home are related to 
medication use? Do you follow your medication prescription instructions? 
How do you feel about taking medication? 
Once an overall finding was developed, the extracted passages from the 
transcripts were placed under each finding with the corresponding codes.  
I tabulated this data to see what findings were represented across the 
households as illustrated in Table 2:  
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Table 2. 
Research findings  
Findings 
Harakeke 
household 
Pōhutukawa 
Household 
Pūriri 
Household 
Kōwhai 
Household 
Storage         
Accessibility of 
medication         
Ineffective 
medication       
Valued pursuits        
Approach to 
medication         
Relationships 
with med. Prof. 
      
Forgetting to 
take medication 
      
Effective 
medication 
      
Effect on daily 
life         
Resources that 
help 
      
Lay knowledge         
In the above table, a tick was given if the finding was discussed or alluded 
to in each household.  Although most findings were present in each 
household, the findings shown in grey dominated more of the discussion in 
that particular household.  It was also vital that the finding was a dominant 
discussion point across all the data sets (discussion, individual interviews, 
diaries and photo elicitation tasks) in that particular household and there 
was a number of extracts that were able to demonstrate the prevalence of 
the finding.  This process provided the structure for the following findings 
chapter, where eleven thematic areas are documented and interpreted in 
relation to each household.  Each household will exemplify a subset of the 
eleven themes; the first three households will present three themes in the 
context of the household and the remaining household will present two 
themes.  
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CHAPTER THREE: FINDINGS 
As described in the previous chapter, I identified eleven emergent themes 
that link with the research aims.  The themes were evident across all four 
households. Some householders, however, discussed some themes more 
than others.  For this reason, and to reflect the complexity and fluidity of 
social meanings medications take on in the lives of householders, I 
decided to narrate the presentation of my findings through each of the four 
households in relation to their knowledge of medications, what it meant to 
take medication, the social practices around the use and storage of 
medications and how medications are accessed and distributed. 
The sections that follow draw on each of the four households to illustrate 
two or three selected themes as they are reflected on in the lives of 
participants and in the context of the households. 
Harakeke Household 
This section presents the findings from the Harakeke household. Firstly, 
definitions of the three key themes from the Harakeke household are 
discussed.  Following this, the findings are presented and examined, 
including extracts from the household discussions, individual interviews 
and diaries.  Lastly, a summary is provided outlining the key concepts 
covered in the section. 
The themes that emerged from the Harakeke household are presented 
below, followed by a broad exploration of the theme in relation to its links 
with the meanings and understandings participants ascribed to their 
medications. 
(i) Storage:  exploring how and where householders stored their 
medications and when and where they administered 
medications gave insight into the consumption and social 
practices associated with medication use. The functionality of 
medication related to where the medication was stored 
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therefore, influencing the householder‟s usage patterns and 
reflected the associated values and meanings that were given to 
the objects. 
(ii) Accessibly of medication: The costs associated with seeing 
medical professionals and obtaining prescriptions, over-the-
counter medication and alternative medications often reflected 
the extent to which medications were perceived of as necessary, 
accessible or otherwise.  Accessibility of medications often 
influenced how participants treated medications, the extent to 
which inaccessibility disrupted daily life routines, and whether 
participants felt they could do without their medications. 
(iii) Ineffective medications: How participants perceived their 
medication‟s effectiveness influenced their usage patterns and 
reflects the associated value to the user.  What medications 
mean to householders can be explored though householders 
interpretations of how medications work and their perceived 
effective or ineffective outcomes. 
Theme One: Storage 
Across all households, medications were stored in a multiplicity of places.  
It was common practice to store medications in places of convenience, as 
the householders liked having them in spaces where they were ingested, 
applied, inserted or injected.  Medications were stored where the 
householders could visibly see their medications; they became visual 
reminders around the home, specifically the kitchen and the bedroom as 
medications were taken around meal times, first thing in the morning and 
last thing at night.  The Harakeke household was the only household 
where a young child resided.  The other households had children 
(mokopuna) visit and stay from time to time, but they were not in 
permanent residence, therefore, discussions around child safety were less 
of a focus. 
Where medications were stored in the Harakeke household are shown in 
the household map below (Figure 1).  This map was drawn by Megan, and 
48 
 
the numbers on the map refer to where medications were stored.  These 
numbers also correspond to the photographs that were taken. 
The bird‟s eye view of the household map outlines where all the 
medications were located across the space of the household.  Most of the 
medications were stored in the kitchen, followed by the living room.  The 
bedroom and bathroom also contained medications.  Although 
medications were found throughout the house, they were placed in 
positions of convenience or in accordance with storage directions, such as 
Sarah‟s liquid antibiotics being stored in the fridge. 
Figure 1. Harakeke household map. 
The Harakeke household stored their medication in places of 
convenience.  Even if Sarah was able to reach and touch the medications, 
they were not placed in safer places as Megan believed that Sarah was 
able to learn not to touch the medications.  The main medication storage 
spaces were in the kitchen and the living room.  Megan also stored 
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Panadol and cough lozenges that she acquired from her family, in her 
handbag.  Other medications were stored in the kitchen fridge, above the 
fridge, on the microwave, kitchen pantry, kitchen cupboards, bathroom 
cupboards, bathroom draws, bedroom vanities, bedroom draws and the 
bedroom wardrobe.  Although a number of storage places are described, 
there were not a lot of medications stored in these areas.  There were only 
32 medication items found in the house (as opposed to hundreds found in 
the other three households).  The majority of these items were Sarah‟s 
medicated creams and antibiotics, and Megan‟s dietary supplements.   
Medications in the household were stored close to where it was most often 
used.  Most of Sarah‟s creams were placed on the bookshelf (shown in 
Figures 3 & 4), close to where Megan changed Sarah‟s nappy or dressed 
her.  During the photo-referencing task, however, Sarah‟s medicated 
cream was also found in the bathroom on top of the toilet, (shown in 
Figure 2) demonstrating that medications are mobile within the space of 
the household and able to be found in multiple locations. For example, 
where they were last administered, consumed and/or applied. 
 
Figure 2. Sarah’s medicated cream’s placed in the bathroom, on top of the toilet 
Kahu and Megan discussed how at times Sarah could reach the 
medicated creams in the bookshelf.  Megan explained that Sarah was not 
able to open the containers but has managed to open the tubes of cream 
and has tasted the contents.  Megan explained that she monitors Sarah 
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most of the time, however there have been occasions where Kahu was 
asked to watch her and she has touched and ingested medications.  When 
Sarah does touch the creams she is disciplined by Megan.  Megan then 
places the creams back to the exact same place (which was within reach 
and sight) so that she learns that she can look but not touch.  Megan said 
that after a while Sarah lost interest in the items and did not bother to 
touch them, until, of course, a new medication came along.  Megan: “Like, 
sometimes if we get a new tube, aye, and if it’s the new stuff she gets 
more curious with but her other ones she’s quite happy just leaving them”. 
 
Figure 3. Sarah’s medicated cream’s in the middle of the bookshelf, in the living 
room. 
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Figure 4. Sarah’s medicated cream’s in the bottom of the bookshelf, in the living 
room. 
As shown in the photographs, Sarah‟s medication creams and tubes were 
stored with other household items such as books, photo albums, photo 
frames, CDs, baby wipes and Sarah‟s soft toys.  They are also within 
reach of Sarah but have become commonplace objects that Sarah sees 
and plays around in her daily life. 
During the process of taking photographs and referencing them to the 
household map, Kahu and Megan recognised all the old and expired 
medication that they had accumulated.  Megan explained that they usually 
store medication until the contents are all gone.  The medication is kept 
and stored because it comes in handy the next time they become unwell.  
Megan: “They [antibiotics] stayed around for a while and then I got sick 
one time and I ended up taking them.  Because I was, like, “Oh, I’ve got 
some antibiotics, that’s right.”  I can’t remember what I took it for but, yeah, 
I took it and then I was sweet.”  Megan explained that she only takes her 
antibiotics until she feels better, then she will keep the remaining 
medication for future use, although she is unsure what the medication is 
specifically prescribed for.  Both Megan and Kahu explained that they use 
medications in this way to fully utilise it for their own ends. 
Medications were stored in a number of areas around the Harakeke home.  
The householders utilised and relied on features of their physical 
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environment such as using the bookcase for storing medications and daily 
routines to help them organise and store their medications. For instance, 
the top of the toilet was used as a temporary storage area for Sarah‟s 
medicated creams as Megan‟s activities of that particular day saw her 
apply Sarah‟s cream in the bathroom.  These daily routines were ever 
changing and occasioned during the day.  Medications were stored and 
used in accordance with their functional purpose, which exceeded the 
need to store medications out-of-reach from Sarah.  Therefore, 
medications became commonplace objects, where they had become „part 
of the furniture‟, which was an intentional practice by the householders.  
The introduction of medications in the Harakeke home has supplemented 
its function as a site for care, a place where Megan cares for her daughter 
placing medications in viable storage areas, which propagates the notion 
that medications become objects of care and the spaces of the home are 
reflected as care sites. 
Theme Two: Accessibility of medication 
Of all households, the Harakeke household was the only one where the 
adults did not have a chronic illness.  Medications presented less of a 
focal point in their data set.  Their daughter Sarah, however, did have a 
chronic illness and access, storage, use and effectiveness of her 
medications were topics of discussion.  Throughout the conversations with 
the household it was clear that cost was a dominant factor in the decisions 
and access options they made.  When accessibility of medications was 
discussed among the other households they focused more on their 
„relationships with medical professionals‟ and their „approach to 
medications‟ (these themes are explored further in the Pōhutukawa and 
Kōwhai households).   
The Harakeke household discussed how they obtained their medication 
through family, friends, pharmacies and supermarkets.  Megan talked 
about how she has received over-the-counter medication and 
supplements from her Mum and Nan because she was not able to afford 
the products herself.  Throughout the discussions with the household, it 
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was clear that cost influenced when Kahu and Megan visited the GP, used 
medications and accessed specialists.   
The cost of GP visits and medication was often the reason for choosing 
not to go to the doctors or to use prescription or over-the-counter 
medication.  Kahu and Megan often felt they did not have enough money 
to pay for the doctor‟s appointment and the medication.  As a result Megan 
and Kahu rarely took medications.  Medications were, therefore 
understood as a product that was helpful when unwell, but were not a 
necessity in the context of their symptoms and daily life.  In New Zealand, 
cost plays a major factor in the decisions people make to go and see a 
doctor (Jatrana, Crampton, & Norris, 2010).  A recent study by the 
University of Otago, found that Māori and Pacific peoples are particularly 
affected by cost barriers when trying to access medication, and are less 
likely to attain prescription items because of the cost (Jatrana et al., 2010).  
Contributing factors include poverty, family structure and individuals 
having multiple health problems.  Research by Jatrana and Crampton‟s 
(2009) research illustrates that cost remains a reason for not accessing 
primary health care or attaining a prescription in New Zealand.   
Self-diagnosis was an important process when deciding whether or not to 
visit a doctor.  Megan discussed how she would self-diagnose her own 
illnesses and if she thought her sickness was „viral‟ then she would not 
visit the doctor.  Megan believed that if her illness was caused by a viral 
infection then the doctor would simply tell her that there was no cure and 
that she did not need to take any medication.  Megan also avoided seeing 
her doctor, and the associated cost of the visit, by simply ringing and 
asking for a repeat prescription when she could.  Nabalamba and Wayne 
(2007) examined the decision process of individuals who decide to seek 
medical attention.  The likelihood of seeking medical attention was related 
to the persons association with need.  Where patients would „self-perceive‟ 
their condition and those with chronic conditions were more likely to seek 
medical attention. Other factors that stopped people from seeking medical 
help included cost, no time, no one to supervise the children, fearfulness 
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and embarrassment.  For Megan the reason to seek medical help needed 
to be legitimised such to as attain medication. 
Kahu discussed how he did not like going to the doctor; as a result, he 
does not use or obtain prescription medications.  He explained that he 
does not like spending money on going to the doctor and then paying for 
prescription medication.  Kahu explained that he does not buy any 
medication over-the-counter because it costs too much and has become 
accustomed to not using medication when he is unwell.  When he does 
use medication, it is usually Megan‟s antibiotics that she had not finished 
taking. 
Kahu: Yeah, I never go to the doctors. 
Facilitator: Because does it cost you. 
Kahu: Yeah.  And even if it was $5.00 I still wouldn’t go.  I just don’t 
see why I should. 
Megan: And the doctor where he goes – he signed up with that free one 
– but it’s always a long wait. 
Kahu: Yeah, I don’t like it. 
Megan: And so the last couple of times when he was going to go he’s 
been waiting and then he’s been, like, “No, I don’t want to go, 
let’s go home.”...  And he won’t wait.  So, he won’t pay and he 
won’t wait!  So, we don’t go. 
Even when the cost factor is removed Kahu still does not access the 
doctor.  Kahu believes that his practices around medication usage and 
access are influenced by growing up in a low-income family where they 
were unable to visit the doctor or afford medication.  So he has become 
accustomed to not using medication and just using home remedies, such 
as taking lemon drinks when he has a sore throat.  It is important to 
acknowledge that Māori men are disproportionately represented in New 
Zealand as having the poorest health status in terms of disease and 
mortality (Willams et al., 2003).   
An epidemiological study on Māori men‟s perception and experiences of 
seeking medical help for prostate problems in New Zealand found, the 
barriers to health seeking behaviours were related to inadequate access to 
culturally safe and appropriate health care for Māori (Willams et al., 2003).  
Health seeking behaviours are thought to be determined by social and 
cultural expectations of what constitutes normal pain and illness, “ethnic 
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groups with consistently poor health status will accept pain and symptoms 
... as a normal part of life, rather than seek treat[ment]” (Willams et al., 
2003, p. 72).  These factors may contribute towards health seeking 
behaviours in the Harakeke household.  During the conversation with 
Kahu it was apparent that medications for Kahu were understood as 
complementary items in the household.  That is, he will not go out of his 
way to attain them however, if they are in the house, he will use them if 
illness symptoms persist. 
Megan and Kahu both avoid trying to spend money unnecessarily on 
doctor‟s visits and medications.  With their daughter Sarah having a 
chronic illness, however, they do not hesitate to take her to the doctors to 
get advice on her illness.  When Sarah was diagnosed with chronic 
eczema Megan‟s Nan advised her to take Sarah to a specialist.  Megan 
had not considered taking Sarah to a specialist.  Megan explained that if 
her doctor had suggested it, Sarah would have been placed on the public 
waiting list and it would have taken at least a year to get an appointment.  
Her Nan, however, offered to cover the cost of seeing a specialist 
privately.  While cost played a factor in Sarah accessing the specialist, this 
was not an option that Megan would have even entertained, had it not 
been suggested by her Nan.   
For the Harakeke household access to medication was based on cost, 
time and necessity, these factors were influenced by the social context in 
which medications were accessed and distributed to the public.  The 
household overcame the expense of medications by gaining access to 
them through family and by basing access decisions on the necessity of 
the health situation and avoiding unnecessary doctor‟s visits.  In the 
Harakeke household medication access is a complex process embedded 
in a social and cultural context that is debatably influenced by cost 
(Jatrana & Crampton, 2009; Jatrana et al., 2010; Willams et al., 2003; 
Zola, 1973), these cost factors may have contributed to the perception and 
process in which medications were accessed and understood. 
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Theme Three: Ineffective medication 
Medical technology and advancements are evolving rapidly (Warden 
Carroll, 1998).  In many cases there are medical ways of alleviating or at 
least managing ailments.  The effectiveness of medication, however, can 
vary from person-to-person (Warden Carroll, 1998).  All households 
experienced different degrees of medications being ineffective, including 
having negative side-effects, slightly reducing symptoms or not reducing 
them at all, being difficult to use or apply and stopping individuals from 
doing certain activities.  Various reasons were given as to why 
medications were considered ineffective.  For example, the medication not 
being taken as prescribed, because they forgot to take it or it was too hard 
to fit into their lifestyle and/or there was a communication break down with 
their doctor resulting in their prescription not being suitable.  In the 
Harakeke household, Kahu and Megan felt their daughter‟s medication 
was ineffective because it only slightly reduced the symptoms of atopic 
chronic eczema and found the creams difficult to use and apply as 
directed by the physician.   
Megan discussed how she originally took Sarah to the doctor where she 
was diagnosed with eczema.  The doctor advised her to apply medicated 
creams over the infected area 10 times a day to prevent Sarah‟s skin from 
drying and cracking.  After a period, the medication did not help and 
Megan explored other avenues of treatment suggested by her family and 
friends.  She tried alternative medication and dietary changes for a short 
time but they did not improve Sarah‟s eczema. 
The medicated creams that were prescribed did not appear to reduce the 
severity of Sarah‟s symptoms.  The cream did not make a difference to her 
rash spots. It spread the eczema around her body. The eczema was now 
at a stage where it covered her entire body except her face.  Although 
Sarah‟s parents felt the medication worsened her illness, they also felt 
they had no other alternative but to continue using the medicated creams, 
because without it, Sarah‟s skin would dry and crack predisposing her skin 
to bleeding and at times, infection.  Sarah‟s GP and specialist had offered 
no other solutions. 
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Megan: They said it was eczema.  And it wasn’t like the type of eczema 
that I had seen before.  You know, I thought eczema was 
different than that but they said it was eczema. 
Kahu: It was like almost after we started the cream it started coming 
on bad, aye? 
Megan: The reverse after that. 
Kahu: It sort of helped it along. 
Megan: Spread it … something like that.  It got worse after we started 
putting it on. 
Facilitator: Do you still use it [the medication]? 
Megan: Yeah, because otherwise it’s even worse. 
Kahu: Yeah, it just gets bad.  It gets dried out. 
During the interview Megan described how she administered Sarah‟s 
eczema cream on a daily basis and gave her medication.  Megan‟s Nan 
then recommended and paid for Sarah to see a specialist, who diagnosed 
atopic eczema and prescribed antibiotics for Sarah.  Both parents 
described how Sarah‟s condition was very difficult to manage, as there is 
no cure for her illness and the medication only slightly reduced her 
symptoms.  In the extract below, Kahu and Megan explain how Sarah‟s 
eczema developed and the treatments they used: 
Kahu: So it sort of just came out of nowhere [eczema].  Because it just 
started looking like rashes first thing and then turned into 
eczema. 
Megan: She just got it all over her body but not on her face and then 
they [doctor] just gave us creams, like, to rub in, like the 
aqueous cream.  And then it just kept getting worse and worse 
and so we kept taking her back to the doctor and then they 
gave us these other Locoid creams to put on as well.  And but 
it’s all just pretty much like managing it.  It’s not going to get rid 
of it. 
Throughout the interview and the medication use diary and photo 
elicitation tasks, both Megan and Kahu talked about how they felt helpless 
when Sarah was in pain. They felt the medication had „let them down‟, in 
that it was not at all effective and that it appeared to have actually 
contributed to the spreading of the eczema.  As Sarah‟s eczema was 
consistently itchy, she scratched her skin continuously, the worst times 
being when she could not sleep due to the irritation.  Kahu: “and those 
ones were just sick looking aye [her eczema rashes]? Like her singlet and 
her t-shirt was just blooded out on one whole side”. 
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During the interview, Megan described how she found it difficult to 
administer Sarah‟s cream ten times a day and only manages three 
applications.  She described how the task is very monotonous and 
draining as Sarah has a tantrum each time she has to put the cream on.  
Megan explained that Sarah would keep still for Kahu when he places the 
cream on her, but he rarely administers the cream.  Megan described how 
she finds the cream disgusting as it has a „gross‟ smell and it sticks to 
Sarah‟s clothes and makes them greasy, with this also deterring her from 
applying the cream more than three times a day. 
Megan and Kahu‟s accounts regarding Sarah‟s medications being 
ineffective invoke a cyclical process in which the behaviours, perceptions 
and decisions feed into each other.  They proposed that the cream initially 
spread her eczema and only reduced her symptoms.  Megan applies the 
cream 30% of the time.  This in turn reduces the effectiveness of the 
cream and contributes to the creams not being used a prescribed (which 
reduces its effectiveness). This contributes to their perception that the 
creams do not work. The cycle begins again with Megan only applying the 
creams three times a day as opposed to the recommended ten.  This 
experience is also presented in the Viswanathan and Lambert (2005) 
study were participants experienced different degrees of medications 
being effective, some participants found their medications to be very 
effective while others reported they took their medication on a regular 
basis but found the medication to not be effective. They explained, 
however, that they regularly „forgot‟ their medication.  The study concluded 
that medication effectiveness was interrelated with the belief in 
medications effectiveness and regular medication use. 
Household summary 
Briefly, patterns of medication use in the Harakeke household reflected 
their understandings of the efficacy of medication.  Kahu and Megan avoid 
using medical services for themselves because of the perceived expense 
and lack of service.  Although Kahu and Megan tried to avoid using 
medical services, their attitude with respect to their daughter was different.  
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While they prioritise medical treatment for Sarah, how her eczema has 
developed, the organic nature of the disease, the perceived lack of 
efficacy of the medication to reduce symptoms, and the fact that there is 
no cure, does not encourage them to persist with medication as 
prescribed.  A cyclical decline to a helpless situation appears to have 
result, with Kahu and Sarah feeling powerless to improve life for Sarah 
and themselves.  In the context of the Harakeke household medications 
are expensive and for this reason not used as directed.  They are 
accessed under-conditions that for Kahu reduce his dignity and contribute 
to him „not being bothered‟.  With respect to their daughter Sarah, 
medications have very little meaning when they are perceived to present 
limited or no hope for an improved future, as well as significantly disrupting 
household routines because of the intense energy required to administer 
them. 
Pōhutukawa Household  
This section presents the findings from the Pōhutukawa household.  
Firstly, definitions of the main themes from the Pōhutukawa household are 
discussed in this section.  Findings are then presented in the context of 
the Pōhutukawa household, including extracts from the household 
discussions, individual interviews and diaries.  Lastly, a summary section 
reviews the key concepts covered in the section. 
The themes that emerged from the Pōhutukawa household are presented 
below followed by a broad exploration of the theme and its links with the 
meanings and understandings participants ascribed to their medications. 
(i) Valued pursuits:  Understanding the value participant‟s place on 
their responsibilities, life goals and ambitions: such as meeting 
social responsibilities, work commitments and whānau well-
being, provides insight into the decision-making processes of 
using, administrating and prioritising medications in their daily 
life. Furthermore, it provides an important perspective on 
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explaining the variations in medication practices between the 
households. 
(ii) Approach to medication: How medications are integrated into 
daily activities and household flows reflect household and 
participant‟s understandings of their medications.  For example, 
whether medications are readily accepted, reluctantly accepted 
or resisted, in turn revealing the effects medications have on 
their day-to-day decisions and lifestyle.  These understandings 
and meanings of medication are an important part of explaining 
the variations in medication practices. 
(iii) Relationships with medical professionals:  The relationships 
participants had with medical professionals often reflected 
prescription practices and the extent to which medications were 
perceived of as necessary, accessible or otherwise.  This often 
influenced how participants treated medications, the extent to 
which inaccessibility disrupted daily life routines, and whether 
participants felt they could do without their medications. 
Theme Four: Valued pursuits 
Many households‟ juggled jobs, relationships and other responsibilities, 
meaning that, at times, their own healthcare needs came last.  Charmz 
(1991) acknowledged that when people are placed in positions where they 
have to compromise their valued pursuits, such as wanting to maintain 
work responsibilities or upholding family obligations, people place pursuits 
first, subsequently compromise their illness management and sacrificing 
their health condition.  Charmaz (2006) acknowledged that medications 
have to be able to fit into people‟s lives, not the other way around.  People 
with chronic illnesses, however, often had to make compromises in some 
way to fit medications into their lifestyle. 
In the Pōhutukawa household, John found that his valued pursuits were 
more important than managing his health so he could live longer.  He 
explained that he would rather continue to meet his social and work 
commitments and integrate his medications in his lifestyle than comply 
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with his prescribed regime and in his words “live a less active and 
productive life”.  John discussed how he has a very busy lifestyle.  He 
works fulltime, is a full time student and has additional responsibilities that 
require regularly travelling long distances.  On average, John has 16-18 
hour days where he can be working, studying and travelling.  John 
maintains that he has not changed his lifestyle and that his medications fit 
into his life, not the other way around. 
John explained that he would continue to maintain his lifestyle and 
medication practices even though he is aware of the potential negative 
health consequences.  John explained that he utilises his medications to 
benefit him and his lifestyle and made it clear that his priorities in his life 
are his study, work and family life, with medication priorities fitting around 
these. 
John: Our goal is to preserve Māori land to get it in the best condition 
so that it will become an asset for future generations.  So if I 
want to achieve [this] goal I need to be able to work long hours, 
do full time work so I need to utilise medications to be able give 
me the energy to do these things which goes against the 
prescription where I have to take my medications at certain 
times. 
Facilitator: So you can’t get the quality of life that you want if you used your 
medications as they prescribe them? 
John: When I'm looking at Pākehā ways of looking at things they want 
to preserve your health first ... regardless if other aspects in 
your life suffer, so that means take meds at a certain time each 
day but that doesn’t fit in with me. 
John‟s main goal is to look after and preserve Māori land for future 
generations. John feels that he needs to maintain his current lifestyle, 
where he has the freedom and flexibility with his medications, in order to 
reach his goals.  John feels that the „Pākehā way‟ of taking medications 
does not give him enough flexibility and would take over his life and 
interfere with his focus.  To John, medications are malleable in their use 
as he is able to utilise the medications to maintain his current 
responsibilities and activities in his life.  For example, John has learnt 
when he injects his insulin it can give him a surge of energy within 30 
minutes.  He utilises that energy to keep him awake if he needs to drive, “I 
was at the beach today and I got really really tired.  So I did the injection, I 
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waited about five or 10 minutes ... So I sort of gear up again.  So I know 
that I don’t have to keep up with the regimen every day I just use it when I 
really need some energy.” „Self managing‟ medication and „self tailoring‟ 
medication is becoming more apparent in compliance literature where 
participants are seen to modify their regimens by taking them strategically 
or symptomatically, or adjusting the dosage amount to avoid adverse 
effects or make the medication regime more tolerable (Elliott, Ross-
Degnan, Adams, Safran, & Soumerai, 2007; Ingersoll & Cohen, 2008; 
Pound et al., 2005).  This was apparent in John‟s case, as he would take 
his medication in a self-recognised strategic manner, allowing him to go 
about his daily activities, whereas without the medication, he was unable 
to maintain his energy levels. 
Gaining insight into John‟s life ambitions and goals is an important part of 
comprehending the complexities of his everyday life in which he uses and 
understands medications.  John recognises that the way he utilises his 
medications is not recommended practice from medical professionals. 
John‟s valued pursuits, however, such as preserving his ancestral land, 
which involves a lot of travel around the country may be more important 
than the long-term consequences of his illness management.  In order to 
fully comprehend John‟s experiences in his everyday life with his 
medications is more complex than identifying his life‟s goals and valued 
pursuits. 
Leventhal, Brissette, and Leventhal (2003) explained that patient beliefs 
around the cause, consequences and controllability of diabetes and 
understandings of their medications are the core drivers when patients 
make decisions about whether or not to take medicines and under what 
circumstances. Through Johns experience with education services, he has 
learnt the consequences of uncontrolled diabetes such as blindness, 
kidney failure, increased risk of heart disease and painful peripheral nerve 
damage (Gaster, 2008).  John strives to avoid such outcomes, by not 
following prescribed regimens and advice from his doctors and educators, 
and admits that he would rather, “go out with a bang and achieve my 
goals”.  Therefore accepting a greater likelihood that he will have a sudden 
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death.  This impression of John facing a sudden death is based on Johns 
own personal opinion. 
John: I have this strategy.  If I continue misusing my medications and 
not following recommendations, there’s a high probability I 
might have a sudden death.  So I don’t want a quality of life 
where I'm so debilitated, where someone will look after me.  
That’s not a positive way I want to look at my life I want to be 
able to live my life and not be bogged down with following this 
and that. I know I don’t have much flexibility with my 
medications but I use all the flexibility I want!. 
John discussed how he takes his medication based on how he feels rather 
than the prescribed administration.  He feels that, although his prescription 
does not allow for much flexibility, he can consume his insulin when he 
feels his body needs it.  In John‟s narration, he made it clear that he wants 
to maintain his lifestyle and quality of life at any cost.  He views 
compliance with medications leading him down a path of debilitation where 
he will live a longer, but not better, life.   
Simmons, Weblemoe, Voyle, and Prichard (1998) explored „personal 
barriers to diabetes care‟ and suggest that the greatest personal barrier is 
when perceived benefits of self-care are outweighed by the perceived 
disadvantages.  John perceives the self-management of his diabetes as 
being functional and adaptable to his lifestyle and priorities in his life.  He 
believes that his medication management works well for him because he 
has an awareness of what his body needs and when he needs time to 
rest. His approach to medication usage, however, is not the recommended 
practice by medical professionals as he is not maintaining regular insulin 
levels and testing.  Simmons and colleagues (1998) state that the benefits 
of sustaining diabetes are less likely to be appreciated by those diagnosed 
if the symptoms are not apparent or severe, do not require medication, 
have less knowledge of the potential harm and have experienced 
dissatisfaction with past care provider.  John has experienced a number of 
the above factors and finds the benefits of adhering to a specific diet and 
medication regime; do not outweigh the benefits of maintaining his valued 
pursuits because he has not experienced any immediate and apparent 
effects from his medication-taking behaviour. 
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Theme Five: Approach to medication 
Chronic illness can affect people in many different ways physically, 
mentally and emotionally (Pound et al., 2005).  Literature illustrates that 
people who have chronic illnesses act in a certain way towards their 
illness.  They can have emotional reactions such as, depression, anxiety, 
a „why me‟ state of mind and can question their identity in terms of no 
longer being considered a healthy person (Carrick et al., 2004; Cohen et 
al., 2001; Doran, Robertson, & Henry, 2005; Herek et al., 1990; Scott & 
Arslanian-Engoren, 2005; Whyte et al., 2002).  Every individual within the 
households presented a different approach to medications whether they 
readily accepted them in their life, accepted their medications reluctantly, 
or, resisted taking their medicines.  Pound‟s (2005) research on resisting 
medications identified all these factors. 
In the Pōhutukawa household, John is, in many ways, very independent 
when it comes to managing his diabetes.  Through many conversations 
and disagreements with his wife, they have learnt as a couple to let each 
other deal with their own health issues, as they do not share the same 
views.  John: “over the years she’s getting use to me, but does not 
necessarily mean she agrees with me”.  John explained that as a nurse 
Rachael believes in the bio-medical model of practice, where you follow 
your doctors and diabetes educators‟ advice and take medication strictly 
as prescribed.  John feels differently, “as a nurse she’s been brought up 
on the Pākehā medical model and what I’m talking about does not fit in to 
that.  Therefore she gets hōhā because I’m a lay person talking about all 
these other things that’s not likened to normal medical [model]”.  John 
takes his medication when he feels his body needs it and only tests his 
blood sugar levels every three months.  John believes that if he routinely 
stays fit, eats a proper diet and feels energetic then he rarely needs to test 
his blood sugar levels.  John was asked if he was confident in his 
approach to keeping himself well.  He replied “it has nothing to do with 
confidence, this is my life and that's what I am living.”  Therefore, John 
believes his approach to medication management and use is about self-
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agency and self-determination, whereby he manages his diabetes and 
does not let the regime rule his lifestyle. 
As well as sharing different health management views, John described 
how he and his wife stored their medications in different places and took 
responsibility for the taking of their respective medication.  Where John 
previously stored his medication reflected his wife‟s requests, as she 
preferred all their daily medication to be stored in a certain kitchen 
cupboard on the third shelf.  When John stored his medications in the 
cupboard, however, he would regularly forget to take his medication.  So 
they compromised and John now stores his medication in his study, where 
Rachael rarely goes. 
Facilitator: The study’s right next to the kitchen so I guess what I’m wanting 
to sort of discover is the relevance of having the pills in the in- 
tray when obviously you’ve got to take the pills with food so 
there must be some kind of routine that you go through that 
allows you to go past your in tray? 
John: Oh, yes.  This is the routine:  my in tray is in the office.  Rachael 
doesn’t want to see me have my medication anywhere so I’ve 
actually come to the in-tray, a place where it doesn’t seem to 
annoy her… she’s really quite tidy and the problem is I live in 
the house too, and I’ll make it untidy!  So I actually need to 
move in different areas that I’m, she knows I’ve got to take 
tablets that have to be somewhere so it’s found a home there 
that tends to be compatible with both of us. 
In this narrative, John explains that his wife prefers medications to be out-
of-sight because it creates clutter and mess.  They have both 
compromised, however, and although John has to make a trip to his study 
to get his medications this is adequate, as he seems to remember to take 
his medications when they are stored in his in-tray.  Therefore, the storage 
of the medications has to do with their personal dispositions as opposed to 
safety or other variables.  De la Cuesta (2005) research discussed how 
caregivers of dementia relatives „create spaces‟ in order to gain more 
therapeutic areas in their home, and how these spaces function as 
environments that support and enable care.  In the Pōhutukawa 
household, the functioning space of the office is transformed into John‟s 
therapeutic space for taking his medication, a space that permits the 
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storage and administration of his medication and allows other spaces in 
the house to remain for family life.  
The management and adaption of chronic illness at home can create 
stress, as it requires adaption by the individual and family members 
(Newby, 1996).  Newby (1996) discusses how family responses to chronic 
illness vary according to severity, disability and coping mechanisms of the 
individual.  In the Pōhutukawa household, it is no different.  As a couple 
both John and Rachael have adapted to one another‟s requests around 
the storage of medications, where medication is taken and they have had 
to compromise when they did not share the same point of view.  During 
conversations with John, however, he made it clear that he was not going 
to compromise when he took his medications and the dosage amount, “I’m 
the one that’s more responsible than anyone else about taking 
medications and ultimately I’m the one that is affected, so I will use my 
medications the best way I see fit.”  John‟s approach to taking his 
medications could be his way of coping with his chronic illness, with the 
stress of managing his medications, juggling his responsibilities and 
maintaining his relationships.  
While John‟s approach to chronic illness management can be perceived 
as the „man alone‟ in terms of care and support from his whānau, for John 
it is about his own self determination; the ability to make his own choices 
in terms of his own life and self agency where he can retain his control.  
Self-care for John is not without the impacts of his relationships with his 
whānau and household, as his home is the care context in which his 
medications are used and stored.  The nature of that care, medications 
and associated medication materials are clearly negotiated with his wife.  
These negotiations contribute to the peace and balance in the household. 
Theme Six: Relationships with medical professionals 
People‟s relationships with their doctors, educators and specialists were 
discussed across all the households.  The Harakeke, Pōhutukawa and 
Pūriri households felt their doctors were only a part of a process in gaining 
medications.  They felt that the doctors and specialists too quickly 
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prescribed medications and felt that they were rushed out the door, rather 
than assessing their health, finding solutions, providing them with 
alternative options and explaining the effects of the medications they 
intended to prescribe.  Several studies have indicated that increasing the 
involvement of the patient in their own treatment outcomes creates 
acceptability, satisfaction and compliance with prescribed treatment 
(Kane, 2001; Lambert & Naber, 2004; Peuskens, 2004). 
Diabetes education can be defined as “an exchange of knowledge, tools, 
and practices that will address the client‟s needs” (Ellis et al., 2004, p. 1).  
This broad definition can encompass different educational approaches 
such as group and individual learning sessions.  In the Pōhutukawa 
household, John received education from individual consultations with a 
diabetic educator and his GP.  The relationship with doctors and diabetes 
educators dominated many of the discussions about medications with 
John.  He talked about how GPs and diabetes educators provided very 
little practical information on the management of diabetes and the support 
provided was minimal and hard to attain. 
During the interview, John related how, when he was first diagnosed with 
diabetes, the information he received from his GP was poor and not very 
informative.  John also felt that he did not know what kind of questions to 
ask because he had little understanding about diabetes and was not sure 
if anyone in his family had been diagnosed with it, “I don’t have the right 
questions to ask and they’re not going to tell me”.  He later found out that 
his sister, mother, grandmother and cousins all have/had diabetes.  Since 
his diagnosis, he received further education from diabetes educators, 
however, he felt the information was not practical and the way they 
presented the information was not appropriate.  In the extract below, John 
explained how the diabetes educators used scare tactics to draw diabetics 
into using their medication as prescribed. 
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John: You listen to the education and they tell you how you’re going to 
die, like, chop your arms off, legs off, go blind and all those 
things.  And they seem to do the crazy thing about trying to 
scare you into something.  And more so, when they tend to do 
that, that’s an old routine of what I’ve been brought up [with] 
before, I end up not listening to them.  So I [don’t] take too 
much notice of that information. 
John explained that diabetes educators focus on negative outcomes that 
can occur when a person‟s diabetes becomes progressively worse.  John 
believes that diabetes education needs to be presented positively, with 
situations where people are able to maintain a good level of health.  
Simmons, Weblemoe, Voyle, and Prichard (1998) conducted a study on 
the barriers to diabetic care in South Auckland and found that the 
effectiveness of diabetic education was interrelated with many of the 
barriers to diabetic care.  Participants in the study felt that the education 
they received lacked practicality in that they could not see the advice 
transferring into their lifestyles and community.  They also found it hard to 
talk to their diabetic educators as they felt intimidated or had 
communication issues, as they needed help with translation (Simmons et 
al., 1998). Johns feels the education he has received on diabetes plays on 
fear, fear of what can happen if you do not follow the medication, exercise 
and diet regimen. This has led him to not communicate with his educator 
and GP honestly about his medication practices.  Therefore, John‟s 
understandings around medication usage and storage mainly come from 
his own personal experience.  As a result of this displacement with 
medical professionals, John understands that his medications are his own 
to interpret and utilise the best way he sees fit. 
John receives his prescriptions from his GP every six months and before 
the prescription is given, he needs to have a check-up.  John finds it 
difficult, however, to schedule an appointment with his GP as they are 
both busy and are rarely available at a mutually agreeable time.  John has 
been advised by his GP to take time off work to make the necessary 
appointment, however he feels that this is not an appropriate answer to 
accessibility issues and that taking time off work is unnecessary.  As he 
69 
 
finds his GP‟s advice inadequate, he chooses to monitor his own condition 
in his own way.   
John: Doctors and educators think we have unlimited sick leave just 
to see them to answer question.  Often their answers are 
pathetic and they carry no responsibility for the cost to the 
clientele  … Just lately, I’ve tried to see my doctor but she’s 
been too busy.  They said Wednesday, Thursday.  I said, “Oh, 
I’m busy.”  She wants to see me more than I want to see her so 
I will just leave it until she panics!  As long as she reorders my 
medication, it doesn’t bother me because they’re not really in a 
position to monitor me properly. 
In the extract above, John explains that he feels that his GP is not in a 
position to monitor his diabetes effectively; therefore, he relies on his own 
“instincts” to manage his illness.  He feels that there is probably a lot of 
useful information about diabetes, but he feels he cannot access it through 
his GP and diabetes educators. He is therefore, selective about what 
information he uses and proceeds to draw on his own personal 
experiences such as working out how to benefit from taking medication at 
a certain time in the day.  John is also selective when it comes to sharing 
information with his GP about the way he uses his medication.  He feels 
that because she is not a specialist she would not understand, “Oh, no.  
My doctor is a general practitioner and I would get hōhā explaining how I 
use my medications to her”. 
Wilson, Hutchinson, and Holzemer (2002) study discussed a similar 
practice as John described, where participants „self tailored‟ their 
medication regimen by relying on three strategies; body listening, gauging, 
and negotiating.  This involves listening to how their body felt rather than 
administering medications at a regular time; gauging, involved making 
comparisons and estimates about the severity of their conditions and 
negotiating with health professionals about medication options and having 
input into determining what medications they used.  John described 
situations where he would listen to his body and gauge the severity of his 
condition, however he never felt comfortable discussing the truth about his 
medication use to any medical professionals.  Therefore, medications 
become a very personal and private practice where John is the main 
decision maker when it comes to caring for his chronic condition. 
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Professionals and diabetes care providers consider diabetes education  as 
a pivotal component of diabetes treatment (Ockleford et al., 2008; 
Wheeler, Wylie-Rosett, & Pichert, 2001).  John viewed his experience with 
diabetes educators and his GP as negative and their advice to be 
impractical.  This created barriers in communication, where questions 
were not being fully understood (or even asked) and inadequate answers 
were provided.  Access was also a problem for John as he was required to 
see his GP on a regular basis, however he felt this process was 
unnecessary because the appointments were not required as he managed 
his own chronic illness without the help of his GP.  Subsequently, John‟s 
relationship with medical professionals leads to experimentation with his 
medication, non-compliance with his prescribed medication regime and 
self-management of his diabetes.  Ultimately, John views his medications 
as tools, which provide him with the means to achieve his lifestyle 
demands, while living with a chronic condition.  This aspiration to live a 
„normal life‟ and meet the social demands of daily living is one of the key 
aspirations for people living with diabetes (Ockleford et al., 2008). 
Household summary 
In summary, the Pōhutukawa household is comprised of a married couple 
with each partner taking responsibility for their own health needs.  John fits 
medications into his life in ways that are convenient to him, rather than as 
prescribed.  He „listens‟ to his body, taking note of tiredness, signs of 
being unwell and malaise.  Contrary to the views of his frustrated wife who 
is a nurse and who has withdrawn from giving him any advice about his 
health care, John adjusts his medication according to how he is feeling or 
to permit other activities like eating and driving.  John finds solace in his 
aspirations to reach his life‟s goals before he passes away and uses this 
account to explain his approach to medication usage and administration.  
John explains that although his approach may seem like an unpractical 
way of managing his health he would rather „go out with a bang‟ than 
endure a long drawn out illness.  John also feels that because he has not 
experienced any severe consequences of using his medications in this 
way he believes that because he is not “critical”, a situation where his 
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organs could fail and his mobility be reduced, he does not need to change 
his current practice. 
Pūriri Household 
This section presents the findings from the Pūriri household.  Firstly, the 
definitions of the three key themes from the Pūriri household are 
discussed.  Following this, the findings are presented and examined 
including extracts from the household discussions, individual interviews 
and diaries.  Lastly, a summary is provided outlining the key concepts 
covered in the section. 
The themes that emerged from the Pūriri household are presented below 
followed by a broad exploration of the theme in relation to its links with the 
meanings and understandings participants ascribed to their medications. 
(i) Forgetting to take medication: not taking medication or not 
taking it as prescribed could have implications for whole 
households, not just for one individual.  Forgetting to take 
medications could disrupt household relationships revealing the 
significance that medications play within social relationships and 
householder roles. 
(ii) Effective medication: How participants perceived their 
medication‟s effectiveness influenced their usage patterns and 
reflects the associated value to the user.  What medications 
mean to householders can be explored though householders 
interpretations of how medications work and their perceived 
effective or ineffective outcomes. 
(iii) Effect on daily life: How medications are integrated into daily 
activities and household flows reflect household and 
participants‟ „attitudes‟ towards their medications. For example, 
whether medications are readily accepted, reluctantly accepted 
or resisted, in turn revealing the effects medications have on 
their day-to-day decisions and lifestyle.  These understandings 
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and meanings of medication are an important part of explaining 
the variations in medication practices. 
Theme Seven: Forgetting to take medication 
In every household, members at some time forgot to take their medication.  
The reasons behind failing to remember to take medications varied 
between individuals, for example, routines were not followed, medications 
were not accessible, memory loss, stress and, in some cases, individuals 
did not believe in the efficacy of their medication so they did not strive to 
remember.  Some of these reasons were reflected in the Pound and 
colleagues (2005) study that found that participants struggled to remember 
to take their medications as routines were not in place or not used, they 
had an underlying belief that taking the medication caused short and long-
term harm.  The adverse effects of not taking one‟s medication varied 
between the householders as some relied heavily on medication to 
manage their illness, and, for others, the adverse effects were not 
immediately apparent.  The consequences of not taking medication also 
related to how much medication was not taken and over what time period. 
In the Pūriri household, four members had chronic illnesses and relied 
heavily on medication to keep them alive.  Medication-taking practices 
were integrated into their every day routines.  These routines enabled 
them to remember to take their medication and for some, reminded them 
to administer others medication.  Routines are an essential part of 
managing medication regimes especially those who take long term 
medications, as they provide a way to integrate and minimise the efforts of 
taking medication (Gamble, Fitzsimons, Lynes, & Heaney, 2007; Sidat, 
Fairley, & Grierson, 2007).  Regular medication-taking resulted in the 
medication being perceived to make a difference.  Taking medication on a 
regular basis, however, was sometimes felt to be enervating, especially 
when considering the householders busy lifestyles. 
In the Pūriri household Tāne administers his father Tui's medication in the 
morning and evening.  At times, however, he finds it difficult to get his 
father to take his pills, as Tui will regularly, and in Tāne view purposefully, 
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forget them, even though they are right in front of him.  In the extract 
below, Tāne discusses how he goes to great lengths to get his father to 
take his medication, which usually involves him placing the medication in 
front of him at meal times. 
Tāne: Dad has a bad habit, if you put meds in front of him and he 
won’t even take it when it’s right there.  You know, and you say, 
because it goes hand in hand with breakfast or lunch or 
whatever it is.  So he can have breakfast and you say, “There’s 
your porridge and here’s your meds”... and I come back ten 
minutes later when he’s finished and he’s wandered off and the 
meds are still there and the porridge is eaten up.  So I pick 
them [up] and get a cup of water, take it down to his room and 
he’ll be at his office or whatever sitting at the desk and I say, 
“Here, you go, you didn’t take your meds.”  So I put it there and 
come back twelve o’clock or something and they’re all still 
sitting there ...  you’ve just got to keep chasing [him]. 
For Tui the perceived forgetfulness of taking his medication may be linked 
to the fact that he does not like taking medications, as he believes that 
once you start to take medications on a regular basis the medications will 
affect your immune system and cause it to become weak.  Therefore, 
when Tāne places the medications in front of Tui more factors may be 
interplaying than the perceived forgetfulness of Tui.  Also, while Tāne is 
focusing on getting his father, and mother when she comes to visit, to take 
their medications, he can forget to take his own medication, compromising 
his own medication regime and placing his health at risk.  Looking after 
others can sometimes affect one‟s own self-care as sacrifices are made to 
fulfil care giving responsibilities (Boland & Sims, 1996; Read & Wuest, 
2007) which include failing to take one‟s own personal medications.  In the 
case of all the households, one main carer looked after other household 
members needs. Having one primary caregiver who takes full 
responsibility for care is very common (Burton-Jones, 1995; Johnson, 
1983; Nygaard, 1991; Parsons, 1997) and if the main carer becomes 
unwell, it can affect the caring structure in the home.  Therefore, the 
application of medications is very important in balancing health, lifestyle 
and relationships in the Pūriri household. 
Although medications were taken routinely on a daily basis, interviews with 
the Pūriri household, indicated that the taking of their medication was not a 
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rigid task.  They felt that a certain amount of flexibility around when to take 
medication was necessary as it enabled them to feel a bit more in control 
over their daily routine.  This supports what is found in the chronic illness 
literature, where people with chronic illness have explored ways of 
simplifying their regimes, such as adjusting pill-taking times, reducing the 
dosage amount or even discontinuing the medication (Adams et al., 1997; 
Charmaz, 2002; Ockleford et al., 2008; Shoemaker & Ramalho de 
Oliveira, 2008).  In other words, they took on more and more control and 
responsibility with their own medication management.  In the following 
extract Tāne describes the household‟s medication routine. 
Tāne: You know when you’re in the hospital and they come round 
every day at the same time as breakfast and then they come 
round with the meds, the doctors always come at a certain time.  
That would be so controlling of your life, it gives you no 
flexibility.  Whereas the way that we’re taking them at the 
moment I’d think we’re reasonably flexible.  We're not so rigid 
and you have to take it within sixty seconds of this time or else 
you’re going to self destruct or something.  We associate the 
taking of meds with meals and so if we have a late breakfast 
then the meds are going to be late.  If we have early breakfast, 
early meds. 
The household‟s daily routine involved taking medication with meals, as it 
fitted in with the prescribed times of morning, midday and afternoon.  Their 
regime became complicated when medication is to be taken at a set time 
before food.  Because meal times are not the same time each day, the 
time to take medication can vary on a daily basis.  Tāne explained that 
they simply avoid taking this medication and ask the doctor for another 
alternative.  Requesting medication changes is not always expressed to 
the doctor as many patients simply discontinue the medication (Charmaz, 
2002; Haslbeck & Schaeffer, 2009; Shoemaker & Ramalho de Oliveira, 
2008).  In Tāne‟s case he explained that he felt he had a good relationship 
with the GP and also knew from past experiences that alternative 
medication options were available.  For the Pūriri household medication 
management is an important part of their everyday life.  By understanding 
their daily practices with medications we learn that their medications are a 
necessary part of their life, where compromises and flexibility are just as 
essential. 
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Forgetting to take medication can have severe adverse effects especially 
when you have several chronic illnesses that require medication.  In the 
Pūriri household four householders had a chronic illness(es) and relied on 
a number of medications to keep them alive and maintain their current 
state of health.  In the extract below, Tāne explains an instance when his 
father, who at the time was living alone, repeatedly forgot to take his 
medication, causing his health to deteriorate and the wound on his leg to 
become infected. 
Tāne: … [a]nd if you went to have a look at the box you would see 
there’s like about twenty blister packs and not one of them had 
been touched ... it cause[d] other complications for him [as] he 
got a wound on his leg and normally his meds would’ve 
assisted with the healing of it but because he wasn’t taking his 
meds he spent three months with the wound and [in] the care of 
the District Nurse.  It ended up turning kind of gangrenous, he 
had to go into hospital for an operation which they cut part of it 
out and he spent the next eight months getting it fixed up...but 
then he moved here and spent from December to now getting it 
right and it’s only just come right and that’s a direct 
consequence of not taking his meds. 
Tāne‟s recounting of Tui‟s lack of compliance and resultant infection 
illustrates the meanings Tāne associates with his father‟s medications.  
They are life giving, infection avoiding and a way to keep hospital 
admissions and medical professionals out of their lives.  As a result, Tui‟s 
leg will never be the same and he now has to wear a compression sock for 
the rest of his life.  His leg also has to be elevated at night to help the fluid 
circulate out of his leg.  Forgetting to take medication has had drastic 
results and now Tāne has developed for Tui, procedures and lifestyle 
changes that he needs to maintain to stay healthy. 
For Tāne, while extremely frustrating and sometimes stressful, reminding 
Tui to take his medication, to raise his leg and assist his father with his 
compression socks, are „small‟ health steps towards avoiding more serious 
and disruptive consequences.  These care giving strategies have not been 
well documented in the literature as the main findings focus on the burden 
of care, such as feelings of loneliness and isolation, physical demands and 
financial costs (Boland & Sims, 1996; Burton-Jones, 1995; Johnson, 1983; 
Kramer, 1997; Nygaard, 1991; Parsons, 1997; Read & Wuest, 2007; Scott 
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& Arslanian-Engoren, 2005).  De la Cuesta (2005) who explored the 
experiences of Colombian family caregivers caring for relatives with 
dementia, identified the „craft of care‟ where caregivers use inventive 
strategies and evolve their lifestyles to restore health.  Like Tāne, the 
caregivers in the study take vigilant care of small aliments and conditions 
to avoid illnesses and conditions worsening.  Medications play a vital role 
in the actions of care giving as they are objects that can represent aroha, 
hope and give the carer a way to provide a means of healing. 
Forgetting to take medication can be the result of change in daily routine 
or current routines being ineffective, however it can reflect a person‟s 
attitude towards their medications, specifically the underlying belief that 
the medications are also doing them harm (Haslbeck & Schaeffer, 2009; 
Shoemaker & Ramalho de Oliveira, 2008).  It is not possible to fully 
comprehend and consider every element which leads a person to 
forgetting their medication, however the consequence of it affects the 
social relationships and householder roles (de la Cuesta, 2005; 
Shoemaker & Ramalho de Oliveira, 2008), reinforces that medications are 
important to the well-being and harmony of the household for the Pūriri 
household. 
Theme Eight: Effective medication 
All households discussed how they viewed the efficacy of their medication.  
Both the Harakeke and Pōhutukawa households had issues with their 
medications not being effective in their use, biomedical outcomes, and 
manageability.  The Pūriri and Kōwhai household found their medications 
were effective and had a positive influence on their health and household.  
Efficacy was related to the medication being compatible with the user‟s 
body in which they experienced very little or no adverse effects, the 
prescription instructions fitting in with their individual lifestyles, and the 
medication being easily accessible and affordable.  Therefore, efficacy 
was due to a number of factors which was not solely related to the 
biomedical outcomes, such as reducing fluid levels in the body (Webster, 
Douglas, & Lewis, 2009).  Research on patient compliance found that the 
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effectiveness of the medications contributed significantly towards the 
patient‟s compliance to their medication regimen (Gordon et al., 2007; 
Shoemaker & Ramalho de Oliveira, 2008; Sidat et al., 2007; Urquhart, 
1994; World Health Organisation, 2003). 
In the Pūriri household, members viewed their medication as mainly 
having a positive effect on their lives.  Tāne, Erin and Tui maintained a 
level of health through a daily medication regime to manage their chronic 
illnesses.  Their medication enabled them to sleep, keep their blood 
pressure down, heal their wounds, maintain organ function, and continue 
to be mobile.  Tāne, Erin and Tui made it clear that they would not be able 
to function, or even live that long, without their medication.  Even though 
they have a high reliance on medications, however, at times they did 
forget to take their medication.   
For the Pūriri household, they believed that for their medication to be 
effective they had to take their medication daily.  When Tui was living on 
his own in town, he became ill because he was not taking his medication 
regularly.  His whānau then decided it was safer for him to move in with 
them so they could monitor his medication-taking practices and overall 
health.  Due mainly to Tāne's monitoring of his father‟s illness and 
administration of his medication, Tui has maintained his level of health and 
has not been admitted to hospital since he moved in with them.   
Tāne: He was actually living in town by himself for about two years 
and he only moved here in December last year.  And he wasn’t 
really keeping up with his meds by himself.  We’d go home and 
find whole boxes of blister packs that he hadn’t touched type of 
thing ... his health has improved since he’s been here.  And, 
yeah, it’s more about routine.  Once you get into a routine or 
when the meds need to be taken then we tend to be on track. 
During the household discussions, Tui expressed that he did not like 
taking his medication; and when he was living on his own he often forgot 
to take it, which resulted in him having to be hospitalised.  The 
functionality of spaces within the home become increasingly significant 
when people become chronically ill, “social and geographical worlds shrink 
through constrained mobility and chronic illness” (Dyck et al., 2005).  
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Therefore the management of chronic illness becomes difficult to maintain 
if home spaces, practices and relationships do not support the 
management of chronic illness (Dyck et al., 2005).  Once Tui moved into a 
home space that supported the management of his chronic illness he was 
better equipped to meet the regime demands of his medication.  As a 
consequence, Tui began to take his medication on a regular basis with the 
help of his son, and began to regain his health.  As a result, his 
medications were perceived differently due to his recent experience of 
maintaining his health. 
For the chronic illness householders, taking medication is a matter of life 
and death.  They rely heavily on the medication and subsequently their 
medications become their insurance to keeping them alive.  During the 
household discussion Tāne outlined how long each member would survive 
without medications. 
Tāne: If Mum goes a day without her meds [there is] a very serious 
chance she’ll have a seizure and a stroke and end up in 
hospital.  Dad, he can go a couple of days without his meds and 
he’s still fine.  Me, I'm gasping for air if I’m out of meds for half a 
day type of thing. 
Tāne‟s narration highlights the awareness he has on his whānau mortality 
without medications.  Medications provide stability and give the users a 
sense of control.  Medications are viewed as „lifesaving‟ and this 
perception was shared across studies with participants who have 
hypertension (Viswanathan & Lambert, 2005), asthma (Adams et al., 
1997), epilepsy (Conrad, 1985), and diabetes (Ockleford et al., 2008).  
Subsequently, people with co-morbidities and complications are more 
likely to endorse medications as being „lifesaving‟ (Viswanathan & 
Lambert, 2005).  For the Pūriri household, they understand medications as 
being vitally important, medications mean that they can maintain a certain 
level of health, and while their medications are not without side-effects, 
they are willing to accept these as a trade-off (Shoemaker & Ramalho de 
Oliveira, 2008). 
Tāne, Tui and Erin described how they took an array of medications but 
did not specifically know what each medication pill was prescribed for.  For 
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them knowing the specific name for the medication or its functions was not 
important, as long as the medication was effective and the side-effects 
were not too severe.  In the extract below, Tāne discussed how he did not 
know what all his medications were prescribed for.  Despite this, he trusted 
that the medications were effective and necessary, viewing his medication 
regime as having a very positive effect on his life. 
Tāne: Yeah, but for some unknown reason some pills that I take I 
haven’t got a clue what they are ... and yet the doctor says it will 
do me good ...  what I [do] know is that without them my health 
deteriorates rapidly in days and I go from being reasonably ok 
to hardly able to breathe and feel like my heart’s about to stop 
at any second. 
Tāne‟s narration discusses how his doctor views the medications as 
„good,‟ therefore encourages him to take his medication.  This 
encouragement, coupled with the immediate effects if he does not take his 
medication, contributes to his compliance with his medications.  Field, 
Ziebland, McPherson, and Lehman‟s (2006) study on heart failure patients 
understanding of medications, shared a similar view, describing how 
participants did not know the name of the pill they were taking but 
recognised it was important because of the recommendation by their GP 
and the medications effectiveness.  Due to the progressive nature of 
chronic conditions, however, treatment options and medications that work 
one day can vary the next day.  Therefore, effectiveness of medications 
and patients compliance should be viewed on a “dose-to-dose basis 
[where] the decision to adhere is made each day, dose by dose” (Wilson 
et al., 2002, p. 12).  For the Pūriri household, each day they take their 
medications to avoid severe health outcomes: their medications enable 
them to breath, stabilise their heart rate, and circulate fluid around their 
body and so on.  How they perceive their medications effectiveness to 
maintain these bodily functions influences their usage patterns and reflects 
their associated values to the user.   
The Pūriri household members discussed how medications were a 
necessity for them to stay well.  Without their daily medication regime 
Tāne, Erin and Tui‟s health deteriorates rapidly, therefore, when they take 
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their medication daily their health is maintained.  Although the medications 
are effective in improving certain aspects of their health, it does not solve 
all ailments, illness, or is not without adverse effects (Webster et al., 2009; 
Wilson et al., 2002).  The effectiveness of medication is not a fixed 
perception as health conditions, environmental factors, relationships and 
social practices change, alter and transform (Armstrong, 2005; Conrad, 
1985; Dowell & Hudson, 1997; Sidat et al., 2007; Urquhart, 1994; Webster 
et al., 2009; Wilson et al., 2002; World Health Organisation, 2003).  For 
the Pūriri household, they believed that their medications were effective 
and had a positive influence in their life, and this was reflected in their 
attitude towards their medications and the way they routinely used their 
medications.   
Theme Nine: Effect on daily life 
Exploring the participants daily life with medications enables the taken-for-
granted world that is usually private and unseen, to be revealed (Couldry, 
2003).  Medications on some level affect the everyday life of its user, 
however the significance of its affects are attributed to a number of factors.  
Factors include prescription regimen, adverse effects, lifestyle, 
responsibilities and relationships inside and outside of the household 
(Haslbeck & Schaeffer, 2009).  Currently there is very limited knowledge 
about the multiple mechanisms involved in the effect medication has on 
ones daily life.  Research examining medication usage has mostly focused 
on older populations, finding them to take many medications concurrently 
and to be considered as at risk of side-effects, such as confusion and falls 
(Thomson & Poulton, 2002).  These studies and other medication use and 
misuse research, however, are focused on compliance issues, where 
users either conform or stray from prescribed regimens (Campbell et al., 
1983; Gilbert, Luszcz, & Owen, 1993; Haslbeck & Schaeffer, 2009; Helling 
et al., 1987). 
Across all the households, medications affect daily life differently, 
according to the individual and relationships involved.  In the Harakeke 
household the application of medicated creams were a huge part of 
81 
 
Megan and Sarah‟s routine and mother daughter caring relationship.  In 
the Pōhutukawa household, self-care and monitoring were a part of John‟s 
daily life with medications.  In the Kōwhai household, daily life orientated 
around Miriama‟s well-being which involved care from her daughter, while 
Noi self managed her own medications.  The Pūriri households daily life 
also orientated around care and self-care with medications, with Tāne 
caring for his father and mother (when she visited), also monitoring his 
own chronic illnesses, with Erin self managing her own medications.  
Within the Pūriri household are four chronically ill members, (including 
Miriama who transitions between the Pūriri and Kōwhai households), and 
between them they take a lot of medication.  Tāne not only has to monitor 
his own chronic illnesses, but also manages his father‟s, and at times, 
mother‟s daily care, as well as working from home.  A large part of the 
household‟s daily life involves the administration and application of 
medications, attending medical appointments and considering the adverse 
effects of medications.  It was evident that the household‟s daily life was a 
balancing act of prioritising needs (for example, having to take medication) 
against wants (wanting to go places but cannot because of the adverse 
effects of the medications).  In the following section the Pūriri household‟s 
daily life with medications will be explored covering how side-effects and 
the application of medications can disrupt daily life, and how a medication 
routine is important to maintaining health and upholding responsibilities. 
Routine is a very important part of the Pūriri household‟s daily life.  
Routine is described as deliberately “designed behavioural patterns [that 
are] used to organise and coordinate activities along different axes of time, 
duration, social and physical contexts, sequence and order” (Haslbeck & 
Schaeffer, 2009, p. 3).  Throughout the interviews the household 
discussed how Tāne had tailored a daily routine around the administration 
of medication, the tasks involved with preparing, tending and changing 
bandages, obtaining medication and making medical appointments.  This 
is reflected in the extract below. 
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Facilitator: And then you take care of your Dad? ... as in getting the 
medication, checking when he’s going to need the next blister 
pack ... 
Tāne: Run him to the doctor.  All those sorts of things. 
Facilitator: How do you find that? 
Tāne: It’s a bit of a headache to get you [talking to Tui] to go to the 
doctor, get the medication, get the blister packs, make sure you 
take the meds in the morning, when we just leave it in the egg 
cup ... and then we’ve got to top it off with having to put you in 
the shower, take the bandage off when you have the bandage 
on, aye?  Cream your leg; make sure you’re ready for the 
District Nurse when she was coming. 
Caring and tending to these responsibilities takes time, patience and care.  
Tane discusses his father‟s medication routine commenting on how he 
monitors, sources, presents, and pursues his father‟s compliance and 
other care needs and his own frustrations.  Interesting here is how Tane 
tells his care story.  The story is told through a narrative of a father – son 
relationship, being told by a son to a father.  The interviewer becomes an 
observer of the conversation even though they are the cause of the 
exchange.  The narrative is a telling of their care relationship, focussed on 
the substances and behaviours that present ways of being together, of 
bringing care into their relationship, and of offering care from son to father. 
While disruptions to daily routines are apparent, sub-routines to respond to 
disruptions demonstrate an enabling resilience.  The story is told in a 
loving and compassionate way but at the same time invites Tui into a safe 
space to contradict or elaborate.  Switching the focus to telling their story 
to his father of their relationship suggests a respect in directness and 
honesty.  To do otherwise, is to reveal the intimacies and struggles of their 
relationship to some other without seeking permission to do so – an act 
tantamount to diminishing the status of his father in public.  Through 
medications, Tane navigates his cultural obligations to care for Tui‟s 
physical and medical needs and cultural status as a father, grandfather, 
elder, and family head.  Reading beyond the medications, illness and 
frustrations of growing old and becoming dependent, we find a son 
motivated by the cultural obligation of manaakitanga, of giving due regard 
to the mana of his father. 
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In the Pūriri household, family life and medication use are interwoven into 
the fabric of the household.  Medications clearly had an effect on 
householder‟s daily lives.  For Tāne and Tui, the taking of the “water” 
tablets (Furosemide) meant that they needed to have ready access to a 
toilet for the best part of the morning.   
Tāne:  [Medications] impact on your lifestyle and routine and choices 
of what you can do during the day ... but in general his meds, 
like Mum’s, the one that wants you to go to the toilet all the time 
to get rid of fluid [Furosemide].  You build your day around that.  
Mum takes her meds in the morning for that so we can’t charge 
out anywhere in the morning that is longer than twenty minutes 
to half an hour from a toilet ... dad is the same although his are 
like, he's about thirty-forty minutes before he has to go. 
The well-being and health of Tāne‟s parents directly affected his lifestyle.   
Tāne can no longer leave the house without considering if there are 
adequate toilet facilities where they were going, which in turn impacts on 
the activities they can do and how long they can travel for.  At times, the 
adverse effects of taking the medication result in it not being administered 
until they are back at home, with this impacting on the routine built up in 
the Pūriri household.  Haslbeck and Schaeffer (2009) identified that people 
with chronic conditions find it particularly challenging to maintain proper 
medication management in their lives, as they consistently have to alter 
and revise them.  For Tāne, as a medication user himself and carer, 
medication must be functional enough to manage the side-effects.  If the 
medication results in too much restriction, compromises must be made.  
Problems and concerns about side-effects of medications have been 
researched, however these studies tend to focus on physical details of the 
adverse effects rather than the effect of medications on daily life  (Carrick 
et al., 2004; Rogers et al., 1998).  In the Pūriri household, medications are 
understood as being a necessary to maintain health and the household 
strives to comply with their medication regime.  Medication usage, 
however, is variable as daily life is complex (Haslbeck & Schaeffer, 2009).   
When the household were discussing the effect medications have on their 
daily life, Tāne spoke about how he has difficulty using his Continuous 
Positive Airway Pressure (CPAP) machine regularly.  He has to use the 
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machine each night as it assists him with his breathing by helping to 
oxygenate his blood.  As explained, in the extract below however, Tāne 
does not feel comfortable using the face apparatus and often does not use 
it.  He explained that even though he understands that he needs the 
machine to help with his breathing, and without it he is at risk of his health 
deteriorating, Tāne found the machine does not meld with his body 
enough to become unnoticed, so he is constantly reminded of the ailment.  
This makes the machine „uncomfortable‟ and „unnatural‟.   
Tāne: For me ... I feel like it’s not assisting me breathing.  It’s like it’s 
stopping me from breathing ... and they keep telling me to 
persevere and eventually you’ll get used to it but I really can’t ...  
I know all the reasons why I’m meant to be using it and there 
are definite side-effects to it all and I’m fully aware of it but 
sometimes it’s just, it doesn’t feel natural, that’s for sure. 
Therefore, even though Tāne has been advised by his specialist to use the 
CPAP machine, and he is fully aware of the health benefits and risks he 
takes if he does not use the machine, Tāne chooses not to use the 
machine regularly because it is uncomfortable and affects his personal 
relationship with his wife.  Therefore, if the medication and its 
administration are not comfortable and manageable, the impacts are too 
great on the user‟s daily life and as a result may not be effectively used.  
People with chronic conditions strive for normalcy and develop strategies 
to integrate medications into their lives, however these strategies are only 
effective through the process of „trial and error‟, as users evaluate side-
effects and the medications usability (Haslbeck & Schaeffer, 2009). 
Medications affect the daily lives of the Pūriri household in a number of 
ways.  For Tāne‟s parents it means taking medications after each meal 
and experiencing their side-effects, which can restrict activities.  For Tāne, 
taking and administrating medications are a part of his daily life, where he 
has to mould his daily activities to the care needs of his parents.  For Erin, 
medications are a part of her daily routine where each meal is followed by 
medication.  Due to the complexity of daily life and responsibilities that 
need to be met, the household‟s routine needs to be flexible and 
adaptable.  However for some householders their medication regime is not 
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very forgiving.  If medications are not taken daily the household structure 
and routine can become disturbed.  Tāne explains the importance of 
maintaining medication responsibilities: “one of the primary reasons why 
you try and keep up with their meds and all their appointments and stuff is 
because; if they deteriorate in any way I’m the one there to support them 
afterwards.  Believe me; I don’t want to be chasing around after them 
more than I’m doing at the moment.”  Therefore medications mean that 
householders can gain a sense of control and certainty in the face of 
illness (Shoemaker & Ramalho de Oliveira, 2008). 
Household summary 
The Pūriri household is a multigenerational household where children, 
parents and grandparents reside.  Both parents and grandparents have 
chronic illnesses and manage their illnesses through self-care and 
supported care perspectives.  Their home provides a spatial context where 
individuals can experience a sense of control and freedom, where 
everyday responsibilities, care practices and routines can be enacted 
(Dupuis & Thorns, 1996).  Their daily life involves an array of medications 
and enables them to create structure when confronted with the chaos that 
illness brings.  Routines were developed to remind and alleviate some of 
the on-going pressure to meet the demands of the medication regimen, 
which Haslbeck and Schaeffer (2009) term „compliance stress.‟  Examples 
of routine disturbance, such as forgetting to take medications, highlight the 
important role medications fulfil, physically, emotionally, and socially.  
When medications are forgotten, an individual‟s health can deteriorate 
rapidly, which in turn can affect their efficacy and create a ripple effect on 
the whānau, as caring responsibilities increase and routines alter.  For the 
Pūriri household medications are understood as a necessity in their 
household that supports stability, mobility, healing and health 
maintenance. 
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Kōwhai Household 
This section presents the findings from the Kōwhai household.  Firstly, 
definitions of the two themes from the Kōwhai household are discussed.  
Following this, the findings are presented and examined in the context of 
the Kōwhai household, including extracts from the household discussions, 
individual interviews and diaries.  Lastly, a summary is provided outlining 
the key concepts covered in the section. 
The themes that emerged from the Kōwhai household are presented 
below followed by a broad exploration of the theme and its links with the 
meanings and understandings participants ascribed to their medications. 
(i) Resources that help: What participants developed, adapted or 
purchased to optimise their medication-taking practices revealed 
to me the lengths to which participants went to integrate 
medications into their households and into their daily lives.  
Resources included personal health diaries, labelling their own 
medication and using pill containers to remember and track 
consumption. 
(ii) Lay knowledge: Lay knowledge is acquired through experience, 
education and emotional comprehension of a phenomenon.  By 
gaining insight into the householder‟s lay knowledge of 
medications, we can begin to understand what medications 
mean to the respective households. 
Theme Ten: Resources that help 
Each household had their own unique routines and practices around 
taking medications.  Some individuals relied on the emplacement of the 
medications to invoke reminders, some relied on other householders to 
remind them, and others were handed their medication on a daily basis by 
a loved one. Other household members developed and adapted resources 
to best optimise their medication-taking practices.  A number of studies 
have looked into the risk factors associated with taking medications at 
home such as, under and over dosing medications, lack of medication 
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administration routine, hoarding, discontinued medication and therapeutic 
duplication, (Hsia der, Rubenstein, & Choy, 1997; Sorensen, Stokes, 
Purdie, Woodward, & Roberts, 2005).  The positive aspect of medication 
use in the home, however, has not been well researched (Mager & 
Madigan, 2010; Read & Krska, 1998). 
During the conversations with the Kōwhai household, I learnt about their 
strategies and routines around taking medications.  This section discusses 
the development and adaption of resources that the Kōwhai household 
members have tailored to best optimise their medication-taking practices.  
These resources included a personal health diary, labelling their own 
medication and using a pill container to administer medication. 
During the initial discussion with the household, Lana showed me 
Miriama‟s personal health diary.  This diary was not something that was 
given to them or suggested by any health service or health worker; it was 
developed by Lana and her brother, Tāne.  They used a plain A4 
workbook to record their mum‟s daily life in relation to her health.  This 
included the medication she was currently on, any appointments she may 
have had in the past and their outcomes, future appointments, daily logs 
from Whānau members, and anything else that they felt was relevant.  In 
the extract below, Lana explains how the development of the health diary 
came about and how it serves to act as a valuable resource when they are 
consulting with medical staff.  She also explains the specific structure of 
the book.  The front of the book is for the daily journal and the back of the 
book holds all her medical notes and hospital discharge papers. 
Lana: Because in terms of information, the medications will tell a 
health professional one thing but they won’t necessarily give all 
the medical history, so the book goes with us everywhere.  It 
goes to day care.  It goes everywhere... 
Facilitator: So is this book something that was told for you to keep? 
Lana: No, we just keep the diary, we’ve got about 20 of these ... what 
happened was that she had a stroke and she went into hospital.  
And we would always visit and what not and sit with her.  But 
she was in there for about six months in hospital going through 
rehab.  And we didn’t know who was coming and going and 
what the specialist was saying or whatever else so we started 
keeping the books and it’s just gone on from there.  So when 
she has a critical incident then it tends to be more medicalised.  
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And she’d have a little write in it from time to time.  Kept all the 
clippings and what not.  And these are her head exercises 
[pointing to a section in the book], finding names and nouns ...  
so that’s basically the book in terms of a medical history and 
just the day to day what’s happening today?  Where did I go?  
Who saw what? ... at the back of the book is all the medical 
information ... all the discharge papers and what not, clinical 
notes ...  and the thing is that she can be admitted into any 
hospital and it’s not necessarily the same hospital all the time.  
So if they have problems with their records because they’re not 
always centralised on the computer system.  So it’s easier for 
us to carry around the medical history. 
Miriama‟s health condition is slowly deteriorating as she is regularly getting 
infections and the severity of her chronic illnesses are progressing, 
affecting her balance and immune system and symptoms persist for longer 
periods.  Her medications are changing and new approaches are taken to 
address her current health condition.  The journal is a vital resource in 
processing and keeping track of medication changes, GP and specialists 
recommendations.  This practice shows that the management of 
medications are an integral part of the Kōwhai household‟s daily lives, as 
they work to document and understand medication use and make 
meaning of their experiences.   
When the Kōwhai household was taking photos of their medication in the 
house, they specifically photographed the cat‟s medication on top of the 
fridge (as shown in Figure 5).  When the household members discussed 
this photo, they talked about how Pango‟s (the cat) medication is 
specifically stored on top of the fridge by his cat food.  When they place 
the medication on the kitchen bench, there has been confusion with the 
bottles, as Miriama‟s medication looks exactly the same as Pango‟s, and 
to add to the confusion, both the cat and Miriama take Warfarin.  To 
eliminate any confusion with the cat‟s medication, Noi labelled each bottle 
and container that belonged to Pango with a cat illustration as shown 
specifically in Figure 6. 
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Figure 5: Pango’s medication on top of the fridge. 
 
Figure 6: Pango's medication with his own labels. 
Taking the right medication is important to the Kōwhai household and, 
once in their possession, they alter the packaging to suit their practices 
and storage spaces, primarily to avoid any medication mix-ups.  This 
practice shows that it was more important change the appearance of the 
medication rather than change their medication-taking practices. This 
illustrates the importance of routine and the extent to which efforts are 
made to integrate medications into daily lives. 
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Another resource that Lana and Miriama rely on is a small „pill container‟, 
with this used to administer Miriama‟s daily medications.  Lana discussed 
how the container is very important part of their daily routine.  In the 
morning she places all Miriama‟s morning pills in the container, prepares 
her mums breakfast, and once Miriama has taken her pills, Lana give‟s 
Miriama her cup of tea.  The pill container was introduced because when 
Lana would give Miriama her pills, she would place them in her hand and 
when she went to put them in her mouth, some of the pills would fall on 
the ground.  The pill container provides a more functional way of 
swallowing all her pills.  If the pill container is still in its storage place or the 
container still has pills in it, it also serves as a visual reminder that Miriama 
has not taken her pills.  The pill container is a valuable resource in 
reminding and administering medication as it aids in the maintenance of 
taking medication on a daily basis.  It aids in ensuring medications are 
taken, emphasising that medications are important to them. 
The Kōwhai household used many medications and their state of health 
relied upon the fact that they needed to take their medication on a regular 
basis.  As the household plainly stated, medications are a matter of life 
and death.  Both Noi and Miriama have had long-term illnesses for many 
years, and due to their complicated medication regimes and related 
medical activity, the household developed resources and safety 
mechanisms to ensure they took their own medications and kept up-to-
date with appointments.  Using resources to maintain their medication 
regimes shows ingenuity and demonstrates the lengths they will take to 
incorporate medication into their everyday lives.  Imrie (2004) discusses 
how the home is part of a person‟s mental and physical well-being as it 
provides privacy, security and functionality.  The household structure 
allows allocation of functions to specific spaces, such as cooking in the 
kitchen.  There are no specifically designed spaces, however, to 
accommodate disease and illness.  Therefore, residents fashion their 
medication usage behaviours around the structure of the home and 
develop resources and strategies to best optimise their social practices 
with medication (Dupuis & Thorns, 1996; Dyck et al., 2005; Imrie, 2004). 
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Theme Eleven: Lay knowledge 
Lay knowledge of health and illness is shaped by personal experiences, 
interactions with other people and broader cultural belief systems and 
shared culture or common understandings in society (Kelleher, Gabe, & 
Williams, 2006).  Across each household, householders recited from their 
own knowledge base and understanding of medications.  The 
householders with chronic illnesses had gained a vast amount of 
experience with medications as they went through many trial and error 
practices, to work out the best regime for them.  In turn, they became lay 
experts, because ultimately they knew what medications and treatment 
methods worked for them and their lifestyles.   
All the Kōwhai household members have a lot of experience with 
medications, whether it is related to their own intake or their whānau 
members.  Noi has had a number of on-going illnesses since she was 
young and has used, misused and discontinued medication.  Due to Noi's 
experience with her on-going illnesses, she is able to recite the medication 
she is currently on, why she is on certain medications and not others, and 
is able to explain how these medications affect her body.  In the extract 
below, Noi is just beginning her initial interview and explains what her 
current medication regime involves and describes their uses. 
Noi:  Kia ora, where do I start?  I’m 60 years old and I am a chronic 
asthmatic, I have Hepatitis C and I’m a cancer survivor.  So all 
of those mean I have a lot of medication in my life.  I’ve been on 
different types of bronchodilators and steroids and other things 
for asthma which I’ve been hospitalised for many times over 
many years ... the miracle drug for me at the moment is 
Symbicort which is a combination of reliever and preventer – 
the blue inhaler and the brown inhaler have been reconfigured 
into the red inhaler so I don’t have to take shots from different 
devices.  I only need the one, which I do twice a day usually if 
things are good.  In flu season, I may have to take them up to 
five or six times and then I start using the blue one as well 
which is the dilator as well as the preventer.  As you can see, I 
know quite a lot about the drugs that I’m on. 
It would seem that Noi has a comprehensive knowledge of her illnesses 
and her medication, listens to her body, and adjusts dosages accordingly.  
Noi communicates that she knows a lot about her illnesses and associated 
medications, highlighting that her understanding and meanings of 
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medications is closely related to her experiences and lay knowledge.  
These pharmacological objects described by Noi are transformed in her 
dialogue as they represent social objects, they present her history of 
illness, memories of experiences with other medications, which help shape 
and form her current experiences with medications (Viswanathan & 
Lambert, 2005).   
During household discussions, Lana spoke about the household‟s 
medications with great knowledge.  She easily recalled what medication 
and devices each person was using and described in detail what 
medication related to each chronic illness and how the medication treated 
the symptoms.  Lana explained that she gained her knowledge about 
medications from the numerous appointments and hospital visits she has 
had with her mum.  Lana explained that she always asks questions when 
she is unsure about medications, procedures and her mother‟s care.  
Lana: “So I’ve gone through the process of knowing what Mum’s 
medications are and what they’re for and all the rest of it.”  Medications 
are not seen as a personal responsibility in this household.  They share 
responsibility and accountability for the use and knowledge of 
medications.  Lana understands that her mother‟s welfare rests in her 
actions and care practices and understands that medications are a large 
part of making sure Miriama stays well. 
Lana is especially familiar with her mum‟s medication and health illnesses.  
Lana not only learnt about her mother‟s medication from consultations with 
health professionals, but is also willing to take Miriama‟s medication 
herself to experience their adverse effects.  Lana discussed how her 
mother was unable to go far from a toilet after she took a Furosemide pill 
and she wanted to be able to understand why.  Lana: “…so any way I 
popped one Furosemide pill and the earth shifted and I understood exactly 
what she meant that it was “I want to go right now.” You’ve got to go to the 
toilet”.  This action allowed Lana to experience her mother‟s world.  The 
understanding she gained from the experience enabled her to become 
more empathetic towards her mother‟s situation and her care needs.  This 
action shows true commitment to understanding Miriama‟s experiences, 
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this enabled Lana to identify with her mother‟s requirements and recognise 
that she was legitimately in need. 
As Lana oversees Miriama‟s medication regime and administers her pills, 
at times she has been in a situation where she had to decide what dosage 
of medication Miriama was to take because the Medical centres and 
Pharmacies were not open.  As Lana explained, Miriama has weekly blood 
tests to monitor her Warfarin levels and depending on the results, her 
dosage levels can change.  Due to Lana‟s experiences and numerous 
discussions with her GP and specialists about Miriama‟s dosage levels, 
she felt equipped enough to make a reasonable decision about Miriama‟s 
Warfarin dosage levels.  This situation demonstrates the level of Lana‟s 
expert knowledge around Miriama‟s medication regime and exhibits the 
lengths she will go to insure her mother gets the right dosage amount of 
medication.  Lana‟s experience with Miriama‟s „medical world‟ has enabled 
her to make informed decisions about her health care needs, if deemed 
necessary.  Lana‟s lay knowledge can be viewed as a type of insurance 
that Miriama is able to get the best care possible from her daughter (Read 
& Wuest, 2007). 
Part of Lana‟s process in understanding the medication her household 
takes, is searching on the internet for information on medications 
components, adverse effects, effectiveness, and consumers experiences 
and opinions.  Once Lana has analysed this information, she makes a 
decision on whether or not to consult with the GP further or begin the 
medication.  On making an informed decision, Lana feels that she can 
forget about the details and particulars of the medication and move on. 
Lana: You know, I just pop them [medication] ... I’ve read the 
information, I’ve gone to the website, I’ve looked at what all the 
side-effects are blah, blah, blah, blah, blah.    Heard everyone 
else’s stories of why they’re on the medication, what it does to 
them, blah, blah, blah, blah, blah.  And I feel fine about my 
medication and I can just forget that information.  It’s not 
irrelevant but it’s too much detail, you know ... What I usually do 
is ...  if Mum goes onto a new medication, I look at what that 
medication is.  I find out what the side-effects are.  I do a kind of 
search online because there’s often forums with people who are 
also taking the same medication, they’re having side-effects or 
stuff that they don’t tell you about in terms of the side effect 
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official pages.  And then weigh up what that information might 
mean.  And then, you know, if all is fine, cool...So long as it 
hasn’t got a huge controversy in terms of the drug that I’m on 
I’m happy about it ... But if it has then I usually go back to the ...  
doctor in question. 
This process described above emphasises the commitment Lana has 
made to oversee her whānau well-being, through careful consideration of 
the facts around using certain medications.  Responsibilities and 
commitments that Lana has demonstrated, are mirrored across cultures, 
socioeconomic status and geographic differences, where filial 
expectations of concerning care of aging parents persists (cited in, 
Donorfio & Sheehan, 2001).  It is important to Lana that she has the 
resources to be able to access knowledge both physically and 
intellectually, as it enables her to become better informed about the 
medication she and her whānau use, enabling her to rationalise treatment 
decisions. 
The Kōwhai household is rich with knowledge around medications as two 
household members have a number of chronic illnesses and are heavy 
users of medication.  Noi demonstrated that, through her vast and long-
term experience with medications, she has gained a lot of lay knowledge 
around her illnesses and consequently become an expert on her own 
health conditions.  As Miriama‟s carer, Lana acts as an advocate for her 
mother by becoming knowledgeable about her mother‟s condition, 
attending medical appointments, seeking advice from medical 
professionals, personal experience and researching online.  The 
knowledge acquired helps reduce the turmoil associated with the 
uncertainty about Miriama‟s ever-changing health status (Boland & Sims, 
1996; Read & Wuest, 2007), as Lana became better informed about the 
associated treatment methods, medications and adverse effects. 
These avenues of knowledge help inform Lana on the care practices she 
should take and legitimate her position as a carer and Miriama‟s illnesses 
(Nichter & Thompson, 2006).  Being able to question medical advice and 
research online enables Noi and Lana to gain an understanding into why 
one experiences adverse effects, why certain pills are prescribed or why 
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specific tests need to be performed.  Understanding enables individuals to 
have a sense of control about their health and become involved in the 
decisions made by health professionals. 
Read and Wuest‟s (2007) study discussed how daughters that accumulate 
knowledge about their parent‟s chronic illness are striving for control, as 
there is a sense of future loss and disruption to the family unit.  This 
concern triggers protective watchfulness and caution around the treatment 
options, including use of medications, in the context of approaching 
unwellness and loss (Read & Wuest, 2007).  This may be the case for 
Lana, however, interpretation of why one cares for another is a complex 
multidimensional construct, where multiple perspectives are in play 
including cultural expectations and values such as reciprocity, gift of 
exchange and whānau responsibilities.  Therefore, gaining insight in the 
Kōwhai households understanding of medications requires consideration 
of the practiced relationships within the household. 
Household summary 
Briefly, the Kōwhai household had their own unique history with 
medications.  As a household, they experienced adversity with 
medications, in some instances provided solace in their life, while other 
medications reduced their independence.  These experiences with 
medications created a knowledge base, enabling the household to learn 
from past experiences.  The household became experts on their own 
bodies and developed knowledge and intuition with those they cared for.  
Experiencing adversity encouraged them to seek answers for themselves.  
They became more informed on the health care decisions suggested by 
medical professionals.  This in turn enabled the household to create 
routines and strategies that best suited their home space and lifestyle, and 
allowed them to accept that medications were a part of their lives and 
existed within the relationships they have with each other.  Medications 
presented more than substances, they symbolised notions of hope, 
history, aroha and care and which in turn gave the medications „social 
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lives‟ and meaning (Bauman, 1996; Olsen, 2003; Sointu, 2006; van der 
Geest, Whyte, & Hardon, 1996).  
Summary of findings 
This research aimed to explore householder knowledge of medications, 
how medications work, and what it means to take medication. 
Furthermore, the research aimed to document social practices involving 
medications within households, such as how, when and where they are 
used, and how they are accessed and distributed. 
Medications in this study were used as a focal point to enter into the 
everyday lives of those families who live with, and manage, chronic illness.  
Entering into four separate domestic domains and listening to differing 
circumstances around the social practices with medications, lead to a 
multifaceted analysis, which mirrored the complexity of everyday life. 
During the analysis process eleven underlying themes emerged, each 
household presenting a slightly different perspective and context to the 
themes. These themes were also more or less prominent according to the 
households‟ experiences with medications. 
Focusing on these eleven themes presented clear indications of what 
medications mean to Māori households.  Firstly, across all the households 
it was evident that medications are managed within their homes.  The 
findings are consistent with literature which acknowledges that the 
management and adaption to chronic illness at home can create stress, as 
it requires adaption by the individual and family members (Newby, 1996).  
This study found that homes do not have specifically designed spaces to 
accommodate disease and illness.  Residents fashion their medication 
usage behaviours around the structure of the home and develop 
resources and strategies to best optimise their social practices with 
medication.  Households created routines and strategies that best suited 
their home space and lifestyle, and allowed them to accept that 
medications were a part of their lives and existed within the relationships 
they have with each other.  Homes were used as care sites in which 
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medications become objects of care through the enactment of 
relationships with other householders.   
The importance of relationships was a key theme presented across the 
household‟s, relationships with others was an integral part of managing 
chronic illnesses, including the management and use of medications.  
Reliance on others gave rise to care and support relationships within the 
households as a mother cared for her daughter, a daughter cared for her 
elderly mother and a son cared for his wife and his elderly parents.  
Support and care also presented as a husband and wife allowed each 
other to express their rangatiratanga.  Although the perspectives on 
medication management and use differed, care and support was still 
present as they gave each other the space to practice their 
understandings of medication management, while offering manaakitanga. 
Cultural values played a vital role in the social structure within the homes 
as household members communally cared for each other. The dependent 
were looked after by loved ones and filial relationships were bound 
together by responsibility, duty and care.  Medications became subsumed 
within these relationships as a part of the everyday practice of caring for 
another, becoming cultural objects.  Within these Māori households, 
medications were viewed as what I refer to as „personal‟ prescriptions and 
„whānau‟ prescriptions.  In the first instance, medications were prescribed 
to the individual person for their health benefit and maintenance.  They 
were also prescribed within a whānau environment, however, where loved 
ones supported and cared for each other by developing and maintaining 
medication regimes and resources, administering and applying 
medications and gaining knowledge on medications.  Factors such as 
accessibility of medications, cost, medication effectiveness and adverse 
effects were perceived, understood and managed within the whānau.  
Household members would alter their daily routines to allow medication 
side-effects to wear off or alternatively take medications at differing times. 
Medications were more than just substances, they symbolised notions of 
hope, history, aroha and care and which in turn gave the medications 
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„social lives‟.  The findings are consistent with the premise that 
medications are material objects with therapeutic uses that enter into, and 
take on meaning within people‟s lives.  They are culturally embedded 
phenomena that carry meanings and shape social relationships and 
practices. 
In the concluding chapter, I will discuss the importance of relationships 
and care in Māori households and how they contribute to the management 
of chronic illness.  Next, I will explore the contributions this research can 
make to the current body of medication literature.  Finally, the future 
research directions will be covered.  
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CHAPTER FOUR: DISCUSSION 
Chronic illness is a significant health issue for Māori.  Through 
advancements in medical technology, people are living longer and 
medications are used to prolong life and manage chronic illness (World 
Health Organisation, 2005).  The shift from acute to chronic illness is no 
longer isolated to the hospital setting as chronic illnesses are increasingly 
being managed in domestic settings (Edward et al., 2001). 
The primary objective of this research was to advance knowledge about 
the meanings of medications in Māori households and the social practices 
that surround medication use.  Even though Māori were specifically 
targeted in this research, they did not present as a homogenous group. 
The meanings of medications are complex.  Medications are understood 
as functional objects, to maintain health and prevent illness.  Medications 
have become cultural objects as they are used in a way that reflects the 
cultural values and bonds within the households.  Within household 
relationships, medications are invested within meaning to show aroha, 
support and care.  Within a Māori whānau context, the values of 
maanakitanga, rangatiratanga, and whanaungatanga were recognised as 
having an integral role in understanding the social practices with 
medications in each household. 
The eleven key findings from this research illustrate the complexities 
involved in the consumption of medications and the dissolving of these 
pharmacological and social objects into cultured domestic contexts, bodies 
and relationships.  This chapter reviews the ways in which Māori 
households manage their medications in relation to their understandings of 
these objects.  I then bind key elements together, discussing the familial 
relationships within these household as central elements for the context of 
care and identity, while considering the value of whānau and how it 
informs contemporary care giving practices in the home.  This leads to an 
exploration of how the severity of one‟s chronic illness can impact on the 
way in which medications are understood and the different meanings for 
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their users.  Consideration is then given to how this research provides 
knowledge of Māori use of medications in the home that can inform 
medical professionals.  Finally, future directions for research are offered. 
Caring, managing chronic illness and culturally patterned 
relationships  
The centrality of familial relationships of care to the management of 
chronic illness through medication use, supports a relational 
understanding of health. This perspective posits that health is 
fundamentally relational and as dependent on social arrangements as 
biological processes (Hodgetts, Sonn, Curtis, Nikora, & Drew, 2010). Such 
a stance is supported by decades of epidemiological research that shows 
that the more functional and supportive the relations between groups in a 
society and the more social cohesions there is the healthier the entire 
population (Wilkinson & Pickett, 2009).  This thesis has contributed to work 
in this area by demonstrating the importance of relationships to the 
management of chronic illness in Māori households. 
In this context, medications represent more than inanimate objects; they 
are diverse and are understood and used by people in everyday life in 
ways that transcend their categorisation as prescription drugs (Doran et 
al., 2005).  Medications not only relieve symptoms and allow the 
maintenance of a certain level of health; they enable people to gain a 
sense of control over the uncertainty of illness and to experience support.  
Medications become central to the ways in which people care for one 
another, how they show their aroha and help fulfil responsibilities (Nichter 
& Thompson, 2006).  During the analysis process, it became evident that 
there was an ever-present underlying theme related to the importance of 
relationships and care in the management of medications. 
In the Harakeke, Pūriri and Kōwhai households, it was clear that if the 
relationships were not present, the chronically ill would not survive. 
Additionally, in the Pohutakawa household there was a high probability 
that the chronically ill may develop dependency, where relationships with 
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others would be paramount to the survival of the chronically ill.  During the 
research, household members described how they cared for each other.  
Certain household members took on the responsibility of obtaining 
information on medication, the administration of medication, storing the 
medication, and attending medical appointments with their whānau.  This 
allowed the carers to ask questions about medications and help suggest 
changes in the medication regime.  These actions and events created 
situations where responsibility, duty and care practices were performed 
and reciprocated as whānau members had been cared for in the past. 
Throughout the household discussions, caring relationships were based 
on reciprocity, manaakitanga, aroha and responsibility.  However, when 
exploring literature on care giving in the home, it was described as a being 
burdened with extra responsibilities, having to worry about another; having 
to place own aspirations and needs on hold (Boland & Sims, 1996).  Care 
was described as having many negative aspects from feeling weighed 
down by responsibilities, not having enough support and resources, and 
the emotional stress it gives rise to (Boland & Sims, 1996; Donorfio & 
Sheehan, 2001; Read & Wuest, 2007; Voysey Paun, 1975). However, in 
the context of this project, the notion of „care‟ was reciprocal in nature, as 
people have to want to be cared for and responsibility for others seen as 
collective, caring while possibly felt as a burden was constructed by these 
participants as a privilege leading to the fulfilment of filial responsibilities.  
While this may contrast with the literature about „caregiver burden‟, further 
investigation of this pattern is required. 
Tying key elements together: Domestic emplacement, 
identity, cultural values and Māori chronic illness 
Presently no one has studied medications within Māori households, how 
Māori people understand medications and how this impacts on social 
practices with medications.  Studies such as Baxter (2002), Davis and 
colleagues (2006), Ellison-Loschmann and Pearce (2006), Harwood and 
colleagues (2005), Ministry of Health and Wellington School of Medicine 
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(2005), and Willams and colleagues (2003) have focused on specific 
chronic illnesses, which explore the barriers to healthcare for Māori, health 
seeking behaviours and the prevalence or specific aliments.  The present 
study provides insight into the everyday lives of those with chronic 
illnesses where medications take on important meanings for users at 
home, enabling people to respond to illness and engage in the 
management of health. 
This research has also extended present understandings of the chronic 
illness experience.  This study demonstrates that experiences with chronic 
illness transcends personal reactions (Pinder, 1990), self-perceptions 
(Charmaz, 2002) and physical reactions (Shoemaker & Ramalho de 
Oliveira, 2008).  Experiences are also influenced by social interactions, 
where relationships become a focal point in the care and maintenance of 
illness.  Literature on social impacts of the chronic experience such as 
Anderson and Bury (1988), Chamberlain and colleagues (2007), and 
Cohen and colleagues (Cohen et al., 2001), recalled social experiences as 
having an impact on the way one may react to issues of identity change 
and responsibilities, where they may influence choices and actions.  
However, little acknowledgement is made into how social experiences 
influence the health and management of the condition, furthermore, the 
importance of relationships within the home. 
In the Harakeke, Pūriri and Kōwhai households, participants discussed 
how medications fitted into their lives and represented more than just a 
lotion or a pill, enabling them to feel like they were actively helping 
another.  Medications not only have medicinal purposes but legitimated 
illness that gave rise to more explicit care relationships as those on 
medications were considered to be in genuine need (Whyte et al., 2002) 
and worthy of assistance.  As material objects situated in specific domestic 
locations, medications are intertwined with people‟s practical experiences 
of being in the world, routines, habits and memories (Olsen, 2003).  
Through daily practices involving the use of medication, people come to 
know and understand themselves (Heidegger, 1982).  Olsen (2003) 
proposes that “…we are always already in the world; the world is part of 
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our being, not something external, „out there‟ to eventually be embodied. 
We are not detached observers of objects, but concerned users of 
things…” (p. 96). People are interwoven into the world through the use of a 
collage of material objects that they often simply take-for-granted until 
these do not serve their purpose. Medication emplacement and use 
constitutes statements of self and relationships with others, including 
family and health professionals. Householders develop „a sense of place‟ 
where memories are associated with particular locations and objects (Dyck 
et al., 2005).  Such places and associated tactics furnish people with a 
sense of connection; history and shared activity (Twigger-Ross & Uzzell, 
1996) with each other; places and homes serving to position the chronic 
illness and what it means centrally within these relationships. 
Householder routines and daily practices with medications become 
customary within the home.  Such practices include, storing medication in 
a certain place in the bedroom, bathroom or kitchen to remind the person 
to take their medication.  Throughout the households, people and those 
who care for them strategically placed their medication in areas of the 
home where they would be seen and noticed, thus prompting them to take 
their medication. Practices such as simply reminding Dad or Mum to take 
their medication by placing medications in a pill container in front of them, 
or on the dining room table, constitute material statements regarding 
familial relations, routine, concern and care.  As part of caring, reminding, 
remembering and asking for compliance are social activities often 
expressed through culturally defined behaviours that demonstrate 
affection, affiliation and humour in exchanges surrounding the use of 
medications. They become expressions and engagements of 
manaakitanga and whanaungatanga.  Caring through placement and 
memory prompting reflects how simple acts have a broader significance in 
social relationship surrounding medication use and how these actions 
reflect and support Māori values.  Cultural obligations are met through 
enactments of giving others their medication, strengthening bonds and 
commitments, in turn preserving the integrity and strength of the family. 
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For Māori, the cultural values of manaakitanga, rangatiratanga and 
whanaungatanga define kinship obligations.  As a lens through which to 
view relationships, manaakitanga provides understanding of practices of 
care and support householders had for one another, as loved ones 
reminded each other to take medication, attended medical appointments 
with them, and provided support to make lifestyle changes and maintain 
routines.  Rangatiratanga highlighted how aroha, status and respect can 
play an integral part in the way medications were used, as care for the 
elderly was conducted in such a way that endeavoured to uphold their 
status and mana, which was simply illustrated in the way a son addressed 
his father during the interview.  When taken together, these values bring 
about an obligation on the part of children to reciprocate earlier care 
provided by their parents and grandparents, in turn enabling the aged to 
discharge their cultural responsibilities as elders (Ritchie, 1992).  
Furthermore, elders have to want to receive care, for example, John did 
not seek care from others as he felt he was physically well enough to look 
after his own health. 
The importance of considering the severity of illness 
Meanings of medications are linked to the relational practices and cultural 
patterning in the home describes pattern that prescribes Māori ways of 
domestic life.  The severity of one‟s illness can also play a vital role in what 
medications mean to the household.  It was evident that the severity of 
one‟s illness influenced the associated meanings individuals and their 
whānau gave to medications.  Such views affected all facets of use and 
understanding, as medications were seen as either a necessity or a choice 
to take. Medications were perceived on a continuum from being life saving, 
through to having no impact on the illness and its symptoms, thus affecting 
the impact medications had on their daily life.  The severity of illness also 
impacted on whether routines and resources were developed and 
maintained. 
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Individuals that had severe chronic illness, or more than one illness, were 
more likely to be dependent on their medications to keep them alive.  This 
dependence, affected their approach to medications, because the use of 
these substances meant the difference between life and death.  If 
medications were not taken routinely, their health would deteriorate 
rapidly.  The importance of taking medications on a regular basis was an 
important priority for the individuals who had severe chronic illnesses.  
Medication and health care needs were prioritised in terms of creating care 
spaces within the home, and developing and maintaining routines. 
Conversely, less dependent medication users, understood medications as 
less of a prominent feature in their everyday lives.  When medications 
were not taken, or applied as directed, and/or no immediate or short-term 
effects were experienced, users perceived medications as being both 
ineffective and prescribed use as more of an ideal, rather than a strict 
requirement.  This practice of medication use lead to a cyclical process 
where medications were not used as prescribed, therefore were not able 
to potentially function as designed, which fed into the perception that 
medications were not effective.  In the context of everyday life for the less 
dependent users, medications took a backseat to priorities in their life; they 
were used and understood as additional annoyances that were 
begrudgingly taken. 
Those with chronic illnesses can experience different stages of symptoms 
in their health depending on the risk, severity and impacts of their 
condition at any one time (Edward et al., 2001).  Medication use can either 
change depending on the proximity of risk to health and past experiences 
also play a factor in how medications are used and understood.  For 
example, prior to Tui experiencing two heart attacks medications were not 
perceived as a necessity, however, the impact of almost dying, changed 
Tui‟s perception, where medications became a priority in his life with the 
help and support of his whānau.  The broader implications of this finding 
acknowledge that whānau play a vital role in the prevention, 
implementation and maintenance of health care including the 
management of medications.  Furthermore, this highlights the importance 
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of relationships and that when professionals prescribe medications or 
advise individuals they need to be aware that these enter into social 
negotiations within households. 
General implications 
Medications have multiple existences.  Once in the hands of sick people 
they represent relief from suffering, maintenance of health, but they also 
constitute identities, moralities, routines, relationships, care, healing and 
home-making (Doran, Robertson, & Henry, 2005; Pound et al., 2005; 
Shoemaker & de Oliveira, 2008).  In this study, I set out to explore the 
meanings of medications in Māori households with chronic illnesses.  I 
found members of households supporting each other to take medications, 
care spaces and routines were created to support the chronically ill and 
lives were structured around customary relationships, and obligations of 
respect and care.  Medications become cultural objects that were used 
within filial relationships used to nurture and care for others.  Relationships 
within the households were paramount to the social practices with 
medications in the home and the success of the management of 
medications.  This finding fits within the premise that health is relational as 
well as physical, psychological and environmental (World Health 
Organisation, 1986).  According to Mason Durie (2004), health is relational 
in that it requires a balanced and supported life that embraces physical 
wellbeing, social support, whānau, cultural participation and spirituality. 
What is clear from the findings is that to understand what medications 
mean to Māori households we need to engage more directly with the 
specific practices, beliefs, environments and relationships, which embody 
the social lives of medications.  Understanding, what role whānau play in 
the management of chronic illness can inform how the households can be 
supported and resourced.  This research has highlighted that the patient 
and their whānau play a central role in their health care.  Supporting self-
management in the home is an important aspect to chronic care, as it will 
enable people to become partners in the process of health management 
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and allow the whānau to be included in the health care process of their 
loved ones. 
Māori with chronic illnesses and their whānau have a vital role in 
managing the illness.  When involved in care planning, whānau may 
support behaviour and lifestyle changes.  For people and whānau to 
manage more effectively and safely at home, they need to develop 
knowledge and understanding of their condition.  Just as the Pūriri and 
Kōwhai households have obtained and integrated knowledge on the 
medications used in the household, whānau need support to understand 
what they can do to keep themselves well, manage symptoms, slow their 
condition‟s progression, and when to seek help.  This approach involves 
re-orientating the health system to provide better and earlier support for 
people to live well with chronic illnesses and long-term conditions as 
medications are prescribed into the lives of whānau, not just on the life of a 
sick person. 
This thesis exemplifies that cultural values requires much greater 
consideration in the formulation of policies and social services that 
address Māori approaches to medications.  Such work is crucial at a time 
when the health disparities are only increasing among Māori in New 
Zealand and with increasing pressure on social welfare and health care 
budgets.  Situating culture in larger society and attention on interpreting 
social issues through the cultural lenses of those concerned will expand 
responsiveness of policymaking and elder care. 
Future research directions 
This is the first ethnographically oriented study of medication use in Māori 
households with chronic illnesses. Offered is a perspective that extends 
beyond individual experiences with specific illnesses to the ways in which 
these medical technologies are integrated into relationships and take on 
meaning.  This made it difficult to compare the present study against an 
established body of knowledge. Research on medication use and meaning 
is dominated by quantitative research methods that have a tendency to 
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collect a much narrower with limited engagement with the realities of 
everyday life.   
Findings from this study indicate that the management of chronic illnesses 
and medications are significantly influenced by the relationships within the 
home; householders relied on each other for care, access to medications, 
management of routines and assistance.  Therefore, the identification of 
potential support avenues, to enhance care relationships within 
households with chronic illnesses, need to be explored.  Support initiatives 
are essential part of maximising the emotional, psychological, and 
technical resources needed for complex care giving and to ensure that 
family members do not deplete their own physical and emotional reserves 
(Ministry of Health, 2010). 
Briefly, evidence-based interventions are urgently needed where it will 
supplement the care receiving experience for patients and their whānau, 
considering the importance of Māori cultural context.  It is hoped that this 
study will serve as a platform for understanding that healthcare in Māori 
households is relational and the need to support those who care for others 
is vital to managing chronic illness. 
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Appendix A: Medications in Everyday Life Information 
Sheet 
 
 
 
Medications in everyday life 
Information Sheet 
What is this research about? 
Medications are widely available and commonly used by many people in New 
Zealand today. However, we know very little about how medications are 
understood by people, and how they are used in people‟s homes. This research 
aims to investigate popular understandings of medications and their uses. It is 
concerned with medications of all sorts – prescription medicines, over-the-
counter medicines, alternative medicines and dietary supplements. It is important 
to note that we are not interested in any form of illegal drugs. The research is 
being undertaken by a team from Massey, Waikato, Otago and Victoria 
universities and is currently funded by grants from the Health Research Council 
and the Royal Society of New Zealand. 
What is involved? 
We are seeking to work with households of least three people, including an adult 
(16 or older) who has been diagnosed with a chronic illness and has been taking 
medication for at least 6 months. We have a number of tasks, outlined below, that 
we would like to complete in each household, although it may not be possible to 
do every one of these in any particular household. Which of these we complete in 
each household can be decided by the household members involved.  
The specific components of the research are: 
Initial household discussion 
First, we will hold a household discussion with all members of your household 
who are interested to participate. This will take place in your home, and involve a 
general discussion about medications, their meanings and what you do with 
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them. We will also ask you about all the medications in your home, and to draw a 
rough plan of your house and locate on it the places where you keep 
medications. We would also like to photograph these settings and link them to the 
plan, but we will only do this with your permission. We would also like to see the 
range of medications, and related things like pill organisers and inhalers, that you 
have in the house, but only those things you are willing to show us. The 
discussion will be digitally recorded and transcribed so that the research team 
can complete their analyses. This meeting should last around two to two-and-a-
half hours altogether.  
Then we have three different projects that we would like different people within 
the household to complete. Anyone who is 16 years of age or more could do 
these, and it is not essential that we do all of them – it depends on how many 
people are present and who is interested to do each.  
a) Carrying out a photo project 
One person from the household will be asked to take photos of anything about 
medications – photos that show us “the world of medications”. We will provide 
detailed information on what is involved in this process. Photographs can be 
taken on your own digital camera or we can give you a disposable camera. 
These photographs will be printed and discussed in a recorded interview with the 
person who took them. The person will have two weeks to take the photographs, 
and the interview to discuss the photos will take about one hour. 
b) Keeping a medication use diary 
One other person in the household, preferably the person with the chronic illness, 
will be asked to keep a medication diary. This involves keeping a daily record of 
any medications taken each day for a week, and writing brief notes about that at 
the end of each day. We will provide detailed information on what is involved to 
this person. The person will then discuss the diary content with us in an interview 
after the week is over. This should take no more than three hours altogether, 
including the interview of about one hour, which will be recorded for analysis.  
c) Keeping a general medication diary 
Another person in the household will be asked to keep a diary for one week, 
noting any time that medications of any sort come to attention in any way (while 
watching television, reading magazines, shopping, and so on – wherever 
medications come to attention). At the end of each day, this person will select 
one issue and write a little about it. Again, we will provide detailed information on 
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what is involved to this person. After the week is over, we will have a meeting 
with that person to discuss the diary entries. This should take no more than 3 
hours altogether, including the one hour interview which will be recorded for 
analysis.  
Finally, after these tasks are completed, we will have a closing household 
discussion with everyone involved to review the project and to gather reactions 
and comments from household members. This discussion will take less than 2 
hours, and will also be recorded for analysis. Your household will be given a $100 
voucher after the closing discussion as compensation for all the time this will 
involve. 
How can you participate? 
You are invited to take part in this study if your household includes at least three 
people, one of whom who has been diagnosed with a chronic illness, has been 
taking medication for at least 6 months and is 16 or over. If this is the case, 
please discuss the project with members of your household and then contact 
Teah Carlson from University of Waikato to discuss your participation. Her 
contact information is given below. She will answer any questions you have and 
make a time to come and meet with the members of your household who are 
interested to participate.  
What are your rights if you decide to participate? 
If your household is willing to take part in this research, you should know that all 
the information you provide during the study will be kept completely confidential. 
All the data will be stored in a secure place, and no one other than the 
researchers will have access to it without your consent. Your names will not be 
used to identify the materials, or used in any reports that come out of the 
research. Any personal or identifying features that are mentioned will be altered 
to make sure that everyone remains anonymous. The materials collected in the 
study will be used in the analysis for the research, and brief extracts from the 
interviews or diaries may be used in publications and presentations arising from 
the research. However, we will take care to ensure that these will not identify you 
in any way. We may also use the house plan and photographs in publications 
and presentations from the research, but these would have all identifying features 
masked. 
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You should also know that you have the following rights: 
 Members of your household do not have to take part in this study at all, 
or in any specific component of it; anyone is free to decline. 
 Members of your household can ask questions about the research 
before agreeing to take part, and anyone who agrees to take part can 
ask questions about the research in general, or any specific component 
of it, at any time during the study. 
 Anyone taking part in the research can decline to talk about any issues, 
during any of our discussions. 
 Anyone taking part in the research can ask for the recorder to be turned 
off at any time during discussions. 
 Your household can withdraw completely from the study up to two 
weeks after our closing discussion. If you do, all recordings, transcripts, 
your house plan, and any photographs taken will be destroyed. 
 You can request a summary of the findings to be sent to your household 
when the study is concluded. 
 
How can you contact us?  
 
Supervisor:  
Dr. Linda Waimarie Nikora 
Researcher:  
Teah Carlson 
Māori & Psychology Research 
Unit, 
Department of Psychology 
Faculty of Arts and Social 
Sciences 
University of Waikato 
Ph: 07 856 2889 ext 8200  
Email: Psyc2046@waikato.ac.nz 
Māori & Psychology Research 
Unit,  
Department of Psychology 
Faculty of Arts and Social 
Sciences 
University of Waikato 
Ph: 021 0769720  
Email: teah.carlson@gmail.com 
 
 
If I have any concerns about this project, I may contact the convenor of the 
Research and Ethics Committee (Dr Robert Isler, phone: 838 4466 ext. 8401, 
email r.isler@waikato.ac.nz) 
 
124 
 
Appendix B: Medications in Everyday Life Consent Form 
 
 
 
Research reference: 
    
 
Medications in everyday life 
Consent Form 
 
We have read the Information Sheet and have had the details of the study explained to me.  Our 
questions have been answered to our satisfaction, and we understand that we may ask further 
questions at any time. 
 
We agree to participate in this study under the conditions set out in the Information Sheet.  
_______________________________________________________________________________________ 
We also consent for data from this project, with all identifying features removed, to 
be archived for further research projects and teaching purposes  
 
Yes  No  
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Date:           _____________ 
 
Signature:   
______________________________ 
Full name (printed): 
________________________ 
Signature:   
_____________________________ 
Full name (printed): 
________________________ 
 
Signature:   
______________________________ 
Full name (printed): 
________________________ 
 
Signature:   
_____________________________ 
Full name (printed): 
________________________ 
 
Signature:   
______________________________ 
Full name (printed): 
________________________ 
 
Signature:   
_____________________________ 
Full name (printed): 
________________________ 
 
 
Would you like to receive a summary of the results?           Yes               No               
Name:                  
______________________________________________________________________ 
Email address:     
______________________________________________________________________ 
Or  
Postal Address:  
______________________________________________________________________ 
______________________________________________________________________ 
If I have any concerns about this project, I may contact the convenor of the 
Research and Ethics Committee (Dr Robert Isler, phone: 838 4466 ext. 8401, 
email r.isler@waikato.ac.nz) 
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Appendix C: Interview Schedule for the household 
discussion 
Topics for household discussions 
The following list of topics to be covered by the researcher during the initial 
household discussion: 
 The meanings of medications (primary focus) 
 Personal medication use, including the use of alternative medications and 
supplements, and storage (who in the household takes medications, what 
medications are taken, where and how are they taken,  what are they 
used for, where are they stored in the home) 
 The flow of medications through the household and beyond (how the 
medications arrived, if and how medications move beyond the house, how 
are medications disposed of) 
 What material objects in the home are related to medication use (e.g., first 
aid kits, glucose meters, asthma inhalers, storage containers) 
 Uses beyond the prescribed 
 Medications beyond prescription (supplements, pharmacy only, OTC, 
alternative – include inhalers, topical creams) 
 Issues of prevention/promotion/maintenance/cure (relation between) 
 Morality – good/bad – Why? How? 
 Risk – safety, compliance, responsibility 
 Personal approach to medications (resisting/passive or active 
acceptance, etc) 
 Relationships involving medications (sharing, caring, taking, nagging) 
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Appendix D: Medication Use Diary Information Sheet 
 
 
 
Medications in everyday life 
Medication Use Diary Information Sheet 
 
What is this part of the research about? 
You have already agreed to be the person in your household who will take part 
in the medication use diary project for the research. In this part of the research 
we would like you to keep a diary recording all the medications you take or give 
to others in the household each day for a week. This includes medications of 
any type – prescription medicines, over-the-counter medicines, alternative 
medicines, dietary supplements, health care remedies. Also, at the end of each 
day, we would like you to think about one episode of medication use from that 
day and write brief notes or comments on that episode. We will give you a diary 
to record the daily medications use and you can use this to write your brief daily 
comment if you wish. Alternatively you could keep your comments on an audio 
recording or typed onto your computer, as you chose. This diary will then be the 
focus for a personal interview at the end of the week, where the meanings of 
your diary entries will be discussed. The interview will be conducted by Teah 
Carlson, will take about one hour, and will be recorded and transcribed for 
analysis.  
What are your rights if you decide to participate? 
The information you provide in the diary and the interview will be kept 
completely confidential, and any personal or identifying features will be altered 
to ensure anonymity. All the data will be stored in a secure place, and no one 
other than the researchers will have access to it without your consent. Your 
name will not be used to identify the materials or in any reports that come out of 
the research. The materials collected in the study will be used in the analysis for 
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the research, and brief extracts from the diary and interview may be used in 
publications and presentations arising from the research.  
You should also know that you have the following rights: 
 You are under no obligation to take part in this project. 
 You can ask questions about the research before agreeing to take part, and 
about the project at any time during the study. 
 You can decline to talk about any issues during our discussion. 
 You can ask for the recorder to be turned off at any time during the discussion. 
 You may withdraw from the project up to two weeks after our discussion. If you 
do, the recording of our discussion and your diary will be destroyed. 
 
How can you contact us?  
Supervisor:  
Dr. Linda Waimarie Nikora 
Researcher:  
Teah Carlson 
Māori & Psychology Research 
Unit, 
Department of Psychology 
Faculty of Arts and Social 
Sciences 
University of Waikato 
Ph: 07 856 2889 ext 8200  
Email: 
Psyc2046@waikato.ac.nz 
Māori & Psychology Research 
Unit,  
Department of Psychology 
Faculty of Arts and Social 
Sciences 
University of Waikato 
Ph: 021 0769720  
Email: 
teah.carlson@gmail.com 
 
If I have any concerns about this project, I may contact the convenor of the 
Research and Ethics Committee (Dr Robert Isler, phone: 838 4466 ext. 8401, 
email r.isler@waikato.ac.nz) 
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Appendix E: General Medications Diary Information Sheet 
 
 
 
Medications in everyday life 
General Medications Diary Information Sheet 
 
What is this part of the research about? 
You have already agreed to be the person in your household who will take part 
in keeping a general medications diary for the research. In this part of the 
research we would like you to keep a diary recording any time that medications 
of any sort come to attention in any way (while watching television, reading 
magazines, shopping, and so on – wherever medications come to attention). 
This can include medications of all types – prescription medicines, over-the-
counter medicines, alternative medicines, dietary supplements, health care 
remedies. Also, at the end of each day, we would like you to think about one 
episode when medications came to your attention that day and write brief notes 
or comments on that episode. We will give you a diary to record these daily 
medications episodes and you can use this to write your brief daily comment if 
you wish. Alternatively you could keep your comments on an audio recording or 
typed onto your computer, as you chose. This diary will then be the focus for a 
personal interview at the end of the week, where the meanings of your diary 
entries will be discussed. The interview will be conducted by Teah Carlson, will 
take about one hour, and will be recorded and transcribed for analysis.  
What are your rights if you decide to participate? 
The information you provide in the diary and the interview will be kept 
completely confidential, and any personal or identifying features will be altered 
to ensure anonymity. All the data will be stored in a secure place, and no one 
other than the researchers will have access to it without your consent. Your 
name will not be used to identify the materials or in any reports that come out of 
the research. The materials collected in the study will be used in the analysis for 
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the research, and brief extracts from the diary and interview may be used in 
publications and presentations arising from the research.  
You should also know that you have the following rights: 
 You are under no obligation to take part in this project. 
 You can ask questions about the research before agreeing to take part, and 
about the project at any time during the study. 
 You can decline to talk about any issues during our discussion. 
 You can ask for the recorder to be turned off at any time during the 
discussion. 
 You may withdraw from the project up to two weeks after our discussion. If 
you do, the recording of our discussion and your diary will be destroyed. 
 
How can you contact us? 
 
Supervisor:  
Dr. Linda Waimarie Nikora 
Researcher:  
Teah Carlson 
Māori & Psychology Research 
Unit, 
Department of Psychology 
Faculty of Arts and Social 
Sciences 
University of Waikato 
Ph: 07 856 2889 ext 8200  
Email: 
Psyc2046@waikato.ac.nz 
Māori & Psychology Research 
Unit,  
Department of Psychology 
Faculty of Arts and Social 
Sciences 
University of Waikato 
Ph: 021 0769720  
Email: 
teah.carlson@gmail.com 
 
If I have any concerns about this project, I may contact the convenor of the 
Research and Ethics Committee (Dr Robert Isler, phone: 838 4466 ext. 8401, 
email r.isler@waikato.ac.nz) 
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Appendix F: Photo Elicitation Information Sheet 
 
 
 
Medications in everyday life 
Photo Information Sheet 
What is this part of the research about? 
You have already agreed to be the person in your household who will take part 
in the photo project for the research. In this part of the research we would like 
you to take photos of anything about medications – photos that show us how 
you see “the world of medications”. These photographs may be about any 
aspect of medications that you want to show – we do not have any specific 
expectations about the nature or type of photographs you might take, only that 
they will involve medications in some way. 
The photographs can be taken on your own digital camera or we can give you a 
disposable camera. You should take the photographs over the next two weeks. 
Please note that you may take photos of people in public places, but you must 
obtain their consent to take photographs of them when they are not in public 
places. Once you have taken around 15-25 photographs, please get in touch 
with me, Teah Carlson, and let me know you have completed the project. I will 
then make a time that is convenient to discuss your photos with me. This 
discussion will cover the meanings of the photos and what you consider they 
show about medications. It will take us about one hour and will be recorded and 
transcribed for analysis.  
What are your rights if you decide to participate? 
If the photographs you take involve identifiable people we will mask their 
features to ensure that they cannot be identified. The information you provide 
during the interview will be kept completely confidential, and any personal or 
identifying features will be altered to ensure anonymity. All the data will be 
stored in a secure place, and no one other than the researchers will have 
access to it without your consent. Your name will not be used to identify the 
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materials or in any reports that come out of the research. The materials 
collected in the study will be used in the analysis for the research, and brief 
extracts from the interview and some photographs (with identifying features 
masked) may be used in publications and presentations arising from the 
research.  
You should also know that you have the following rights: 
 You are under no obligation to take part in this project. 
 You can ask questions about the research before agreeing to take part, and 
about the project at any time during the study. 
 You can decline to talk about any issues during our discussion. 
 You can ask for the recorder to be turned off at any time during the discussion. 
 You may withdraw from the project up to two weeks after our discussion. If you 
do, the recording of our discussion and your photographs will be destroyed. 
 
How can you contact us?  
 
Supervisor:  
Dr. Linda Waimarie Nikora 
Researcher:  
Teah Carlson 
Māori & Psychology Research 
Unit, 
Department of Psychology 
Faculty of Arts and Social 
Sciences 
University of Waikato 
Ph: 07 856 2889 ext 8200  
Email: 
Psyc2046@waikato.ac.nz 
Māori & Psychology Research 
Unit,  
Department of Psychology 
Faculty of Arts and Social 
Sciences 
University of Waikato 
Ph: 021 0769720  
Email: 
teah.carlson@gmail.com 
 
If I have any concerns about this project, I may contact the convenor of the 
Research and Ethics Committee (Dr Robert Isler, phone: 838 4466 ext. 8401, 
email r.isler@waikato.ac.nz) 
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Appendix G: Medication Use Diary Consent Form 
 
 
 
Research reference: 
    
 
Medications in everyday life 
Medication Use Diary 
 
I have read the Information Sheet and have had the details of the study 
explained to me.  My questions have been answered to my satisfaction, and I 
understand that I may ask further questions at any time. 
I agree to participate in this study under the conditions set out in the 
Information Sheet 
 
Signature: ________________________     Date: ______________________ 
Full Name – printed 
______________________________________________________________ 
 
If I have any concerns about this project, I may contact the convenor of the 
Research and Ethics Committee (Dr Robert Isler, phone: 838 4466 ext. 8401, 
email r.isler@waikato.ac.nz) 
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Appendix H: General Medications Diary Consent Form 
 
 
 
Research reference: 
    
 
Medications in everyday life 
General Medications Diary 
 
I have read the Information Sheet and have had the details of the study 
explained to me.  My questions have been answered to my satisfaction, and I 
understand that I may ask further questions at any time. 
I agree to participate in this study under the conditions set out in the 
Information Sheet 
 
Signature: ________________________     Date: ______________________ 
Full Name – printed  
______________________________________________________________ 
 
If I have any concerns about this project, I may contact the convenor of the 
Research and Ethics Committee (Dr Robert Isler, phone: 838 4466 ext. 8401, 
email r.isler@waikato.ac.nz) 
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Appendix I: Photo Elicitation Consent Form 
 
 
 
Research reference: 
    
 
Medications in everyday life 
Photographs 
 
I have read the Information Sheet and have had the details of the study 
explained to me.  My questions have been answered to my satisfaction, and I 
understand that I may ask further questions at any time. 
I agree to participate in this study under the conditions set out in the 
Information Sheet 
 
Signature: _______________________     Date: _______________________ 
Full Name – printed  
______________________________________________________________ 
 
If I have any concerns about this project, I may contact the convenor of the 
Research and Ethics Committee (Dr Robert Isler, phone: 838 4466 ext. 8401, 
email r.isler@waikato.ac.nz) 
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Appendix J: Photograph table 
Table 1. 
Photograph table 
Photograph 
Reference 
People Place Object 
Household 1, 
Photo 1 
- Kitchen bench 
Jug, plates, plant, 
medication bottles 
Household 1, 
Photo 2 
- Kitchen pantry 
Cans of food, plastic 
containers, panadol 
packet 
Household 1, 
Photo 3 
Megan Living room bookshelf 
Books, soft toys, 
medicated creams 
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